Primary Focal Segmental Glomerulosclerosis FSGS (WP2572);PTPRO,LAMA5,AGRN,SYNPO,PTK2,VCL,CD151,IRF6,TLR4,DNM1,VTN,PLAUR,JAG1,FYN,NCK1,TGFB1,CTSL,KIRREL3,KIRREL2,YWHAQ,AKT1,ITGAV,CAMK2B,DKK1,ITGB3,CD2AP,KRT8,NPHS2,LAMB2,NPHS1,PLCG1,CDKN1B,CR1,PAX2,PODXL,LMX1B,MYO1E,SCARB2,MT-TL1,MYO1E,FAT1,LMX1B,ITGB4,MT-TL1,COL4A5,CDKN1C,MME,VIM,CDKN1A,CD151,PODXL,NPHS1,PLCE1,CD2AP,ACTN4,MYH9,SMARCAL1,WT1,INF2,TRPC6,ACTN4,CD2AP,PLCE1,NPHS2,NPHS1,MYH9,SMARCAL1,WT1,INF2,TRPC6,LAMB2,ITGB4,CD151,SCARB2,WT1,PCNA,MKI67,CDH2,CLDN1,WT1,SYNPO,COL4A3,COL4A4,ACTN4,LIMS1,NPHS1,NPHS2,CD80,NOTCH1,SYNPO,CTNNB1,NOTCH1,LRP6,LRP5,TRPC6,TLN1,ILK,ITGB1,ITGA3,DAG1,PARVA,ILK,UTRN,WNT1
Gastric acid production (WP2596);Secretin,VIP,CCK,GRP,MUC6
Common Pathways Underlying Drug Addiction (WP2636);DRD4,DRD1,DRD2,GNAS,CALM1,CAMK2A,PPP1R1A,PRKACG,MAP2K1,MAPK3,CREB1,CAMK4,ADCY1,GJB1,MAP2K2,ACTB,ADCY1,GRIA1,GRIN1,GRM1,PRKCA,GNAI1,MAPK1,ACTG1,ACTG2,ADCY8,GRIA2,GRIA3,GRIA4,GRIN2A,GRM5,CAMK2A,GRIN1,GRIN2A,PRKCB,PRKCG,PRKACA,PRKACB,PPP1CA,PPP1CB,PPP1CC,PRKACG,PRKACA,PRKACB,RAF1,ARAF,ARAF,RAP1B,RAP1A
Aripiprazole Metabolic Pathway (WP2640);CYP2D6,CYP3A43
Heroin metabolism (WP2645);CES1,CES2,CES2
exRNA mechanism of action and biogenesis (WP2805);DICER1,XPO5,Drosha,ERI1,DGCR8,AGO2,DICER1
Human Complement System (WP2806);HSV-gC,FnBPA,FCGR3A,IBSP,C4a,SELE,C4BPA,ITGA2,CR2,DCN,FPR1,ClfB,KLKB1,Efb,OmpK36,ARRB2,C1QBP,Protein-A,CD55,FGB,Gpm1p,FnBPB,C5AR1,SSL7,C3AR1,LAMA5,LfhA,CSNK1A1,Ehp,CFHR2,gp350,C3a-desArg,C5,C3d,CPN1,TLR2,SELP,C7,FGA,PTX3,CbpA,PROS1,SFTPA2,C9,C1S,C6,PRNP,ClfA,CD40,SPP1,Sfb,CALR,C3a,SERPING1,CD59,MBL2,StcE,C5a-desArg,ICAM2,VCP,GNA15,C3c,WAS,ALB,THBS1,SIC,FCER2,C4b,SELPLG,FGG,SSL10,CFHR4,GNAI2,MAp44,PRKCA,C5AR2,CFP,HIV-gp41,CD93,ITGB3,CD19,TXN,SSL5,OMCI,FCN2,ITGA2B,ELANE,C4-A,A2M,Skp,F13A1,PLAUR,PRKACA,GNA1870,C3f,ICAM1,MASP1,C2,VTN,CFH,PLG,Sbi,FGA,APCS,ADM,C8A,CLEC4M,CHIPS,SSL11,F10,RPS19,C3,MAp19,C5,GNAI3,APOA1,FKBP2,CR1,C3(H2O),FCN1,FGB,SELL,CFI,LAMB1,FKBP2,SFTPA1,LAMC1,LRP2,C4a-desArg,CD46,CRP,VSIG4,FN,CFD,ADIPOQ,KLKB1,MASP1,PTX3,CRP,DCN,ITGA2,CALR,VCP,LAMA5,LAMB1,LAMC1,C3,LRP2,CPN1,CPN1,KLKB1,CFD,LAMA5,LAMB1,LAMC1,VCP,HSV-gC,CFP,SERPING1,CD46,CR1,CD55,Efb,Ehp,Sbi,FN,C3,Sbi,CFH,Sbi,CFH,Sbi,CFH,CbpA,PTX3,CFH,CRP,PRNP,SSL5,KLKB1,C3d,CFH,CFH,CFI,CFI,CFI,CD46,CFI,CFI,CFI,VCP,C5,LfhA,CFHR2,LAMA5,LAMB1,LAMC1,CFI,CR1,VSIG4,CR1,HSV-gC,APCS,FGB,FGA,FN,TXN,Efb,ClfA,APOA1,C5,SSL7,CFHR2,C5a,C5b,C5AR2,CPN1,CPN1,SSL5,C9
Mammary gland development pathway (WP2814);PGR,EGF,ESR1,STAT5A,ERBB2,FOSL1,AREG,FN1,VIM,NRIP1,MYC,TIMP1,CCND1
Felbamate Metabolism (WP2816);CYP3A4,CYP2E1,CYP3A4,CYP2E1
Bladder Cancer (WP2828);DAPK1,CCND1,E2F1,VEGFA,FGFR3,EGF,C-MYC,CDH1,DAPK2,THBS1,EGFR,CDKN1A,MSK1,CDKN2A,CDKN2A,IL8,ERBB2,p85-Beta,MMP1,BRAF,MDM2,DAPK3,HRAS,TP53,TYMP,RB1,HRAS,p85-ALPHA,RASSF1,CDK4,NRAS,KRAS,RAF1,ARAF,DAPK1,DAPK2,DAPK3,RASSF1,MMP2,MMP9,HBEGF,UPK3A,SRC,MMP2,MMP9,MAP2K1,MAP2K2,MAPK1
Differentiation Pathway (WP2848);NT5E,FGF2,CXCR1,SHH,BMP4,TGFB1,NOG,BMP4,KIT,EGF,VEGFA,FGF4,IGF1,HGF,NOTCH1,EGF,BMP4,NOG,WNT3A,HGF,FGF4,EGF,NODAL,FGF10,FGF10,BMP4,VEGFA,KITLG,TPO,FLT3LG,KITLG,CSF1,IL6,IL3,VEGFA,BMP4,KITLG,TPO,IL3,EPO,INHBA,FGF2,BMP4,FLT3LG,TPO,FGF2,VEGFA,FGF2,TGFB1,PDGFB,IL3,IL6,VEGFA,KITLG,IL11,DKK1,VEGFA,WNT1,DKK1,WNT1,VEGFA,TGFB3,NTF4,FGF2,BMP4,FST,NTF4,BMP4,FGF2,GDF5,INS,INS,TF,VEGFA,TPO,EPO,IL6,IL3,IL11,CSF1R,TNFSF11,BMP4,WNT2B,WNT5A,WNT7B,WNT2,FGF2,IL6,IL6R,BMP4,FGF2,INHBA,SHH,IGF1,FGF8,WNT1,ALK,LEFTY1,SHH,BMP4,CNTF,FGF2,NODAL,DKK1,PDGFA,EGF,FGF1,FGF2,NOG,SHH,SHH,INHBA,INHBA,BMP4,IGF1,TPO,EPO,FLT3LG,FGF2
Hematopoietic Stem Cell Differentiation (WP2849);NFATC2,LMO2,FOS,CSF1,SPI1,IKZF1,CSF3,CBFA2T3,MYB,NCKAP1L,KLF1,VAV1,TRIM29,STAT5A,KCNH2,LYL1,IL5,GATA1,KITLG,TPO,IL3,EPO,IL6,IL1A,CSF2,IL1B,KITLG,IL3,CSF2,CSF2,CXCR4,MXI1,RIOK3,ACVR1B,MIR15A,MIR16-1,TPO,TPO,GATA1,GATA1,GATA1,ABO,ITGA2B,GP9,GYPA,SPI1,RUNX1,NOTCH1,MIR223,FLI1,ITGA2B,GATA2,NFE2,CD61,IL3,IL6,KITLG,CSF2,CSF3,IL3,IL6,KITLG,CSF2,CSF2,IL3,IL3,IL6,KITLG,CSF2
Endoderm Differentiation (WP2853);STAT1,NANOG,PTHLH,EPB41L5,LAMC1,PRDM14,SMAD3,RTF1,TGFB1,NODAL,BPTF,SOX17,GATA4,HNF1B,PAX9,LEO1,OTX2,DAB2,SFRP1,GDF3,NOTCH1,HOXA1,EXT1,PAF1,PABPC1,EOMES,POU5F1,ONECUT1,FOXA1,NKX2-1,CTNNB1,TCF7,MIXL1,CTR9,DUSP5,SMAD4,WNT8A,ELAVL1,CER1,FOXA2,DKK1,APP,TNRC6C,BMPR1A,TBX21,SMAD2,CAND1,BMP7,SOX2,NOG,DUSP4,CDC73,LEF1,HOXC11,HHEX,GATA6,JARID2,LHX1,MIR373,MIR373,MIR375,MIR141,NR3C1,DUSP2,EZH2,FOXH1,SIAH2,RAB38,APC,SOX7,MAP2K3,WNT3
Dopaminergic Neurogenesis (WP2855);GBX2,OTX2,TGFB1,LMX1B,EN1,EN2,SHH,FGF8,WNT1,ALDH1A1,GLI1,GLI2,LMX1A,OTX2,WNT1,MSX1,FOXA2,SOX2,STAT3,EN1,EN2,LMX1B,PITX3,NR4A2,FOXA2,NEUROG2,NKX2-2,ASCL1,NEUROD1,NKX6-1,TH,DDC,SLC6A3,SLC18A2,PITX3,CDKN1C,RET
Mesodermal Commitment Pathway (WP2857);PIAS1,NLK,BCORL1,DIP2A,AHDC1,CRTC1,ELK4,PBX3,ZFHX4,PLCH1,WDFY2,WDCP,RARG,PARP8,WDFY2,GRHL2,HES7,SESN1,RGS10,KLF5,ZIC2,CSRP2,CUL4B,DLL1,DDAH1,SESN1,TRIM28,ATP8B2,CCND1,PAX6,ASCC3,ZNF462,NABP2,MEIS1,MIR302C,CEP250,EMSY,PBX1,ARID5B,TBX6,CCDC6,ELP4,ASCC3,SCHIP1,HNF4A,ADAM19,PLCH1,C9orf72,PARP8,GATA6,TRIM5,SMAD6,FOXC1,CEP250,PHF6,ZNF462,LATS1,CCDC88A,HPRT1,ARL4A,MBTD1,PBX1,FOXA1,TCF4,FOXA2,TOX3,POU5F1,CSRP2,MIXL1,SLC2A12,ARL4A,PITX2,ACACA,EMSY,EMSY,TOX,TRERF1,CCND1,C6orf201,SOX2,MSGN1,FOXA2,ATP8B2,HPRT1,RARB,LEFTY1,BHLHE40,TRERF1,VAV3,TCF4,GATA3,SOX17,LEFTY2,NANOG,FZD4,FZD5,FZD8,FGF8,AXIN2,NFE2L2,SOX2,UBR5,SOX21,C1QBP,ZIC3,TRIM71,DNMT3B,WDHD1,JARID2,CTBP2,MTF2,ZIC5,AEBP2,NCAPG2,ZNF281,GRHL2,TET1
Ectoderm Differentiation (WP2858);TSKU,SMAD4,PGM1,PLCXD3,CELSR2,PPFIBP2,FZD4,FZD8,ROR2,MIR34C,ASTN1,LDB2,CCL2,TNFRSF11B,BCAS3,GAS2L1,PIM1,ZBTB2,CLVS1,BAZ1A,HIST1H2BH,ZNF219,GRAMD1B,ANKS1B,FOXL1,GATA6,UBTF,GREB1,DMD,C1GALT1,KCNK10,NLK,MECP2,MYC,ZFHX4,ZBTB2,MIR361,RRBP1,WDR44,KIFC3,PTPRB,NARS2,ARHGDIG,POU2F2,PODXL,CLDN11,ELOVL2,SKIL,SORCS1,PRKAG2,PHF8,SPRY2,TRIM33,RHPN1,FZD5,PLXNA2,STC1,JAKMIP1,MYC,MZF1,LY6E,ST8SIA4,SERPINB6,ARHGDIG,AES,NFATC1,ZBTB2,GLB1,PI4KA,EDA,ARX,RGMA,TRPM2,MIR15B,MYORG,STX16,CROCCP2,ELOVL4,TOX3,CAP2,SOCS2,ABCC4,TCF7L1,HESX1,SIX6,MAFB,TFAP2C,SOX2,TFAP2A,ZBTB2,FHL2,SKIL,BCOR
IL1 and megakaryocytes in obesity (WP2865);IL1R1,PAR1,ICAM1,IL1B,TIMP2,SELENBP1,MMP9,PLA2G7,IRAK1,TLR1,IL18,MYD88,TIMP1,CCR3,PIK3CA,NLRP3,FCER1A,MYD88,Thrombin,IFNG,S100A9,HBEGF,CCL2,TLR2,MMP9,IL1R1,NFKB1,IL1B,IL1R1
Extracellular vesicle-mediated signaling in recipient cells (WP2870);SMAD4,SMAD2,SMAD3,WNT3A,WNT5A,ERBB2,EGFR,MFGE8,TSPAN8,DKK4,TGFA,TGFB1,CD133,AKT1,MTOR,HGF,HGFR,PI3K,HRAS,KRAS,RAF1,TGFBR1,TGFBR3,TGFB1,TGFB2,TGFB3,APC,AXIN1,CTNNB1,AKT1
Liver X Receptor Pathway (WP2874);NR1H3,NR1H3,NR1H3,RXRA,RXRA,ABCG8,CYP3A4,ABCG5,CYP2B6,CYP7A1,SREBF1,FASN,SCD
Pregnane X Receptor pathway (WP2876);SRC,NCOA2,NCOA3,PSMC5,NRIP1,SRPX2,NR1I2,RXRA,HSP90AA1,PPARGC1A,NR1I2,HSP90AA1,RXRA,NR1I2,DNAJC7,DNAJC7,CYP3A7,UGT1A6,UGT1A3,UGT1A9,CYP2A6,UGT1A4,SLCO1B1,SRPX2,NCOA3,FOXO1,CYP4F12,CYP3A4,UGT1A1,ABCC4,NRIP1,CYP2B6,GSTA2,PSMC5,PPARGC1A,NCOA1,NCOA2,ABCB1,CYP2C9,CYP3A5,CYP2C19,SULT2A1,ABCC2,ABCC3
Vitamin D Receptor Pathway (WP2877);BCL6,STS,LRRC25,TREM1,LPGAT1,ITGAM,VDR,RXRA,VDR,RXRA,VDR,IRF4,HLA-DRB1,CLEC16A,HSD17B2,CDKAL1,Col13A1,TNFAIP3,FGF23,CYP24A1,CST6,DEFB4,CD40,PRKCQ,IRF5,Il1rL1,HLA-DQA1,CLPTM1L,Camp,TNFSF4,STAM,HIF1A,CTLA4,CLMN,MXD1,PTH,TRPV5,TRPV6,CYP27B1,PTGER4,TNFSF11,PRDM1,RASGRP1,SLC34A2,CYP7A1,CYP2B6,CYP2C9,THBD,Klotho gene,CASP5,TRAK1,LRP5,DUSP10,SEMA3B,KLK6,SULT2A1,SerpinB1,NRIP1,CYP3A4,SPP1,CEACEM1,PTHrP,S100A2,BGLAP,ASAP2,ID4,SOSTDC1,BTLA,CD14,KLF4,ALOX5,IL12A,CD97,SLC37A2,SATB1,CBS,LLRC8A,MYO9B,BDKRB1,NINJ1,NRIP1,CD200,CD9,TPM1,ALP1,SLC2A4,CYP1A1,S100G,ATP2C2,SLC8A1,CALB1,TGFB1,STEAP4,ADAMTS5,TNFRSF11B,HILPDA,ALPPL2,CLDN2,ATP2B1,SULT1C2,S100A9,MED9,LCE-1F,ABC D1,CDX-2,DACT2,KNG1,IRF8,MX2,NOX1,TGFB2,ORM2,EPHB4,ABC B1,JUNB,CYP2S1,G6PD,S100A8,TIMP3,CEPBA,CDC34,GLT8D4,CYP3A5,CASP14,ORM1,LCE-1D,ABC A11,EFNA5,TIMP2,KRTAP4,KRT13,KRT71,KRTAP10-4,S100A4,SPRR1B,S100A6,KRTAP10-2,KRTAP5-4,LCE-2B,KRT34,KRTAP5-1,KRT16,KRTAP10-7,KRT38,KRTAP8-1,SALL4,EFCAB4A,HNF1A,EFCAB4B,CYP2D6,ID1,KRTAP10-9,DEFB109,KRTAP12-2,DEFB132,CREG2,COLEC11,ZNF257,CST1,CA9,PNOC,DNER,DND1,CDKN1A,LGALS9,CDKN1B,IL25,SFRP1,ADRA1B,BMP6,IGSF9B,ADRB2,MEG8,NFATC2,CCND1,CDKN2D,GADD45A,CCNE1,CDKN2A,CDK2,CDKN2B,CDKN2C,CCNC,MYC,FOXO1,IGFBP1,IGFBP3,PPARD,IGFBP5,G0S2
Farnesoid X Receptor  Pathway (WP2879);NR1H4,NR1H4,RXRA,NR1H4,RXRA,NR1H4,RXRA,UGT2B4,SULT2A1,SLC27A5,SLC10A1,CYP7A1,NR0B2,FGF19,IRS2,ABCB11,BAAT,CYP3A4,FKBP5,IP6K3,ABCB4,NR0B2,PPARGC1A,SLCO2B1,CYP8B1
Nuclear Receptors Meta-Pathway (WP2882);SLC7A11,CYP2A6,HSP90AA1,IL17B,SLC26A2,NR3C1,KEAP1,CCL2,SPRY1,PPARD,CYP2B6,SMARCA1,CAVIN2,CYP3A4,NCOA1,EPHA2,NR0B2,TGFB2,KTN1,NR0B2,HBEGF,CES1,SRGN,PTGR1,PPARGC1A,PDK4,UGT1A3,ZIC2,TSC22D3,ABCB11,NCOA2,SMC1A,RGS2,CBR1,CYP1A1,TGFB1,BHLHE40,ARL5B,IL12A,SLC2A11,GSTA2,SLC2A1,EPHA3,CYP2C9,ADGRF4,BAAT,GPX3,UGT1A1,TNFAIP3,ALDH3A1,SRC,UGT1A9,B3GNT5,FGD4,ABCC3,MAFG,GPR153,TGFA,SLC2A6,DNAJB1,SP1,CYP3A5,CYP7A1,CYP4A11,CES3,SULT2A1,CAP2,GSTA1,UGT1A3,PTGS2,THBD,CYP8B1,IL12B,IFNG,PPARA,UGT2B7,UGT1A9,SULT2A1,CES5A,PPARA,CCL20,NAV3,EDN2,ANGPTL4,ACOX1,PDGFB,ABCB1,SLCO2B1,TXN,SP1,GSTA3,IP6K3,SEC14L1,SLC7A5,UGT1A3,NFE2L2,HSPA1A,CYP2A6,ABCG5,IRS2,SOD3,POU5F1,NR0B2,ABCB4,SLC2A10,IL11,DNAJC7,CYP1B1,NFKB2,MGST3,TXNRD3,GSR,NR1H4,SLC19A2,IL1B,FKBP5,NCOA6,CYP1A2,MGST2,MGAM,MAFF,GSTT2,FTL,LRRC8A,TGFB1,SRXN1,EPB41L4B,CDC42EP3,BIRC3,SERTAD2,HGF,CYP7A1,GSTA4,SLC10A1,GPX2,MT1IP,ABCC2,GPAM,UGT1A4,SULT1A1,DNAJC15,JUN,SLC2A9,EGR1,S100P,ETNK2,GADD45B,ABCC3,SNAI2,CPEB4,SERPINA1,TXNRD1,PCK1,FTH1,STAT3,NQO1,JUNB,G6PD,ACKR3,AMIGO2,ADH7,MFGE8,SLC27A5,CYP2C19,TGFBR2,PRDX6,PRDX1,STOM,SCNN1A,MYOF,JUN,GGT1,HSP90AB1,NR1I3,ENC1,PPP1R14C,CES2,ALOX5AP,SQSTM1,GCLC,GCC1,UGT1A7,CES4A,FGF13,PDE4B,CYP3A4,CYP4A11,ABCC5,SLC2A7,NR1H3,SLC2A13,PGD,CYP7A1,SLC2A4,FASN,GCLM,AGER,ACAA1,CDKN1C,RXRA,BLVRB,UGT2B4,UGT1A9,FGFBP1,SREBF1,UGT1A6,SERPINB2,SLC2A2,UGT1A4,BIRC2,CYP3A4,PMP2,GSTA5,AKAP13,TNS4,NRG1,KAT2B,GSTT1,ME1,ABCC4,HMOX1,POLK,ALAS1,SLC2A8,CBR3,GSTA2,SULT2A1,ESR1,SLC2A12,CYP2B6,GSTP1,CES3,UGT1A4,PTPA,EP300,TGFBR3,CYP3A7,ANKRD1,ABHD2,SPINK13,SERPINB9,HSP90AA1,UGT1A6,PPARGC1A,EHHADH,CYP2A6,SLC2A14,CUL1,ABCC2,DNER,PLK2,ABCG8,PRRG4,UGT1A7,MGST1,SLC2A5,SLC2A3,FGF19,UGT1A1,NR1I3,DNAJC7,HSP90AA1,RXRA,NR1I3,NCOA1,EP300,UGT1A6,AHRR,SRC,CDKN1B,AIP,CYP1B1,UGT1A1,ALDH3A1,GSTA2,AHR,JUND,NQO1,IGFBP1,NFE2L2,BAX,JUN,CYP1A2,EGFR,HSP90AA1,TNF,PTGES3,IL2,HES1,ARNT,CDC37,CYP1A1,AHR,ARNT,AIP,SRC,SRC,CDC37,AHR,ARNT,AHR,UGT1A9,NR1H3,SCP2,CPT1A,APOC3,FABP1,CCND1,PLTP,DBI,APOA2,CPT2,APOA1,CYP4A11,ACADM,CDK4,CYP7A1,MYC,SLC27A1,KLK15,APOA5,CDK1,CYP8B1,PPARA,PPARA,RXRA,SLCO1B1,HSP90AA1,NR1I2,SRPX2,NCOA3,FOXO1,CYP4F12,CYP3A4,UGT1A1,DNAJC7,ABCC4,NRIP1,CYP2B6,GSTA2,PSMC5,PPARGC1A,NCOA1,NCOA2,ABCB1,NR1I2,RXRA,NR1I2,NR1I3,NR1I2,NR3C1,RXRA,NR1I3,NR1I2,NR3C1,HSP90AA1,PTGES3,HSP90AA1,PTGES3,NR3C1,HSP90AA1,PTGES3,NR3C1,NR3C1,NR3C1,NR3C1,NR3C1,NR3C1,NR1H3,RXRA,PTGES3,RXRA,NR1H3,CYP2B6,CYP2C9,VDR,RXRA,CYP3A4,VDR,RXRA,VDR,ESR1,ESR1,ESR1,ESR1,ESR1,ESR1,ESR1,NR1H3,RXRA,NR1H4,RXRA,NR1H4,RXRA,NR1H4,UGT1A4,UGT1A6,UGT1A9,UGT1A3,CYP2C9,CYP3A5,CYP2C19,SULT2A1,ABCC2,ABCC3,EHHADH,FOXO1,RXRA,GSTM5,GSTM1,GSTM2,GSTM3,GSTM4,SLC5A2,SLC5A1,SLC5A4,SLC5A10,SLC5A9,SLC5A6,SLC5A11,SLC5A12,SLC5A3,SLC5A7,SLC5A8,SLC5A5,SLC6A2,SLC6A1,SLC6A4,SLC6A11,SLC6A9,SLC6A6,SLC6A13,SLC6A14,SLC6A3,SLC6A7,SLC6A8,SLC6A5,SLC6A16,SLC6A15,SLC6A18,SLC6A20,SLC6A17,SLC6A19,SLC39A2,SLC39A1,SLC39A4,SLC39A10,SLC39A9,SLC39A6,SLC39A11,SLC39A12,SLC39A3,SLC39A7,SLC39A8,SLC39A5,SLC39A13,SLC39A14,NFE2L2,KEAP1,NFE2L2,NFE2L2,NFE2L2,SCD
NRF2 pathway (WP2884);SLC2A1,CES3,ME1,PRDX1,GSTA1,SLC2A11,GPX2,HGF,UGT1A4,FGF13,BLVRB,GCLC,MGST3,SLC7A11,NFE2L2,GSTA3,SLC2A13,ABCC2,TXN,ABCC4,SOD3,SLC2A9,GPX3,ADH7,EPHA3,GSR,HSP90AB1,GSTT1,SLC2A7,SLC2A14,SRXN1,UGT1A7,PGD,CBR1,ALDH3A1,CYP2A6,PPARD,CBR3,TGFB1,G6PD,UGT1A6,TXNRD1,TGFB2,ABCC3,UGT1A9,GSTP1,CES5A,PTGR1,GSTA5,UGT1A1,PRDX6,HSP90AA1,GGT1,GSTA4,NQO1,DNAJB1,CES1,CES4A,TGFA,GSTT2,UGT2B7,SLC2A10,SLC2A12,GSTA2,GCLM,ABCC5,MAFF,NRG1,SLC2A5,MGST2,SERPINA1,SQSTM1,EGR1,CES2,SLC2A4,SLC2A2,UGT1A3,SLC2A6,SLC2A8,FTL,EPHA2,HMOX1,MAFG,HBEGF,HSPA1A,KEAP1,FTH1,TGFBR2,SLC2A3,PDGFB,AGER,TXNRD3,CYP4A11,RXRA,GSTM5,GSTM1,GSTM2,GSTM3,GSTM4,SLC5A2,SLC5A1,SLC5A4,SLC5A10,SLC5A9,SLC5A6,SLC5A11,SLC5A12,SLC5A3,SLC5A7,SLC5A8,SLC5A5,SLC6A2,SLC6A1,SLC6A4,SLC6A11,SLC6A9,SLC6A6,SLC6A13,SLC6A14,SLC6A3,SLC6A7,SLC6A8,SLC6A5,SLC6A16,SLC6A15,SLC6A18,SLC6A20,SLC6A17,SLC6A19,SLC39A2,SLC39A1,SLC39A4,SLC39A10,SLC39A9,SLC39A6,SLC39A11,SLC39A12,SLC39A3,SLC39A7,SLC39A8,SLC39A5,SLC39A13,SLC39A14,NFE2L2,KEAP1,NFE2L2,NFE2L2
Differentiation of white and brown adipocyte (WP2895);LEP,ADIPOQ,SLC7A10,HOXC8,HOXC9,PRDM16,CIDEA,EBF3,HSPB7,ZIC1,MPZL2,BMP2,BMP4,SMAD1,SMAD5,SMAD9,CEBPB,CEBPG,PRDM16,ZNF423,PPARG,CEBPA,BMP7,SMAD9,PLAC8,PRDM16,PPARGC1A,PPARGC1B,SMAD5,SMAD1,CEBPB
Interactome of polycomb repressive complex 2 (PRC2) (WP2916);MTF2,ELL,JARID2,TRIM35,STK38,THRAP3,BCLAF1,STK38,SETX,MORC3,RBBP7,AEBP2,EZH2,EED,SUZ12,EZH1,RBBP4
Hypoxia-mediated EMT and Stemness (WP2943);DICER1,ZEB1
Copper homeostasis (WP3286);MTF2,STEAP2,APP,STEAP1,SP1,STEAP4,ADAM9,ADAM10,ADAM17,STEAP3,FOXO1,CCS,SLC31A1,COMMD1,SLC31A2,MT1A,MT1B,MT1E,MT1F,MT1G,MT1H,MT1JP,MT1L,MT1X,MT2A,MT3,MT4,PRNP,ATP7B,XAF1,ATOX1,MDM2,TP53,MAPT,PIK3CA,MTF1,CPHL1P,ATP7A,CASP3,CCND1,JUN,AKT1,SOD3,BACE1,COX11,COX17,XIAP,FOXO3,APC,SOD1,PTEN,GSK3B,SLC11A2,SCO1,SCO2,APP,COX17,ATP7B,ATP7A,STEAP3,STEAP4,SLC31A1,ATOX1
EV release from cardiac cells and their functional effects (WP3297);ERBB4,MIR143,KLF2,CXCL12,PRL,RGS16,MYB
Melatonin metabolism and effects (WP3298);MAP2,MTNR1B,SULT1A1,EDN1,CALM1,CYP1B1,ACHE,CAMK2A,ARNTL,CYP2D6,TRAF6,IRAK1,PER2,MTNR1A,CLOCK,PRKCA,AANAT,GSK3B,SIRT1,ADRB1,NFKB1,FOXO1,CYP1A1,PER3,ECE1,PER1,CYP1A2,ASMT,CYP2C19,CRY2,CRY1
Dual hijack model of Vif in HIV infection (WP3300);CUL5,RUNX1,ELOC,APOBEC3G,CBFB,UBB,ELOB,RBX1,CBFB,CBFB,CBFB
eIF5A regulation in response to inhibition of the nuclear export system (WP3302);EIF5A,XPO4,IGF2BP1,EIF5A,EIF5A,XPO4,EIF5A,IGF2BP1,XPO1,EIF5A,IGF2BP1,XPO1
Evolocumab Mechanism (WP3408);PCSK9,LDLR,PCSK9,LDLR,PCSK9,LDLR,LDLR,LDLR
MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma (WP3593);HES1,VEGFA,HIF1AN,HEY1,HIF1A,VEGFB,VEGFC,HIF1A
Circadian rhythm related genes (WP3594);MAGEL2,FBXL21,GNAQ
miR-517 relationship with ARCN1 and USP1 (WP3596);USP1,ARCN1,CDKN1A,ID1,ID2
Composition of Lipid Particles (WP3601);CETP,LCAT,LPL,LDLR
Photodynamic therapy-induced AP-1 survival signaling. (WP3611);TRAF6,PDGFRA,MAPK11,JUNB,IL6,HSP90AA1,IL2,TRAF5,IFNG,TNFSF10,TNF,CCND1,TRAF2,MAPK13,FOS,MMP2,MAPK12,MAP2K7,MAPK14,MAP2K3,MAP3K5,MAP2K4,MAP2K6,TNFRSF1A,TNF,FOS,TNF,CCNA2,CCNE1,EGFR,HBEGF,FGF7,FASLG,FAS,RB1,TP53,CDKN1A,BCL2,BCL2L1,BCL2L11,BCL3,CDKN2A,BID,CFLAR,NFE2L2,BAK1,BCL2L11,BCL2L1,TP53,BAX,MCL1,BCL2,BMF,ELK1,JUN,ATF2,MAPK8
Photodynamic therapy-induced unfolded protein response (WP3613);UBE2E1,DNAJB9,XBP1,PDIA6,EDEM1,XBP1,NFE2L2,ATF4,EIF2A,ATF6,HSPA5,ATF6,ERN1,EIF2AK3,ATF6,HSPA5,XBP1,HSP90B1,ERP27,CALR,DDIT3,HSPA5,DNAJC3,DNAJB9,ASNS,DNAJB11,SULT1E1,NARS,ATF3,DDIT3,BBC3,PPP1R15A,BCL2L11,TRIB3,WARS
Photodynamic therapy-induced NF-kB survival signaling (WP3617);CCND1,VEGFA,IL1A,IL1B,IL2,IL6,IL8,CSF2,TNF,EGLN2,IKBKB,CHUK,NFKB1,RELA,REL,NFKB2,TRAF6,TNF,PTGS2,ICAM1,VCAM1,CXCL2,CD40LG,SELE,TNFRSF1A,NFKB1,RELA,REL,NFKB2,RELB,RELB,PTGS2,CFLAR,BIRC2,BIRC5,BIRC3,BCL2A1,BCL2L2,MMP3,MMP9,VEGFA,MMP2,MMP1,PTGS2
Lung fibrosis (WP3624);ELMOD2,RTEL1,CXCL2,SPP1,DPP9,FGF1,CCL4,SMAD7,TERC,CTGF,SFTPA2,PARN,CCL2,SERPINA1,SKIL,TNF,SFTPA1,IL6,EDN1,ELN,CSF3,GREM1,DSP,TERT,MECP2,CXCL8,STN1,CALCA,TGFA,IL13,IL1B,CCR3,CCL5,PDGFA,CCL11,ATP11A,FGF2,CMA1,IL5,EGF,TIMP1,IL12B,BMP7,PDGFB,PTX3,NFE2L2,MMP9,FGF7,MUC5B,CEBPB,CYSLTR2,HMOX1,MMP2,HGF,SFTPC,CCR2,IL4,CSF2,PLAU,FAM13A,CCL3,MT2A,IGF1,TGFB1
NAD metabolism, sirtuins and aging (WP3630);PARP1,NAMPT,NFKB1,HIF1A,FOXO1,TFAM,SIRT1,ROS1,FOXO3,TFAM,TFAM,PPARG,SIRT3
Imatinib and Chronic Myeloid Leukemia (WP3640);ABL1,BCR,MYC,ABCB1,ABCG2,KIT,PDGFRA,PDGFRB,CDKN1B,SKP2,CSF1R,GADD45A,FOXO3,NOP2,SPRED2,LYL1,PIM1,PIM2,CSF1R,GAB2,FLT1
NAD+ biosynthetic pathways (WP3645);SIRT1,NADSYN1,QPRT,TDO2,IDO1,CD38,BST1,NMNAT1,ACMSD,NAMPT,NAPRT,PARP1,SIRT2,NMNAT1,PARP4,PARP2,TNKS,TNKS2,SIRT3,SIRT4,SIRT5,SIRT6,SIRT7,SIRT7
Hepatitis C and Hepatocellular Carcinoma (WP3646);BIRC3,MAPK14,RRM2,VEGFA,FASLG,COL4A2,RAC1,BCL2L1,CXCR1,BIRC5,MIR34A,VAV2,STAT3,PODXL,PTPN11,UCHL1,MAPK3,CCND1,VEGFA,FRZB,TP53,JAK1,CXCL8,MMP1,MIR744,NFKB1,AKT1,MYOF,IL6R,LEF1,BRCA1,CD44,IL6,SOS1,CASP9,CCND1,TGFB1,CTTN,SMAD3,PTGS2,E2F2,GRB2,HIF1A,MYC,CASP3,CDKN1A,HNF1A,MYC,JUN,CCND1,MYC,MYC,CASP9,CASP7,MIR34A,MIR155,MIR34A,MIR155,MIR34A,MIR155,MIR24-1,MIR24-2,MIR92A2,BIRC3,BCL2L1,NOS2,MIR34A,MAPK8,JUN,CCND1,CXCL8,MMP1,SMAD4,CDKN1A,TGFBR1,MIR24-1,MIR24-2,MIR744,MIR155,FASLG
Pathways Affected in Adenoid Cystic Carcinoma (WP3651);SMARCA2,SMARCE1,ATRX,ARID1A,SRCAP,CREBBP,MORF4L1,KAT6A,BRD1,EP300,KANSL1,SETD2,NSD1,KMT2C,CMTR2,ARID4B,BCOR,BCORL1,KDM6B,KDM6A,ARID5B,JMJD1C,HIST1H1E,HIST1H2AL,PRKDC,ATM,CREBBP,SMC1A,BRCA1,TP53,UHRF1,TLK1,MYBL1,MYB,NFIB,CREBBP,MYCBP,NCOR1,MYCN,CEBPA,MGA,MAX,SMARCA2,IL17RD,FGF16,ERBIN,FGFR4,INSRR,PIK3CA,ERBB2,HRAS,PTEN,MAGI1,MAGI2,RAF1,AKT1,FOXO3,MAP2K2,CNTN6,NOTCH1,CTBP1,FOXP2,DTX4,FBXW7,MYCN,MAML3,NOTCH1
Interleukin-1 Induced Activation of NF-kappa-B (WP3656);AJUBA,PRKCZ,PRKCZ,IL1A,SQSTM1,TRAF6,AJUBA,TIFA,SQSTM1,UBE2V1,TIFA,UBE2N,UBE2V1,PRKCZ,UBE2N,SQSTM1,TRAF6,IRAK1,IRAK1,AJUBA,PRKCZ,TIFA,SQSTM1,UBE2N,UBE2V1,TRAF6,IRAK1
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease (WP3668);MAPK3,SMAD4,MAPK8,MAPK1,TGFBR2,POSTN,SHC1,RUNX2,FBN1,CTGF,NR2C2,LTBP1,MAPK14,ANGPT2,ENG,TGFBR3,TGFBR1,SMAD2,SMAD3,AGTR1,SERPINE1,FBN2,FBN3,LTBP2,FLNA,SMAD2,SMAD3
LncRNA-mediated mechanisms of therapeutic resistance (WP3672);WNT6,HIF1A,ABCB1,BCL2L1,TP53,CDKN1A
BDNF-TrkB Signaling (WP3676);BDNF,PLCG1,PIK3CG,TRPC3,TRPC6,SHC1,GRB2,SOS1,BRAF,MAP2K1,MAPK1,GAB1,GAB2,AKT1,TSC1,TSC2,RHEB,MTOR,RPS6KB1,EIF4EBP1,MKNK1,RPS6KA1,CREB1,DLG4,NRAS,ARC,EEF2K,HOMER1,NTRK2,ADCY1,NTRK2,NTRK2,GRIN1,DLG4,DLG4,KRAS,HRAS,DLG4,BDNF
Cell-type Dependent Selectivity of CCK2R Signaling (WP3679);ITPR1,GNAI1,GNAQ,CCKBR,RYR1,TRPC1,DAGLA,CCK,PLCB1,CNR1,CD38,CCK,CCKBR,RYR2,RYR3,RYR1,RYR2,RYR3
Association Between Physico-Chemical Features and Toxicity Associated Pathways (WP3680);CBL,FZD1,ACTA1,PLCG1,CAMK1,ACTR3,GRB2,STAT5A,SOS1,DVL1,ELK1,MYLKP1,CTNNB1,ROCK2,SHC1,PPP2CA,MYC,JUN,WNT16,NEFH,NEFM,AKT1,AXIN1,RAF1,PAK1,PIK3CG,MAP2K1,SOD1,NEFL,PTK2,GSK3B,FN1,RAF1,DAAM1,MAPK8,NCK1,RHOA,ACTR2,CDKN1A,GPX1,NOS1,MYL1,MAPK1,MAP2K4,TGFA,WNT11,PFN1,CDKN1B,SRC,MYLK,NOS1,SOD1,SOD1,FZD2,FZD3,FZD4,FZD5,FZD6,FZD7,FZD8,FZD9,FZD10,APC,PFN2,PFN3,PFN4,EGFR,ERBB2,ERBB4
Canonical  and Non-canonical Notch signaling (WP3845);JAG1,JAG2,DLL1,DLL3,DLL4,DLK1,DLK2,MFAP1,MFAP2,DNER,CNTN6,ADAM10,NOTCH1,NOTCH2,NOTCH3,NOTCH4,PSEN1,PSEN2,RBPJ,MAML1,MAML2,MAML3,HES1,HEY1,RRAS,CHUK,LEF1
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling (WP3850);IGF1,IGF1R,IRS1,PIK3CG,PDK1,AKT1,MTOR,FBXO32,TRIM63,MAP1LC3A,GSK3B,EIF2B2,RPS6KB1,EIF4E,IGFBP5,ITGB1,ILK,TNFa,TNFRSF1A,PTEN,MSTN,ACVR2B,SMAD2,SMAD3,PRKAB1,PRKAB1,PLD1,PPARGC1A,TNFRSF1A,TNFSF9,NFKB1,NEB,WASL
ERK Pathway in Huntington's Disease (WP3853);BDNF,EGF,RPS6KA5,ELK1,CREB1,CASP3,CASP7,MAPK1,MAP2K7,HRAS,RAF1,GRM1,NTRK2,EGFR
TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition (WP3859);RUNX2,CDH16,TNC,SMAD3,SMAD4,ID1,MAPK1,FN1,SNAI1,CDH6,VIM,SMAD2,SNAI2,AKT1
RIG-I-like Receptor Signaling (WP3865);CYLD,TMEM173,DDX3Y,MAPK8,MAPK14,MAPK13,MAPK12,MAPK11,CXCL8,DDX17,DDX58,ISG15,TRIM25,ATG5,ATG12,NLRX1,MAVS,DHX58,RNF125,IFIH1,TKFC,OTUD5,TRAF3,TRADD,TANK,AZI2,TBKBP1,FADD,RIPK1,SIKE1,IKBKE,TBK1,IKBKG,CASP8,CASP10,DDX3X,PIN1,IRF3,IRF7,IKBKG,CHUK,IKBKB,NFKBIA,NFKBIB,NFKB1,RELA,MAPK10,MAPK9,MAP3K7,MAP3K1,TRAF2,TRAF6,IRF3,IRF7,NFKB1,RELA,IFNG,IFNA1,IFNB1,IFNE,IFNK,CXCL12,CXCL10,ISG15,SNW1
Cannabinoid receptor signaling (WP3869);CYP3A4,CYP2C19,PRKACB,PRKACA,ADCY1,PRKAR1A,PRKAR2B,PRKAR1B,PRKACG,CNR1,CYP2C9,DAGLB,AHR,NAPEPLD,ADCY7,DAGLA,FAAH,ADORA2A,CNR2,CYP1A1,PRKACB,PRKACA,PRKAR1A,PRKAR2B,PRKAR1B,PRKACG,PRKACB,PRKACA,PRKAR1A,PRKAR2B,PRKAR1B,PRKACG
Regulation of Apoptosis by Parathyroid Hormone-related Protein (WP3872);PTHLH,ITGA6,ITGB4,PIK3CG,AKT1,BCL2,GSK3B,MYC,BCL2L1,BCL2L2,BCL2L10,BCL2A1,BAX,BAK1,BOK,BID,BCL2L12,BCL2L13,BCL2L14,BCL2L15,GSK3A
ATR Signaling (WP3875);RAD9B,RAD1,CHEK1,RAD9A,HUS1,RPA1,ATR,ATRIP,RPA1,RPA1,RPA1,RPA1,RPA1,RPA1,RPA1,RPA1,RPA1,ATR,ATRIP,RPA1,RPA1,RPA1,RPA1,RPA1,ATR,ATRIP,TOPBP1,HUS1,RAD9B,RAD9A,RAD1
Simplified Depiction of MYD88 Distinct Input-Output Pathway (WP3877);TLR1,TLR2,TLR4,TLR5,TLR6,TLR7,TLR8,TLR9,TLR10,IL1A,MYD88,TRAF6,TIFA,IRAK1,UBE2N,UBE2V1,NFKB1,MYD88,MYD88,MYD88,MYD88,MYD88,TRAF6,TIFA,UBE2N,UBE2V1,IRAK1
ATM Signaling Network in Development and Disease (WP3878);MRE11,RAD50,NBN,KAT5,ATF2,HMGN1,ATM,ATMIN,PPM1D,PTPA,PPP5C,MAP3K5,LBR,HSPB1,G6PD,STK11,PRKAA1,TSC2,MTOR,TRIM28,IKBKG,NFKB1,DCLRE1C,DCLRE1C,H2AFX,PRKDC,RIF1,TP53BP1,RNF20,RNF40,HMGN1,MDC1,RNF8,RNF168,CDK5R1,RBBP8,CHEK2,RASGRF1,CHEK1,SMC1A,ATR,BUB1,CEP63,AURKB,CDK1,CDK5,ATM,HDAC4,PTPA,MRE11P1,ATM,ATM,ATM,MRE11,RAD50,NBN,ATM,NBN,MRE11,RAD50,ATM,ATM,MRE11P1,MRE11P1
Acetylcholine Synthesis (WP528);PDHA1,PDHA2,PEMT,PCYT1A,CHKA,ACHE,CHAT
Adipogenesis (WP236);IGF1,PTGIS,PPARD,CREB1,MIXL1,GH1,ID3,WNT10B,STAT5A,STAT5B,DLK1,NR3C1,DDIT3,LIF,CEBPB,CYP26A1,CYP26B1,RXRA,RARA,NR1H3,LPL,SREBF1,FAS,RBL1,GATA3,GATA2,PPARG,MEF2A,MEF2B,MEF2C,MEF2D,ASIP,TNF,MIF,TGFB1,SERPINE1,SLC2A4,SCD,TWIST1,LEP,RETN,DF,GTF3A,RB1,RBL2,ADIPOQ,ADFP,AGT,CDKN1A,E2F1,SP1,HMGA1,PLIN,IL6,GADD45A,GADD45B,CEBPD,BMP1,BMP2,BMP3,BMP4,NDN,FOXO1A,KLF5,FOXC2,PPARGC1A,NCOA1,NCOA2,PPARA,STAT3,STAT2,STAT1,STAT6,SOCS1,SOCS3,CNTFR,LIFR,IL6ST,MBNL1,OSM,CTNNB1,UCP1,WNT5B,WNT1,SMAD3,FZD1,DVL1,TCF1,RXRG,FRZB,INS,PBEF1,SPOCK,TRIB3,GATA4,NR2F1,NRIP1,RORA,PRLR,ADPN,CUGBP1,HIF1A,KLF6,KLF7,SFRP4,NCOR1,NCOR2,KLF15,EGR2,EBF,EPAS1,AHR,C10orf70,WWTR1,GDF10,IRS1,IRS4,BSCL2,LMNA,AGPAT2,ZMPSTE24,LPIN1,LPIN2,LIPE,PCK1,PCK2,CEBPA,IRS2,IRS3P,LPIN3,E2F4
Alanine and aspartate metabolism (WP106);GOT2,ASL,ABAT,DARS,ASPA,DARS,AGXT,GPT,GAD2,GAD1,ASS,PC,GOT1
Apoptosis (WP254);MIR29B1,MIR29A,PMAIP1,CASP9,MDM2,BAK1,TRAF3,IRF1,NFKB1,FAS,BIRC2,DIABLO,AKT1,GZMB,TNFRSF21,BAD,NFKBIA,CASP1,RIPK1,IRF2,NFKBIB,LTA,CASP4,IRF6,CASP3,PRF1,TNFRSF1A,IGF1R,RELA,CHUK,BAX,APAF1,TNFRSF1B,CASP10,BIRC3,BID,TNFRSF25,MAPK10,TRAF1,IKBKB,IRF5,DFFA,CYCS,NFKBIB,BBC3,IRF3,CASP2,HRK,TP73,CASP11,CASP7,MYC,TNF,IGF2,CRADD,IKBKG,BOK,TRAF2,CFLAR,BCL2L2,PIK3R1,TRADD,BIRC5,IGF1,TNFRSF10B,JUN,BNIP3L,DFFB,TRADD,BCL2,TNFRSF1A,IRF7,RELA,BCL2L1,IRF4,NFKBIE,TP53,MAP2K4,RIPK1,CDKN2A,CASP8,BIRC4,BAD,NFKBIA,FASLG,TNFSF10,NFKBIE,HELLS,NFKB1,FADD,MCL1,CASP6,BCL2L11,MAP3K1,TP63,MIR29B2
Biogenic Amine Synthesis (WP550);GAD2,DDC,TPH1,HDC,DBH,DDC,TH,PNMT,ACHE,COMT,PAH,CHAT,AANAT,GAD1,MAOA,ASMT,MAOA,DDC
Complement Activation (WP545);C1S,C1QB,C1R,C1QA,C1QG,C8A,MASP2,C2A,C3,C9,C8B,C6,C4B,DAF,C4A,C7,C5,C2,C4B,C3B,C2A,C4B,C5B,C1QB,C1QG,C1QA,C1R,C1S,C8G,MASP1,C3B,CFBb,C3,C3,CFB,CFD,C3B,CFP,C3B,CFBb,CFP,C5
Complement and Coagulation Cascades (WP558);C2,PLAT,ADN,F8,SERPINA5,F9,F2R,CLU,SERPINA1,TFPI,CFH,FGB,KLKB1,MASP2,C5R1,A2M,MCP,F13B,F10,F7,CR2,F3,SERPING1,C1S,C1QG,BDKRB1,C7,F5,VWF,PLAU,SERPINF2,C3AR1,THBD,Hc,CFI,F2,C1R,PROC,Daf1,PROS1,PLAUR,C1QB,SERPINE1,C6,C1QA,C8G,F12,MBL1,C9,SERPINC1,109821,PLG,SERPIND1,C3,H2-BF,MASP1,CPB2,C4,KNG1,CR1
Cytokines and Inflammatory Response (WP530);IL1A,IL1B,TRA,TGFB1,IL10,CD4,IL1A,IL3,IL10,IFN1@,IL4,IL3,IL10,IL13,IL3,CSF1,IL7,IL1A,IFNG,IL2,IFNG,TRB,IFN1@,IL4,CSF3,TNF,TNF,IL15,IL5,CXCL2,IL2,CXCL1,TGFB1,IL6,IL12B,IL15,HLA-DRA,IL2,IL12B,IL11,IL3,IL6,TNF,CSF2,IL6,TNF,IL2,IL1B,IL12,IL15,IL6,PDGFA,IL1B,IL1A,IL10,TGFB1,IL1A,CSF2,IFNB1,IL6,IFNG,TNF,IL13,IL4,IL4,IL1B,IL5,IL4,IL2,TNF,TNF,IL1B,IL2,HLA-DRB1,IL2
DNA Replication (WP466);ORC5L,RFC1,POLD2,RFC4,RPA1,PCNA,ORC6L,MCM5,CDC45L,CDC7,GMNN,UBC,POLD4,MCM6,CDT1,RFC5,RPA4,ASK,RPA2,POLD1,MCM2,CDK2,RPA3,PRIM1,PRIM2,ORC2L,RFC3,MCM10,POLD3,POLA2,ORC4L,MCM7,MCM4,POLE2,UBA52,CDC6,ORC3L,POLE,ORC1L,RFC2,MCM3,POLA
Eicosanoid Synthesis (WP167);ALOX5AP,PTGDS,PTGES2,DPEP1,PTGIS,PLA2G2A,ALOX5,TBXAS1,PTGS1,GGT1,PLA2G6,ALOX15,ALOX15B,PTGES,ALOX5,LTA4H,PTGS2,LTC4S,ALOX15,ALOX5AP,PNPLA8,ALOX12,ALOX5
Electron Transport Chain (OXPHOS system in mitochondria) (WP111);ATP5A1,NDUFB6,ATP5I,SLC25A5,COX15,COX6B1,UCRC,COX6C,ATP5J2,ATP5O,ATP5G2,NDUFC1,ATP5B,NDUFA8,UQCR,NDUFA3,SLC25A14,NDUFV2,NDUFA6,COX2,NDUFB9,NDUFS6,UQCRFS1,NDUFA2,ND4L,ATP8,NDUFS5,COX5A,UQCRC2,COX11,ATP5J,SDHB,COX1,COX7A2L,NDUFS7,COX6A1,SLC25A27,NDUFS4,COX7A1,COX4I1,SLC25A6,ATP5L,NDUFB1,UCP3,UQCRH,NDUFA9,NDUFB3,ATP5G1,NDUFB4,COX7A2,ND6,ATP5S,SDHA,ND2,NDUFAB1,COX7B,QP-C,SLC25A4,UQCRB,ND5,DAP13,SCO1,SDHD,ATPIF1,NDUFB7,NDUFA1,UQCRC1,NDUFB5,COX5B,ATP6,COX3,NDUFS3,COX8A,ND1,NDUFV1,SDHC,ATP5G3,COX6A2,SURF1,NDUFS1,NDUFA7,ND4,ATP5H,NDUFC2,NDUFB2,NDUFS2,COX7C,ATP5D,NDUFB10,COX17,NDUFA4,NDUFA5,ATP5F1,ATP5E,ATP5C1,NDUFV3,NDUFA10,UCP2,ND3,NDUFS8,NDUFB8,CYTB,UCP1
Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation (WP314);SPTAN1,IL1A,FAF1,CASP7,HSPB1,RIPK2,DFFB,PAK1,APAF1,DAXX,MAPKAPK2,CASP8,PARP1,DFFA,ARHGDIB,CYCS,FASLG,CASP8,FADD,HSPB1,CASP10,RB1,ACTA1,MAPK8,JUN,MAPKAPK3,MAP2K4,CASP6,HSPB1,HSPB1,APAF1,PAK2,MAP3K7,LMNB1,LMNB2,CASP9,DAXX,CFLAR,BCL2,MAP3K1,CASP3,CASP3,HSPB1,TNF,PRKDC,FAF1,LMNA,FAP1,HSPB1,DFFB,FAS,HSPB1,HSPB1,ACTB,ACTG1
Fatty Acid Biosynthesis (WP357);ACSS2,FASN,ECHS1,ACSL5,FASN,PECR,ECHDC2,ACACA,ECHDC1,ACSL4,FASN,SCD,ACAS2,FASN,ECHDC3,FASN,ACLY,FASN,ACSL3,HADHSC,FASN,ACACB,ACSL1,PC,ACAA2,FASN,MECR,DECR1,ACSL6,ECH1
Focal Adhesion (WP306);PDGFRA,CAPN2,RAC1,LAMA1,COL1A1,MAPK3,VTN,HGF,SHC3,THBS3,PIK3R1,FGR,BRAF,ITGB6,ITGA10,COL4A4,THBS1,ILK,CCND2,THBS4,LAMA2,TNR,ITGB8,ROCK1,ITGA6,FYN,PPP1R12A,TNK2,VAV1,ELK1,PDGFD,VEGF,MET,KDR,CRK,Catnb,ITGA2,RELN,ITGA5,MAPK8,PAK3,PARVB,ZYX,IBSP,SPP1,COL6A2,PTK2,JUN,PAK6,ITGAV,ITGB1,LAMA5,ITGA4,RAF1,BUB1B-PAK6,ITGA2B,MAP2K1,LAMB1,FIGF,FLT1,PDPK1,ERBB2,EGF,CAV1,MYLK,CAV3,MAPK1,CHAD,BCL2,COMP,TNC,LAMC3,CRKL,SHC1,LAMB2,PIK3R3,CDC42,RAP1B,PTEN,LAMA3,ACTB,GRB2,ITGA9,COL4A2,PAK4,CCND1,TXK,RAC3,TESK2,SRMS,COL1A2,MAPK9,ITGA8,VEGFB,AKT2,COL5A3,PDGFRB,VASP,SOS1,LAMA4,ARHGAP5,COL2A1,LAMB3,RAP1A,TNK1,COL5A2,DOCK1,ITGB7,COL4A6,XIAP,PIK3R2,THBS2,HCK,IGF1,FLNA,GSK3B,BLK,LAMC1,FN1,LAMC2,PGF,ITGA3,PIK3CA,TNN,BIRC3,CCND3,BIRC2,AKT1,TNXB,PAK1,PXN,PIP5K1C,BAD,ITGA1,IGF1R,ACTN4,SRC,ACTG1,HRAS,ITGA7,PDGFA,BCAR1,VCL,CAV2,PIK3CB,ITGB5,AKT3,STYK1,TLN1,ROCK2,RAC2,PIK3CD,PDGFC,VWF,ITGA11,ITGB4,RAPGEF1,ITGB3,EGFR,VEGFC,PAK2,DIAPH1,PTK6,RHOA,RASGRF1,MYLK2,PDGFB,MYL5,COL4A1,SHC2,SHC4,PRKCA,PRKCB,PRKCG,ARHGAP35,PPP1R12B,PPP1R12C,PPP1CA,PPP1CB,PPP1CC,PPP1CC,MYL7,MYL10,MYL12A,MYL12B,MYL2,MYL9,MYLPF,MYLK3,MYLK4,ACTN1,PARVA,PARVG,FLNB,FLNC,TLN2,MAPK10,VAV2,VAV3
GPCRs, Class B Secretin-like (WP334);CALCR,CALCRL,CRHR1,CRHR2,GIPR,GLP2R,GLP1R,GCGR,GHRHR,PTHR2,PTHR1,ADCYAP1R1,SCTR,VIPR1,VIPR2,CD97,EMR1,CD97,EMR2,LPHN1,LPHN2,LPHN3,ELTD1,GPR64
Glucocorticoid and Mineralcorticoid Metabolism (WP237);CYP21A2,CYP17A1,HSD11B1,HSD11B2,CYP11B2,HSD3B1,HSD3B1,HSD3B2,CYP11A1,CYP17A1
Apoptosis Modulation by HSP70 (WP384);MAP3K1,CASP8,CASP3,FADD,BID,CASP2,CASP6,CASP7,FAS,CASP8,PDCD8,CYCS,APAF1,CASP9,CYCS,NFKB1,FADD,TNFRSF1A,RIPK1,MAPK10,HSPA1A,HSPA1A,HSPA1A,FASLG,TNF-alpha
Inflammatory Response Pathway (WP453);IGHA2,IGHA1,CD86,TNFRSF1B,LAMB2,IFNG,IGHM,THBS3,VTN,IL2,IL4R,IL2RB,LCK,LAMB1,IL2RG,IL4,COL3A1,CD40,COL1A1,LAMC2,COL1A2,CD28,CD40LG,TNFRSF1A,FN1,CD80,IL2RA,LAMC1,ZAP70,LAMA5,THBS1,IL5,IL5RA
Insulin Signaling (WP481);STXBP2,PIK3CD,PIK3C3,PSCD3,PTPRF,RAC1,GSK3B,PTP,MINK1,GRB2,SHC3,IRS1,SLC2A1,RPS6KA4,IKBKB,MAP4K4,SOCS3,PRKCH,KIF5B,IRS1/2,EHD2,ARF6,GYG,AKT2,SRF,MAP3K2,RAB4A,PRKCD,AKT1,CAP1,RHEB,PFKM,STXBP1,PIK3R3,MAPK12,PIK3R1,MAP3K5,IRS2,PIK3C2G,PIK3R2,MAPK10,MAP3K3,MAP4K1,MAPK3,RPS6KA3,PTEN,ELK1,SHC1,CRK,TRIB3,STXBP4,RPS6KA6,INSR,XBP1,FOXO1A,EIF4EBP1,TBC1D4,PRKCB1,MAP2K7,RPS6KB2,SOS1,RAC2,FOS,PIK3CG,RRAD,PIK3CA,IRS4,SGKL,APS,MAPK13,GYS1,TSC2,PIK3CB,EHD1,MAP3K1,MAP4K3,ENPP1,MAP2K6,SNX26,SLC2A4,MAP3K8,PFKL,TSC1,MAP3K12,RPS6KA5,STX4A,IGF1R,PRKCZ,SNAP25,MAP2K4,GRB14,PRKCQ,RPS6KA1,MAPK7,RPS6KA2,MAPK14,RPS6KB1,RHOQ,MAP3K11,PRKAA2,SNAP23,PTPN1,MAPK8,INPPL1,CBLB,MAP3K7,STXBP3,INPP4A,SGK,CBL,PIK3R4,MAPK11,MAPK9,PTPN11,GYS2,JUN,SOCS1,MAPK6,EIF4E,SHC2,FLOT2,CBLC,MYO1C,GAB1,RHOJ,GSK3A,PRKCI,PRKAA1,SORBS1,SOS2,MAP3K13,PPP1R3A,RAF1,ARF1,FRAP1,PRKCA,LIPE,MAP2K3,MAPK4,MAP4K2,PDPK1,HRAS,RAPGEF1,FOXO3A,MAP2K5,GRB10,EGR1,MAP3K10,VAMP2,PIK3C2A,MAPK1,FLOT1,PIK3CA,MAP2K1,MAP3K6,SGK2,MAP3K4,MAP3K9,KIF3A,MAP4K5,MAP2K2,MAPK8,MAP3K14
Integrin-mediated Cell Adhesion (WP185);CDC42,SHC1,SHC3,ARAF,BRAF,RAF1,MAPK4,MAPK7,CAPNS1,MYLK2,ARHGEF7,RAC1,RAC2,RAC3,PDPK1,VAV2,VAV3,ROCK2,ROCK1,SORBS1,SOS1,GIT2,PIK3R2,ZYX,CAV1,CAV2,CAV3,FYN,GRB2,SEPP1,HRAS,PTK2,PTK2,RHO,CSK,BCAR1,SRC,AKT1,AKT2,MYPN,CAPN2,CAPN3,CAPN5,CAPN7,CAPN9,CAPN10,CAPN11,CAPN6,PAK2,PAK3,PAK4,PAK6,TLN1,MAP2K3,MAP2K5,MAP2K6,MAPK12,AKT3,DOCK1,CRK,RAPGEF1,RAP1A,RAP1B,MAPK1,MAPK6,MAP2K1,MAP2K2,CAPN1,ITGA2,ITGA3,ITGA4,ITGA5,ITGA6,ITGA8,ITGA9,ITGA10,ITGA11,ITGA2B,ITGAE,ITGAD,ITGAL,ITGAM,ITGAV,ITGAX,ITGB1,ITGB2,ITGB3,ITGB4,ITGB5,ITGB6,ITGB7,ITGB8,SRC,VCL,TNS1,MAPK10,PXN,ILK,PAK1,VASP,ITGA7,ITGA1,MIR34C
TCA Cycle (aka Krebs or citric acid cycle) (WP78);IDH3B,SDHA,SUCLG2,ACO2,SUCLG1,DLST,IDH3G,SDHC,ACO2,IDH2,SDHD,SDHB,CS,IDH3A,DLD,OGDH,FH,MDH2,SUCLG1
Matrix Metalloproteinases (WP129);MMP2,MMP9,MMP7,MMP12,MMP20,MMP10,MMP3,MMP11,MMP19,MMP14,MMP15,MMP16,MMP17,MMP24,TIMP2,TIMP3,TIMP4,BSG,TNF,MMP26,MMP28,MMP23A,MMP25,MMP27,TCF20,MMP21,MMP1,MMP8,MMP13,TIMP1,MMP23B
Notch Signaling (WP268);MAML1,PSEN2,APH1B,RBPJL,DVL3,DTX3,DLL3,JAG2,HDAC1,JAG1,DTX2,NUMB,LFNG,NCOR2,TNF,PTCRA,DVL2,CREBBP,DTX3L,KAT2A,APH1A,NOTCH3,DTX1,ADAM17,NOTCH2,DLL1,RBPJ,DVL1,DLL4,NUMBL,RFNG,NCSTN,NOTCH4,NOTCH1,CIR,CTBP1,INPP5K,MFNG,HES5,HES1,DTX4,PSEN1,MAML3,CTBP2,KAT2B,HDAC2
Nuclear Receptors in Lipid Metabolism and Toxicity (WP299);CYP7A1,CYP7A1,CYP7A1,CYP4A11,PPARG,PPARA,PPARD,ABCD3,ABCD2,ABCA1,ABCA1,ABCA1,ABCB4,ABCB11,ABCB1,ABCC2,ABCC3,ABCG1,ABCG5,NR1H4,NR1H3,CYP8B1,NR1I2,NR1I3,CYP4B1,RARA,RARG,CYP3A4,VDR,CYP3A4,CYP26A1,RARB,CYP2E1,CYP2C9,CYP2C9,CYP2B6,CYP2B6,CYP1A2,CYP24A1,CYP2C9,CYP3A4,CYP27B1,MIR33A,MIR33B,MIR33A,MIR33B,MIR33A,MIR33B
Nucleotide Metabolism (WP404);PRPS1,PRPS2,DHFR,MTHFD2,ADSL,IMPDH1,ADSS,POLA,POLB,POLG,POLD1,NME2,SAT,SRM,OAZ1,HPRT1,RRM1,RRM2,RRM2B,RRM1
Oxidative Stress (WP408);MGST1,SP1,SOD2,NFKB1,MT1X,NFIX,NOX1,MAPK10,NFE2L2,GCLC,HMOX1,MAPK14,TXNRD2,FOS,CAT,CYP1A1,JUNB,GSTT2,SOD3,GPX1,NOX4,XDH,TXNRD1,GPX3,UGT1A6,MAOA,GSR,TXN2,NQO1,SOD1,CYBB,NOX3,NOX5
Cytoplasmic Ribosomal Proteins (WP477);RPL37A,RPL10A,RPL8,RPL3,RPL3L,RPL9,RPL12,RPLP2,RPLP1,RPL13A,RPL23,RPL27A,MRPL19,RPL17,RPL23A,RPL26,RPL35,RPL7,RPL4,RPL6,RPL7A,RPL13,RPL14,RPL15,RPL18A,RPL18,RPL19,RPL21,RPL22,RPL24,RPL27,RPL28,RPL29,RPL31,RPL32,RPL34,RPL35A,RPL36,RPL37,RPL38,RPL39,UBA52,RPL41,RPL36A,RPSA,RPS3,RPS9,RPS5,RPS15A,RPS16,RPS20,RPS14,RPS23,RPS29,RPS13,RPS11,RPS15,RPS3A,RPS4X,RPS4Y1,RPS6,RPS7,RPS8,RPS10,RPS12,RPS17,RPS19,RPS21,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,FAU,RPLP0,RPS6KA2,RPS6KA1,RPS6KA3,RPS6KA6,RPL11,RPL5,RPS6KB1,RPL10,RPL30,RPS2,RPS18,RPS6KB2
Signaling of Hepatocyte Growth Factor Receptor (WP313);FOS,PTPN11,ELK1,MAP4K1,PXN,MAPK1,PIK3CA,PAK1,GRB2,PXN,MAPK8,Met,PTK2B,JUN,SRC,RAP1B,CRKL,GAB1,SRC,HRAS,STAT3,CRK,PTEN,MAP2K2,RAF1,PTK2,RAPGEF1,RASA1,MAPK3,RAP1A,MAP2K1,ITGB1,PTK2,DOCK1,HGF,PTK2B,ITGA1,SOS1
Statin Pathway (WP430);ABCA1,ABCG8,APOA1,APOA4,ABCA1,APOC2,MIR33A,APOC3,APOC1,APOA5,CYP7A1,SCARB1,PLTP,ABCG5,APOA2,LCAT,LDLR,APOB,DGAT1,LPL,MIR33B,SQLE,LIPC,SOAT1,APOE,LRP1,FDFT1,CETP,HMGCR
Synthesis and Degradation of Ketone Bodies (WP311);ACAT1,HMGCS2,HMGCL,OXCT1,BDH
Translation Factors (WP107);EIF2B1,EIF2B2,EIF2B3,EIF2B4,EIF2B5,EIF2AK3,EIF2AK2,EIF3S1,EIF3S2,EIF3S3,EIF3S4,EIF3S5,EIF3S6,EIF3S7,EIF3S8,EIF4A1,EIF4A2,EIF4B,WBSCR1,EIF4E,SUI1,SUI1,PAIP1,EIF4EBP1,EIF4EBP2,EIF4EBP3,EEF1A2,EEF1B2,EEF1D,EEF1G,EEF2,ETF1,GSPT2,PABPC1,EIF4G1,EIF4G3,EIF2S1,EIF2S2,EIF2S3,EIF5B,EIF1AY,EIF1AX,KIAA0664,EIF3S10,EIF3S9,EIF2AK1,EIF5,EIF5A,EEF2K,ITGB4BP,EEF1A1
p38 MAPK Signaling Pathway (WP400);MAPKAPK2,GRB2,TRAF2,MAPKAPK5,HSPB1,SHC1,MAP2K6,MAP3K9,RAC1,TGFBR1,MEF2D,ATF2,STAT1,CREB1,MAP3K5,MKNK1,MAP3K7,RIPK1,RPS6KA5,MAPK14,ELK1,MAX,MAPK14,HRAS,CDC42,HMGN1,PLA2G4A,MAP2K4,DDIT3,RASGRF1,MAPKAPK2,TGFB2,DAXX,MAP3K1,MYC,TRADD
Selenium Metabolism and Selenoproteins (WP28);Sp3,JUN,eEFSec,Sars2,Scly,eEFSec,GPX1,GPX2,GPX4,DIO1,SEPP1,TXNRD1,SepW,SPS2,DIO2,DIO3,GPX3,GPX6,SelH,SelI,SelK,SelM,SEPN1,SelO,SepX1,SelS,SelT,TXNRD2,TXNRD3,SelV,Secp43,Sla,TXNRD3,TXNRD2,Selenbp1,Fabp1,TXNRD1,Rpl30,NFKB-p105,FOS,NFKB-p65
One Carbon Metabolism (WP241);MAT1A,BHMT,GRX1,MTHFS,DHFR,MTHFD2,MTHFD1,MTHFD1L,FOLH1,MTFMT,DNMT1,MTHFD1,MTR,MTHFR,MTHFD1L,FTCD,DNMT3b,KIAA0828,ALDH1L1,AMT,MTRR,MAT2B,FTCD,SHMT1,AMT,TYMS,MTHFD1,GART,SHMT2,MTHFD1L,DNMT3a,ATIC,MTHFD2,AHCY,TCN II,GART,DHFR,DHFR
Wnt Signaling Pathway and Pluripotency (WP399);FZD8,APC,CTBP1,MMP7,DVL2,CTNNB1,WNT3A,JUN,FZD10,NFYA,PRKCI,ESRRB,WNT10B,PLAU,WNT2B,CBP,PPP2CA,PPP2CB,TCF7,TCF7L2,PRKCA,LEF1,SOX2,ZBTB33,RACGAP1,MAPK10,FZD2,WNT16,WNT2,WNT9B,WNT5A,PPP2R1A,TCF7L1,PPARD,P300,PRKCQ,FBXW2,NLK,PPM1J,WNT1,PRKCB1,PRKD1,FOXD3,MYC,WNT6,DVL1,PAFAH1B1,MAP2K4,WNT11,TP53,CCND1,WNT3,PPP2R2B,MAPK9,PPP2R3B,POU5F1,WNT7A,CTBP2,PPP2R1B,PPP2R5E,PRKCZ,LRP6,FZD4,DVL3,Prkcc,FOSL1,AXIN2,FZD9,RHOA,FZD6,NKD1,FZD7,NKD2,FRAT1,AXIN1,NANOG,PPP2R5C,GSK3B,WNT4,PPP2R2A,CSNK1E,PPP2R2C,FZD3,CTNND1,WNT10A,LDLR,MAP3K7,WNT11,PRKCE,FZD5,CCND3,PPP2R3A,PRKCH,CD44,WNT7B,WNT5B,FZD1,PRKCD,PPP2R4,LRP5,CCND2,LRRK2-mut,CTNNB1,CTNNB1
Non-homologous end joining (WP438);PRKDC,XRCC5,XRCC6,XRCC6,XRCC5,PRKDC,PRKDC,XRCC4,XLF,XRCC5,XRCC6,RAD50,MRE11,XRCC4,NHEJ1,XRCC5,XRCC6,XRCC5,XRCC6,PRKDC,XRCC5,XRCC6,PRKDC,XRCC5,XRCC6,PRKDC,XRCC5,XRCC6,PRKDC,XRCC5,XRCC6,PRKDC,XRCC5,XRCC6
Osteoblast Signaling (WP322);PDGF Ra,PDGF Rb
Phase I biotransformations, non P450 (WP136);CES5A,ESD,LIPA,PON3,CES2,PON2,CES1,PON1
Cholesterol Biosynthesis Pathway (WP197);NSDHL,FDPS,HMGCS1,SC4MOL,SQLE,IDI1,MVD,CYP51A1,HMGCR,DHCR7,PMVK,SC5DL,FDFT1,LSS,MVK,FDPS
EBV LMP1 signaling (WP262);PDLIM7,TRADD,IRAK1,TRAF1,MAP3K14,IKK-alpha,NFKB2,RELA,NFKB2,RELA,MAP3K7,MAP3K7,MAP3K3,TRAF6,IKBKG,CHUK,IKBKB,HSP90,MAPK1,RELA,NFKB1,MAPK8,NFKBIA,NFKB1,RELA,RELA,NFKBIA,NFKB1,CXCL8,IFNB1,CCL20,TNF,CCL5,NFKB1,RELA
Glutathione metabolism (WP100);GGTLA1,GGT1,GGTLA1,GPX1,GSR,ANPEP,GSTA1,GSTM2,GPX2,GSS,GCLC,GSTA5,IDH1,GGT1,GCLM,GGT1,GPX3,GSTT2,ANPEP,OPLAH,GGTLA1,GSTT1,GPX4,G6PD,GSTM1
Irinotecan Pathway (WP229);UGT1A10,ABCC2,NPC1,CES2,CES1,CYP3A4,BCHE,ABCC1,CES2,CES1,ABCC2,ABCC1,UGT1A9,CYP3A4,CES1,UGT1A1,ABCC2,UGT1A1,ABCC1,CYP3A5,CES2,ABCG2,CYP3A5,CES1,SLCO1B1,CES2,CYP3A4
Striated Muscle Contraction Pathway (WP383);TNNI3,DES,MYBPC1,TCAP,TNNI1,MYOM1,ACTA2,ACTG1,TNNT1,ACTA1,MYL4,TNNI2,MYBPC3,MYH6,TNNC1,TPM2,TNNC2,VIM,TPM3,MYL3,MYL2,NEB,ACTN3,MYH8,ACTC,MYH3,TPM4,TTN,TNNT3,TNNT2,MYL9,MYBPC2,DMD,ACTN4,TMOD1,ACTN2,TPM1,MYL1
Selenium Micronutrient Network (WP15);RELA,NFkB1,NFkB2
Endochondral Ossification (WP474);AKP2,Osteopontin,FGFR3,MMP13,Aggrecan,BMPR1A,IHH,FGFR1,IGF2,BMP6,IGF1,SLC38A2,TGFBI,CAB39,MEF2C,COL2A1,ADAMTS5,RUNX3,PTH,FGF18,CALM1,Adseverin,RUNX2,FGF2,SOX6,PTCH,NPP1,PKA,KIF3A,PTCH1,TNAP,RUNX2,C4ST1,Cathepsin L2,TGFB2,AKT,Growth hormone,GLI3,HMGCS1,VEGFA,MMP9,SERPINH1,BMP7,CDKN1C,Sox9,THRA,RUNX2,STAT1,ADAMTS1,THRA,GH receptor,PLAU,MGP,STAT5,COL10A1,ADAMTS4,TGFB1,IGF1R,TG737,DDR2,Bapx1,Carminerin,FrzB-1,PLAT,HDAC4,PTHrP,PTHR1,SOX5,TIMP3
Folate Metabolism (WP176);NFkB1,FOLR1,RELA,MCP1,MCP1,p53,FOLR4,FOLR3,SLC19A1,NFkB2,FOLR2,SLC46A1
NLR Proteins (WP288);TAK1,ERBB2IP,ERK,JNK,NEMO,IKKalpha,IKKbeta,RelA,p50
EPO Receptor Signaling (WP581);EPOR,JAK2,SRC,EPOR,STAT1,SHC1,GRB2,MEK1,ERK1,ERK2,MEK2,PDK1,PKB,PI3K,EPO,EPO,SOCS1,STAT5B,CISH,STAT5A,STAT3,STAT3,STAT1,CD45,PTP,GRB2,RAF1,SOS1,IRS2,JAK2,IRS1,RASA1,RAF1,SOS1,RAS
Oxidative phosphorylation (WP623);ATP5A1,ATP5B,ATP5D,ATP5E,ATP5G2,ATP5G1,ATP5F1,ATP5G1,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,ATP6,ATP6AP1,ATP6AP2,MT-ATP6,MTCO3P12,NDUFA11,NDUFS7,ND1,ND2,ND3,ND5,ND4L,ND4,NDUFA2,ND6,CI-42KD,NDUFA8,B13,NDUFA4,NDUFA9,B9,FASN2A,B14.5a,CI-SGDH,B14,CI-75Kd,NDUFS2,ASHI,NDUFS3,NDUFS8,NDUFB2,NDUFS6,AQDQ,NDUFB10,KFYI,NDUFS5,CI-51kD,GZMB,B15,B18,B17,B14.5b,CI-SGDH,B22,NDUFV2,NDUFB4,NUOMS,NDUFV3
Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) (WP688);FMO2,FMO3,FMO1,FMO5,FMO4
Sulfation Biotransformation Reaction (WP692);SULT1E1,PAPSS2,SULT1A1,PAPSS1,G6PD,SULT6B1,SULT4A1,SULT1A4,SULT1A2,GSR,SULT2A1,SULT1C3,SLX1A-SULT1A3,SULT1C4,SULT1C2,SULT1C4,SULT1B1,SULT2B1
Benzo(a)pyrene metabolism (WP696);CYP3A4,AKR1C2,AKR1C3,CYP1A1,AKR1A1,EPHX1,AKR1C4,CYP1A1,AKR1C1,CYP1B1,CYP1B1
Estrogen metabolism (WP697);COMT,UGT1A6,CYP1A2,UGT1A1,UGT1A1,SULT1E1,COMT,UGT1A6,SULT1A1,ARSE,UGT1A6,NQO1,CYP3A4,UGT1A1,CYP1A1,SULT1A1,UGT2B7,UGT1A6,COMT,UGT1A9,UGT1A6,UGT1A1,UGT1A6,COMT,UGT1A9,UGT1A6,CYP1A2,GSTA1,UGT2B7,CYP3A4,UGT1A1,UGT1A6,UGT1A6,UGT1A3,GSTM1,ARSC,CYP1A1,NQO1,ARSD,UGT1A1,UGT2B7,SULT1A1,CYP1B1
Aflatoxin B1 metabolism (WP699);AKR7A2,CYP1A2,AKR7A3,GSTT1,GSTM1,CYP2A13,EPHX1,CYP1A2,CYP1A2,CYP2A13,CYP3A4,CYP3A4
Metapathway biotransformation Phase I and II (WP702);GSTA5,CYP4B1,NDST4,GSTA4,AKR7A2,NAA30,NAT1,SULT1C4,UGT1A5,NAT2,UGT1A4,CYP39A1,CYP27A1,CYP2D6,NDST2,CYP2U1,FMO5,NDST3,HS6ST1,GSTT2,UGT1A7,CYP4F3,AKR1C2,CYP4X1,HS3ST1,MGST2,HS3ST3A1,CYP2A7,CYP4F22,GPX1P1,CHST7,TPMT,GLYAT,HNMT,BAAT,FMO3,CYP2B6,CYP2C19,CHST1,GSTA1,CYP24A1,CHST3,UGT1A10,CYP4F12,UGT2B4,SULT1B1,UGT1A9,CYP27C1,CYP2A6,SULT1C4,CYP46A1,CYP2C9,CYP4V2,NAT6,GSTM4,GPX2,CYP11B1,CYP2C18,CYP4F11,GLYATL1,UGT1A1,CYP1A2,AKR1B1,HS3ST2,NAT14,GPX3,CYP1B1,GLYATL2,GSTO1,CYP20A1,CYP2S1,SULT1E1,CYP19A1,CYP21A2,AKR7A3,CYP26C1,SULT2A1,HS6ST2,CYP27B1,CYP26B1,GSTT1,AKR1A1,FMO1,UGT2B7,NAA20,UGT2A2,INMT,NNMT,GSTM2,AKR1C3,CYP2W1,NAT10,CHST11,CHST9,SULT1C3,GAL3ST4,CYP3A7,UGT2B15,UGT2B11,CYP7A1,GSTZ1,CYP4F2,CHST2,CYP2F1,GAL3ST1,HS3ST5,GSTK1,GAL3ST3,HS2ST1,CYP8B1,CYP1A1,GSR,SULT4A1,HS6ST3,CYP11B2,GSTM5,CYP4Z1,AKR1C4,UGT2A1,NDST1,AKR1C1,KCNAB1,GSTCD,CHST13,CYP7B1,CYP11A1,CYP2C8,UGT2A3,CHST10,SULT1C2,EPHX1,NAT9,NAT8L,SULT1A2,NAA50,HS3ST4,UGT1A6,GPX4,CYP2R1,HS3ST3B1,SULT2B1,GSS,GPX5,CYP4F8,EPHX2,CHST5,UGT2B28,CYP3A4,GSTM1,KCNAB3,FMO2,GSTA3,KCNAB2,NAA40,FMO4,CYP26A1,SULT1A1,CYP2E1,CHST14,SULT6B1,HS3ST6,CYP17A1,CHST4,MGST1,UGT2B17,SULT1A4,AKR1B10,NAT8,CYP3A43,SLX1A-SULT1A3,UGT1A6,CYP3A5,GSTA2,GSTP1,COMT,CHST6,UGT1A3,CYP2J2,MGST3,AKR1D1,GSTO2,GSTM3,GAL3ST2,GSTT2B,CHST8,CYP2A13,CYP51A1,CHST12
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways (WP706);C4A,NFKB1,REST,POU3F2,HTR1A,REST,FEV,CHRNA4,YBX1,AR,NKX2-2,TPH1,CHRNB4,ADCYAP1,DEAF1,RYR2,HES5,ASCL1,KCNH2,CDCA7L,PPARGC1A,NFYA,SLC6A4,KCNQ1,IL10,MAOA,CAV3,TPH1,CREB1,FOXM1,GATA3,HTR1A,TPH2,GATA2,PHOX2B,TPH2,CAV3,DDC,C4B,NKX3-1,VIPR2,SP1,MAOA,HES1,VIPR1,RYR2,CC2D1A,ADCYAP1R1,SP1,LMX1B,POU3F2,NR3C1,HSPD1,FEV,DDC,TNF,PPARGC1B,ADCYAP1,REST,CTCF,KCNQ1,EP300,GNB3,KCNH2,SCN5A,RORA,AVP,IL6,IL6R,HTR2A,PHOX2A,RET,ECE1,TLX3,EN1,ESR2,HADHA,ACADM,IL8,JUN,MIR16-1,SSTR1,SSTR2,TACR1,HIF1A,TP73,SP1,PKNOX1,PBX1,MIR130A,NGF,CREBBP,HES1,NEUROD1,NR3C1,MIR210,NFKB1,REST,MAZ,MEF2C,SP3,CREB1,SP1,SP1,EGR1,REST,BHLHE40,TCF3,DLX2,RUNX3,CREB1,HIF1A,THRB,PLP1,ALDOA,CTNNB1,SOX2,NANOG,POU5F1,BDNF,NTRK2,GABRA1,CHRM2,GJA1,SNTA1,KCNJ8,GJA1,PRKAR2B,YWHAE,YWHAZ,PRKAR1B,PRKAR2A,YWHAQ,YWHAG,PRKAR1A,YWHAH,YWHAB,PRKACB,PRKACA,SLC9A3,CASP3,FMO3,G6PC,GCK,GPD1L,GRIN1,HADHB,HTR3A,SCN3B,SCN4B,SST,AQP4,CPT1A,IL1A,IL1B,IL1RN,IL13,TSPYL1,VEGFA,SCN5A,CHAT,PAH,TH,DDC,NOS1AP,MAP2,TAC1,SLC1A3,SLC25A4,SNAP25,SST,TAC1,HTR3A,TH,CHAT,SLC9A3,BDNF,NTRK2,AQP4,GRIN1,SP1,NFKB2,JUN,HDAC9,MYB,CEBPB,SNTA1,GPD1L,SP1,JUN,NR3C1,REST,JUN,CREB1,POU2F2,CREM,REST,NFKB1,CHRNB2,CHRNA7,HDAC1,MBD1,MECP2,NFKB1,CREBBP,GABRA1,CREB1,VAMP2,TPPP,ATP1A3,GAPDH,HSP90B1,TF,SPTBN1,YWHAG,HIF1A
DNA Damage Response (WP707);GADD45A,FAS,PMAIP1,RB1,ATR,CDK2,CDKN1A,FANCD2,CDK4,CASP9,CHEK2,SMC1A,CDC25A,SFN,RAD9A,ATM,GADD45G,RFC,CCND1,RPA2,CDKN1B,TLK2,c-Myc,CYCS,CCNB1,BBC3,GADD45B,SESN1,BID,E2F1,TP53AIP1,RB1,CDK6,E2F1,CHEK1,TLK1,TP53,CCNB3,CCNE2,BAX,CDK1,CDC25C,CCNE1,CASP8,RAD17,CCND2,PRKDC,RRM2B,DDB2,RAD50,GADD45B,ATRIP,CCND3,CDK5,NBN,GADD45A,BRCA1,CASP3,MRE11,HUS1B,GADD45G,H2AFX,CREB,PIDD,TNFRSF10B,APAF1,PML,CCNB2,RAD1,ABL1,RAD51,RAD52,MDM2
DNA Damage Response (only ATM dependent) (WP710);WNT7A,BAK1,PIK3R3,JUN,PLAU,ABL1,IRS1,MYC,RAC1,CCNG2,RAC1,PIK3C2G,ATM,FOXO3,BCL6,CDC42,CDKN1B,NRAS,PIK3C3,WNT11,PIK3R4,c-Myc,PIK3CA,DVL3,BIK,AXIN1,MAPK2,WNT16,PIK3CD,BCL2,CAT,BAX,PEPCK,PIK3C2A,SMAD3,MAPK10,CCND1,SOD2,ERBB2,BCL2L11,TGFB,PIK3CG,WNT16,WNT7B,RAC2,MAPK9,MAP3K4,WNT2,PDK1,WNT5B,MDM2,APC,MAP3K1,PPP2R5C,CCND3,HRAS,FASLG,GRB2,KRAS,PIK3R1,SHC1,WNT5A,WNT10A,PIK3CB,TCF-4,TCF-1,PMAIP1,BAD,TCF-3,CCND2,FRAT1,WNT6,CTNNB1,PIK3R2,LDLR,DVL1,BCL2L11,SOS1,DVL2,LEF1,WNT3,TP73,PPP2R5E,WNT1,SOS2,MAP3K7,FOSL1,WNT2B,MAPK8,HMGB1,WNT4,WNT3A,CDKN1A,GSK3B,SCP2,RHOA,WNT10B,PTEN,PIK3C2B,MAPK9,G6PC,SMAD4,PIK3R5,TGFB1,TP53,MLKL,INSR,RBL2,APC,CTNNB1
Vitamin A and Carotenoid Metabolism (WP716);Bcmo1,Rbp7,Aldh1a1,RARa,Aldh1a2,Abcg8,Rdh12,Rdh5,Dhrs3,Cyp26b1,Npc1l1,Aldh1a3,Aldh1a3,Abcg5,Lpl,Cyp2e1,RPE65,Bcdo2,MAPK,Scarb1,Sult2b1,LRAT,RXRb,Rdh10,Retsat,Rbp1,Rdh12,RXRa,Adh4,Sult1a1,Cyp26a1,Awat,Bcmo1,Cd36,RARg,Aldh1a2,Scarb1,LRAT,Aldh1a1,Rdh5,Rdh8,Adh1,RXRg,Crabp2,Crabp1,Rlbp1,Rbp2,Bcmo1,Rbp4,RARb,Retinol dehydrogenases
Serotonin Receptor 2 and STAT3 Signaling (WP733);HTR2A,GNAQ,JAK2,STAT3
Globo Sphingolipid Metabolism (WP1424);ST6GALNAC3,ST6GALNAC4,FUT1,ST6GALNAC5,FUT2,FUT9,A3GALT2,B3GALT5,ST6GALNAC2,A3GALT2,ST6GAL2,A4GALT,ST8SIA1,ST6GALNAC6,ST3GAL2,ST6GALNAC1,ST3GAL1,GALNT2,ABO,ST6GAL1,A4GALT,ABO,GCNT1
Nucleotide-binding Oligomerization Domain (NOD) pathway (WP1433);NOD1,COPS6,NOD2,RIPK2,CASP9,CASP8,ACAP1,RAC1,SUGT1,NLRP2,NLRP3,NLRC4,NLRP12,NLRP4,HSP90AA1,NLRP1,CARD6,CARD9,NDUFA13,CASP1,MEFV,PYCARD,NAIP,NFKBIA,RELA,NLRP7,NLRP10,CHUK,IKBKB,IKBKG,IL1B,IL18,CASP5,CARD8,DUOX2,AAMP,XIAP,PRDM1,CASP7,AIM2,ERBIN
Influenza A virus infection (WP1438);matrix protein 1,PB1-F2 protein,neuraminidase,haemagglutinin,BCL2,NS1,polymerase 1,PB2,PB2,NS2,nucleocapsid protein,haemagglutinin,PA,matrix protein 2,PA
Serotonin Transporter Activity (WP1455);SCAMP2,Hic-5,SLC6A4,ITGB3,IL1B,PP2A,Syntaxin 1A,MAOA,nNOS,TPH2,IL1R1
Glycine Metabolism (WP1495);SHMT1,SHMT2,MTHFR
Vitamin D Metabolism (WP1531);RXRA,Parathyroid hormone,CYP2R1,DHCR7,CYP27A1,Vitamin D binding protein,RXRB,VDR,CYP24A1,CYP27B1
Vitamin B12 Metabolism (WP1533);IF*,HC,CUBN,TCN2*,Megalin,MCP1,MCP1,TCN2*,RELA,NFkB1,NFkB2
TFs Regulate miRNAs related to cardiac hypertrophy (WP1559);NFkB,NFkB,RAS,AKT1,Calcineurin,AKT1,MIR29A,TGFbeta,MEF-2,AKT2,STAT3
Folate-Alcohol and Cancer Pathway Hypotheses (WP1589);ALDH1A1,MTR,ALDH1A1,C/EBPB,CYP2E1,ADH5,CREB1,CYP2E1,ALDH1L1,MTHFR,ALDH1L1,CBS
Heart Development (WP1591);HEY2,VEGFC,MAPK1,SMAD1,FGF8,FOXH1,GATA4,CTNNB1,NKX2-5,ERBB3,IRX4,PTPN11,TBX5,NOTCH1,NKX2-5,BMPR2,TBX20,BHLHE40,MEF2C,SMYD1,BMP2,MEF2C,NKX2-5,FOXC1,TBX5,BMP10,NKX2-5,MIR145,FOXC2,HEY1,MIR1-1,GATA4,NFATC4,ISL1,MIR143,NFATC1,TBX2,VEGFA,NOTCH1,GATA4,BMPR1A,SHH,VEGFB,FGF10,GATA6,GATA4,SRF,TBX20,SMAD4,HAND2,NFATC2,MEF2C,TBX1,TBX2,FOXA2,BMP4,BMP2,NKX2-5,PITX2,SRF,NFATC3,TBX5,TBX5,HAND1
Nicotine Activity on Dopaminergic Neurons (WP1602);GNG2,KCNK3,SLC18A2,CHRNB2,ADCY2,DRD4,GNAI1,PPP1R1B,PPP1R1B,GNAI1,DRD3,PRKACA,CHRNA4,CDK5,CHRNA4,DRD2,GNB1,CHRNA5,CHRNA6,GNB1,CHRNB2,DDC,KCNK9,DRD3,GNG2,CHRNA3,PPP1CA,TH,DRD2,CHRNB2,CHRNA4,PPP1R1B,DRD4
Codeine and Morphine Metabolism (WP1604);CYP3A4,CYP2D6,UGT2B7,UGT2B7,SLCO1B1,UGT2B7,UGT1A1,ABCC2,ABCB1,UGT1A1,CYP2D7,ABCC3,UGT1A3,UGT1A8,UGT1A9,UGT1A10
Cori Cycle (WP1946);TPI1,SLC2A4,GPI,GPT,Hexokinase,SLC2A1,PGAM1,LDHA,Insulin,SLC2A2,GAPDH,SLC2A4,PFKP,PGK1,Hexokinase,GPT,LDHA,SLC2A1,G6PD,TALDO1,PGK2
Thyroxine (Thyroid Hormone) Production (WP1981);TSH,TRH,TSHR,SLC5A5,Thyruglobulin (Tg),Thyroidperoxidase
Sterol Regulatory Element-Binding Proteins (SREBP) signalling (WP1982);PRKACA,SCAP,CDK8,PRKAA2,CAMP,PRKAG2,AKT1,AMFR,PRKAG3,KPNB1,SREBF2,PIK3CA,INSIG1,LPIN1,NR1H2,NFYA,PRKAB2,RNF139,SREBF1,ATF6,PRKAA1,MBTPS1,FGF21,GSK3A,PRKAB1,RBP4,PRKAG1,MTOR,HMGCR,SIRT1,SCAP,SCAP,INSIG2,INSIG1,INSIG2,SREBF1,SREBF2,SREBF1,SREBF2,SREBF1,SAR1A,SCAP,SREBF2,SREBF1,SAR1B,SAR1A,SAR1B,SEC23A,SEC23B,SEC24A,SEC24B,SEC24C,SEC24D,SEC13,SEC31A,SEC31B,SEC13,SEC23A,SEC23B,SEC24A,SEC24B,SEC24C,SEC24D,SAR1A,SCAP,SREBF2,SREBF1,SAR1B,SEC31A,SEC31B,MBTPS2,SCAP,SREBF2,SREBF1,SREBF1,SREBF2,CREB1,SP1,NFYA,CREB1,SP1,YY1,YY1,PPARGC1B,MED15,MED15,LSS,HMGCS1,MVD,IDI1,FDPS,FDFT1,SQLE,CYP51A1,LPL,LDLR,SCARB1,ACACA,GPAM,FASN,DBI,ACLY,MDH1,PPARG,ACSS1,SCD,SIRT1,INSIG1,INSIG2,SREBF2,SREBF1
Integrated Breast Cancer Pathway (WP1984);NUP85,PLK3,RPP38,CDH1,E2F1,CDC25A,GRN,RASGRP3,CERK,FADD,ERAL1,DHTKD1,HDAC1,MAPKs,TSC1,CASP8,CASP9,IMPA1,RAP1A,GDI,RHO,ITPKC,KRAS,P38,CSNK1D,CASP3,CREB1,IRS1,MYCBP2,BARD1,NCOA3,NCOA3,ESR1,RHO,BRCA2,PPP4R3B,FOXO1,ABL1,HMGCR,CASP3,STK11,TSC2,TFPI,XRCC3,AHR,EP300,ANXA1,SP1,RASGEF1A,BARD1,BAX,PPP4R3A,PHB,JUN,PLK3CA,BMPR1A,VEGFA,P13K,AURKA,GADD45A,MTOR,RAD54L,DAG1,PPP4R3A,CDC42,ERK,CDK7,CYP19A1,RALGAPA1
Genes targeted by miRNAs in adipocytes (WP1992);GJA1,HCN2,HCN4,HDAC4,KCNJ2,KCNQ1,TMSB4X,TMSB4X,GJA1,HAND2,IGF1,HCN2,KCNE1,SRF,PTBP2,HCN4,ERG
SREBF and miR33 in cholesterol and lipid homeostasis (WP2011);SREBF1,SIRT1,HMGCR,MED15,SIRT6,MTOR,NR1H3,PPARA,PPARGC1A,FASN,SCD,SREBF2,HMGCS1,LDLR,ABCA1,PRKAA1
Regulation of Microtubule Cytoskeleton (WP2038);RHO,MAPT,PHLDB2,TPPP,LIMK1,TESK2,MAPKAPK2,DVL1,PRKCA,PARD6A,TAOK1,SPRED1,ROCK1,RAC1,MARK1,CFL2,GSK3B,MARK2,PAR3,MARK2,PTEN,AKT1,EPHB2,CDC42,PIK3CA,GNAQ,WNT3A,PTPRA,STAT3,STMN1,PAK1,PRKACA,AURKB,CAMK4,CDK1,KIF2C,ABL1,TRIO,TIAM1,SRC,CLASP1,CLIP1,MAP1B,DPYSL2,MAPRE1,APC,mDIA*,mDIA*,MAPRE1,CLIP1,CLIP1,CLIP1,CLASP1,MAPRE1,APC,RAC1,RHO,mDIA1*,GNAQ,RHO,RHO,MAP1B,EPHB2
Alzheimers Disease (WP2059);NAE1,APP,MIR101-1,APBB1,GAPDH,ADAM10,BACE1,PSENEN,PSEN1,NCSTN,APH1A,IDE,MME,LPL,APOE,LRP1,FAS,TNFRSF1A,FADD,CASP8,HSD17B10,BID,CYCS,CALM1,CHP,BAD,CALM2,CALM3,CALML3,CALML5,PPP3CA,PPP3CB,PPP3CC,PPP3R1,PPP3R2,CHP2,ADAM17,PSEN2,APAF1,CASP9,CASP3,SNCA,GRIN1,CACNA1C,GRIN2A,GRIN2B,GRIN2C,GRIN2D,CACNA1D,CACNA1F,CACNA1S,GNAQ,PLCB1,PLCB2,PLCB3,PLCB4,TNF,IL1B,MAPK1,MAPK3,CASP12,RYR3,PSENEN,ATP2A2,ATP2A1,ATP2A3,EIF2AK3,ERN1,ATF6,ITPR1,ITPR2,ITPR3,CAPN1,CAPN2,TP53,CDK5R1,NOS1,CDK5,MAPT,GSK3B,CASP3,CASP7,MIR29A,MIR29B1,MIR29C,MIR132,MIR132
Neural Crest Differentiation (WP2064);BMP7,RHOB,MYB,ITGB1,WNT1,TFAP2A,ZIC1,PAX3,PAX7,DLX5,MSX1,MSX2,FOXD3,SNAI1,SNAI2,WNT3A,FZD3,GSK3B,CTNNB1,TCF7L1,TCF4,GBX2,AXIN2,AXIN1,DVL3,DVL2,DVL1,BMP4,SMAD1,ID1,NOTCH1,DLL3,NOTCH4,NOTCH2,DLL4,NOTCH3,DLL1,HEY2,TWIST1,SOX10,FGF2,HES5,HES1,RBPJ,HES5,HES1,FGFR1,FGFR2,FGFR3,ZIC5,MYC,SOX9,SOX10,ISL1,CDH6,CDH2,CDH1,SOX5,ETS1,PAX3,PAX7,NFKB1,CDH7,TFAP2A,SNAI1,SNAI2,FOXD3,ID1,SOX9,NFKB2,NEUROG1,SOX10,PHOX2B,GFAP,OLIG1,OLIG2,GJB1,ASCL1,MITF,PMP22,MPZ,MBP,FOXD3,PAX3,LHX1,LHX2,BMP4,FGF8,FGF19,SOX10,PAX3,PAX7,SOX5,MITF,HDAC1,HDAC2,HDAC3,HDAC4,HDAC5,HDAC6,HDAC7,HDAC8,HDAC9,HDAC10,HDAC11,CTBP2,DCT,SOX5,SOX9,COL2A1,COL11A2,MIA,WNT8A,HOXB1,PRTG,OLIG3,TBX6,HOXA1,LHX5,TLX2,TFAP2B,DMBX1,HAND1
Type III interferon signaling (WP2113);IRF9,IL28A,IL29,IL28B,JAK1,IL10RB,TYK2,IL28RA,STAT1,STAT2,STAT1,STAT1
Arrhythmogenic Right Ventricular Cardiomyopathy (WP2118);LEF1,JUP,ACTB,PKP2,CACNB2,ITGB6,ACTN2,JUP,ITGA9,CACNA1C,TCF7L1,CTNNA3,ITGA6,ITGA3,JUP,ITGB8,DSP,ATP2A2,CACNG6,ITGA2,DSP,ITGA1,DSP,ITGB7,ITGAV,ITGB5,ITGB3,ACTG1,SLC8A1,SGCB,ITGA7,SGCD,CTNNB1,CACNG8,ITGB4,ITGA2B,DSC2,CTNNA3,CACNG4,DSG2,ACTG1,PKP2,PKP2,DSG2,CACNB4,ITGA11,ACTN1,DSG2,CDH2,CACNB1,CACNG7,JUP,ACTN4,ITGA8,DSC2,RYR2,JUP,LMNA,CTNNA1,TCF7L2,DSG2,SGCG,PKP2,CTNNA1,DAG1,ACTB,CACNA2D1,DSC2,CTNNA2,PKP2,CACNA1D,TCF7,ITGA5,CACNG3,CACNG5,DAG1,ITGA4,EMD,CDH2,CTNNA2,CACNG1,CACNA1F,PKP2,JUP,CACNA2D3,CACNA1S,JUP,DSC2,CACNA2D4,ACTN3,ITGB1,CACNG2,DES,LAMA2,ITGA10,CACNA2D2,SGCA,JUP,CACNB3,GJA1,GJA1,GJA1,GJA1,DSP,DSP,DSP,DMD,DES
Endothelin Pathways (WP2197);ATP2A2,NOS3,COX2,PTGIR,ADCY10,RIIAD1,ADRA1A,CALCA,CALCRL,RAMP1,NPY,NPY1R,GUCY1B2,EDN1,ECE1,CNN1,PRKCA,GNA15,MYL1,MAP2K1,EDNRA,MYLK,MAPK1,EDNRB,RAF1,PLCB1,CAD,CALM1,EDN1,GNB5,GNG13,EDNRB,GNA15,GNB5,GNG13,PLCB1,PRKCA,GNAS,GNB5,GNG13,GNA15,GNB5,GNG13,ADRB1,GNAS,GNB5,GNG13,CALCA,CALCA,GNAS,GNB5,GNG13,NPY,NPY,GNAI1,GNB5,GNG13
Glial Cell Differentiation (WP2276);GAP43,MBP,PLP1,MAG,CNP,TPPP,MIR206,MSN
Deregulation of Rab and Rab Effector Genes in Bladder Cancer (WP2291);MADD,MLPH,MYRIP,RPH3A,RPH3AL,SYTL1,UNC13D,SYTL2,EXPH5,SYTL3,SYTL4,SYTL5,TBC1D10A,RAB27A,RAB27B,GCC2
Trans-sulfuration pathway (WP2333);MTR,MAT2B,DNMT1,AHCY,CBS,CTH,CTH,GOT1,MPST,GCLM,CSAD,GCLM
miRNA Biogenesis (WP2338);RAN,XPO5,DROSHA,DICER1,DGCR8,DICER1
Corticotropin-releasing hormone signaling pathway (WP2355);PRKCQ,SP1,PTK2,PRKAA2,ACACA,NOS3,JUN,JUNB,JUND,FOS,FOSB,FOSL1,FOSL2,IL8,TLR4,CACNA1H,NR4A1,NR4A1,NCOA2,TRIM28,CRHBP,CRH,RHOA,IL18,PRKCI,PRKCD,HSD3B1,TCF4,TFAP2A,CTNNB1,MAPK3,IL2,KRT1,MAPK9,NR4A2,CRHR2,MAPK1,CRH,SP1,CYP11A1,HSP90AA1,IVL,CRHR1,NR4A1,TFAP2A,CRH,CRHR1,EPAC,CTNNB1,KRT14,Receptor,Ligand,RELA,PRKCB,PRKCA,GNAQ,CREB1,GNB5,GNB3,GNB2,GNB1,ADRBK2,GNA11,GNAO1,GNAS,GNAI2,GNAI1,MAP2K1,BRAF,RAP1B,PLCG2,PLCB3,PLCG1,GSK3B,PARP1,CASP9,CASP3,CASP12,MAPK8,MAP3K5,ERN,CYP21A2,CYP17A1,STAR,CYP11B1,CYP11A1,CAMK2A,HSD3B2,GRK6,ADRBK2,ECE1,NFKBIA,GJA1,CRHR2,ARRB1,SULT2A1,ADRBK2,CRH,ARRB2,RELA,BCL2,AKT1,POMC,NR4A2,FOS,ARRB1,ARRB2,ECE1,CRH,CRHR1,CRHR2,CRH,CRHR1,CRH,GNAZ,ELK1,TBX19,FOS,NFKB1,NFKB1,NFKB1,MAPK14,NR4A1,CRH,CRHBP
Gastric Cancer Network 1 (WP2361);KIF15,ESM1,NOTCH1,C21ORF33,AURKA,MYBL2,LIN9,Cyclin A,CENPF,NUP107,SMOC2,Histone H3,MCM4,Histone H4,KIF20B,APC,UBE2C,RNF216,S100P,E2F7,ECT2,TOP2A,ERVK6,INO80D,RUVBL1,ACTL6A,GATS,TPX2,CEP192
Histone Modifications (WP2369);H3F3A,ASH1L,H3F3B,HIST1H3D,HIST1H3J,HIST2H3A,HIST2H3C,HIST2H3D,DOT1L,EHMT1,EHMT2,EZH1,EZH2,KMT2A,KMT2D,KMT2C,KMT2E,NSD1,PRDM2,SET,SETBP1,SETD1A,SETD1B,SETD2,SETD3,SETD4,SETD5,SETD6,SETD7,KMT5A,SETD9,SETDB1,SETDB2,SETMAR,SMYD1,SMYD2,SMYD3,SMYD4,SMYD5,SUV39H1,SUV39H2,KMT5B,KMT5C,EZH1,EZH2,EED,AEBP2,KMT5B,KMT5C,KMT2A,KMT2D,KMT2C,KMT2B,SETD1A,SETD1B,SUV39H1,SUV39H2,SETD2,HIST1H4C,HIST1H4H,HIST1H4I,HIST1H4J,HIST4H4,HIST1H3C,KMT2B,HIST1H3G,HIST1H4K,HIST1H4E,HIST1H3H,HIST1H4B,HIST1H4L,HIST1H3A,HIST1H4G,HIST1H3F,HIST1H3B,HIST1H4F,HIST1H3I,HIST1H4D,HIST1H4A,HIST1H3E
Parkinsons Disease Pathway (WP2371);DDC,EPRS,DAT,UCHL1,Parkin,SNCA,TH,LRRK2,PINK1,DJ1,HTRA2,CYCS,GPR37,SEPT5,SNCAIP,UBB,UBA1,UBA7,UBE2L3,UBE2L6,UBE2J2,UBE2G1,UBE2G2,UBE2J1,ATXN2,SYT11,CCNE1,CCNE2,SNCA,SNCAIP,MAPK12,MAPK11,MAPK14,MAPK13,CASP6,CASP9,CASP2,CYCS,CASP7,CASP3,APAF1
Oncostatin M Signaling Pathway (WP2374);HIF1A,VEGFA
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway (WP2380);IKK1,IKK2,IkkG,CYFIP1
Cardiac Progenitor Differentiation (WP2406);POU5F1,INS,NANOG,SOX2,LIN28A,LIN28B,ZFP42,THY1,SOX1,PAX6,SOX17,FOXA2,NCAM1,T,ANPEP,MIXL1,ROR2,WNT3A,BMP4,INHBA,GSK3B,FGF2,MESP1,MESP2,KDR,KIT,CXCR4,PDGFRA,NOTCH1,ISL1,NKX2-5,GATA4,TBX5,TBX20,MEF2C,MAPK14,BMP1,NOG,NODAL,TGFB1,DKK1,MYH6,TNNT2,TNNI3,MYLK3,SIRPA,MEF2C,TNNT2,ACTC1,MYL2,SCN5A,IRX4,IGF2,IGF1,WNT3A,NRG1
Dopamine metabolism (WP2436);TYR,SOD1,DDC,DDC,NQO1,TH,PRKACA,PRKACB,PRKACG,PPP2CA,PPP2CB,MAOA,COMT,MAOB
Retinoblastoma Gene in Cancer (WP2446);RB1,E2F1,TFDP1,ABL1,ABL1,RBP1,HDAC1,SKP2,CDKN1B,CDKN1B,CDK2,CCNE1,MYC,CCNA2,MDM2,TP53,DNMT1,PRMT2,MCM7,SUV39H1,RAF1,MAPK13,CDKN1A,CCNE2,CDC25A,CCNE1,CCND3,CDK1,PLK4,NPAT,CCDC6,CCNB1,CCNB2,MCM6,MCM7,RFC4,TOP2A,CDC45,MCM3,RFC5,RFC3,MCM4,POLE,POLA1,PRIM1,ORC1,CDT1,SMARCA2,CHEK1,PCNA,RPA1,MSH6,PRKDC,BARD1,CDK1,TTK,SMC2,KIF4A,RRM1,RRM2,DHFR,DCK,HMGB2,TYMS,STMN1,RABIF,HLTF,ANLN,HMGB1,CDC7,WEE1,POLE2,CDC25B,SMC3,SMC1A,FANCG,FAF1,POLD3,H2AFZ,SAP30,SIN3A,RBBP7,RBBP4,CDK4,CCND1,MIR29B1,MIR29B2,RB1,RB1,TFDP1,E2F1,RB1,SKP2,RB1,TFDP1,E2F2,RB1,RB1,MDM2,TFDP1,E2F1,MDM2,RBP1,HDAC1,TFDP1,E2F1,RB1,RB1,TFDP1,E2F1,RB1,RB1,RB1,TP53,E2F1,E2F3,TFDP1,TFDP1,E2F1,TFDP1,E2F2,TFDP1,E2F3,TFDP2,E2F1,TFDP2,E2F2,TFDP2,E2F3,RBP1,HDAC1,TFDP1,E2F2,RB1,RBP1,HDAC1,TFDP1,E2F3,RB1,RBP1,HDAC1,TFDP2,E2F1,RB1,RBP1,HDAC1,TFDP2,E2F2,RB1,RBP1,HDAC1,TFDP2,E2F3,RB1,RBP1,HDAC1,TFDP2,E2F1,RB1,E2F2,TFDP1,RB1,E2F3,TFDP1,RB1,CDK6,CCND1
Amyotrophic lateral sclerosis (ALS) (WP2447);PPP3CA,p38,NOS1,PPP3CB,RAB5A,MKK6,NEFH,ALS2,TNFalpha,NEFM,CAT,MKK3,RAC1,PPP3CC,CCS,GPX1,DAXX,ASK1,NEFL,PRPH,TP53,APAF1,CASP3,CASP9,CASP1,BID,SOD1,BCL2,BCL2L1,BAX,BAD,CASP12,TNFalpha,TNFR,SOD1,ASK1,SOD1,SOD1
HIF1A and PPARG regulation of glycolysis (WP2456);GAPDH,LDHA,TPI1,GPD1,GPAT3,SLC2A1,PPARG,HIF1A,HIF1A
Nanoparticle triggered autophagic cell death (WP2509);INSR,TSC1,BCL2,AMBRA1,ATG9B,VMP1,ATG10,ULK1,TSC2,BECN1,ATG14,CHAF1A,UVRAG,BECN1,SH3GLB1,CHAF1A,MAP1LC3A,ATG3,ATG4A,ATG7,ATG12,ATG5,ATG16L1,ULK2
T-Cell Receptor and Co-stimulatory Signaling (WP2583);LCK,ZAP70,PLCG1,AKT1,PKC-a,SHP1,NFKB1,Ras-GAP,RasGRP,IL2,Calcineurin,PDK1,CSNK1A1,GSK3A,GSK3B,DYRK1A,DYRK2,NRON,FYN,TCRA,TCRB,CD8A,CD8B,CD28,CTLA4,PDCD1
Aryl Hydrocarbon Receptor (WP2586);KLF6,VEGF,CCL1,p27Kip1,ARNT,AIP,CYP1A1,EGFR,AIP,AHR,AIP,AHR,AHR,HSP90,HSP90,TNF-,CDC37,RAF1,MAP2K1,COX-2,SRC-1,Rel A,p50,Rel A,p50,SRC-1,CD36,Nrf2,CYP1A2,CYP1B1,p21cip1,CDK2,Rb,E2F1,AHRR,NRAS,HRAS,KRAS
Secretion of Hydrochloric Acid in Parietal Cells (WP2597);ATP4A,HRH2,CCKBR,CHRM1
Structural Pathway of Interleukin 1 (IL-1) (WP2637);IL1A,IL1R1,IRAK1,IRAK2,MYD88,IRAK4,TOLLIP,TRAF6,IRF7,MAP3K3,MAP3K1,TAB1,MAP3K7,MAP2K3,MAP3K14,CHUK,MAPK11,MAPK3,MAP3K8,MAPKAPK2,RPS6KA5,ELK1,MBP,SAFB,RELA,IL1A,IL1RAP,TAB2,TAB3,MAP2K6,MAP2K4,MAP2K7,MAP2K1,MAP2K2,TANK,IKBKB,MAPK14,MAPK1,ATF2,MKNK1,MAPK9,FOS,MYC,MKNK2,EIF4E
Lidocaine metabolism (WP2646);CYP3A4,CYP1A2,CYP1A2,CYP3A4
Cardiac Hypertrophic Response (WP2795);NIK,MAPKKK,GC-A,TAK1,Calmodulin,PLA2,Calcineurin,CaMK,MEF2,PKC,PKD,PKG-I,NFAT,NFAT,MAPKKKK,JNK,RAC1,RAF1,MEK2,MEK1,ERK1,ERK2,MEK4,MEK7,MAPKKK,MAPKKK,ERK5,MEK5,MEK6,MEK3,p38,IKK-beta,I-kappa-B,NF-kappa-B,NF-kappa-B,CDK 7,CDK 9,PDK1,AKT1,AKT2,GSK3-beta,mTOR,HDAC 4,HDAC 7,HDAC 5,HDAC 9,HDAC 4,HDAC 7,HDAC 5,HDAC 9,IKK-alpha,IKK-gamma
Mammary gland development pathway (WP2813);MIR429,MIR200B,MYC,SFRP1,ITGA6,ALPL,ZEB2,CLDN4,TERT,ERBB4,ITGB1,TGFB1,NRG3,MIR200A,CCND1,AKT1,CDH1,TNF
Mammary gland development pathway (WP2815);CHI3L1,SOCS3,MYC,MMP9,E2F1,STAT3,TP53,BAX,CDH1,IL6ST
Mammary gland development pathway (WP2817);ORAI1,ERBB2,CCND1,PGR,YY1,PRL,Galanin,TTC9,TPM3,BCL2L1,TNFSF11,ERBB1,EIF4E,MYC,PNCK,PTPN1,EGFR,ELF5,IKKA,CAV1,CCND1,ESR2,JAK2,GJB2,ERBB4,ERBB3,CSN2,ESR1,USF2,CEBPA,BCL2L1,CEBPB,ATP2C2,NR3C1,TNFRSF11A,Galanin,PRLR
ACE Inhibitor Pathway (WP554);NOS3,AGTR2,BDKRB1,AGTR1,TGFB1,CTSG,KNG1,ACE,CMA1,REN,CYP11B2,MAS1,ACE2,AGT,NR3C2,ATP6AP2,ACE,BDKRB2,ACE,ACE2
Blood Clotting Cascade (WP272);F12,F13B,F9,F8,F11,F7,F10,F2,F12,KLKB1,FGG,F10,PLG,F3,F5,F9,F8A1,F2,PLAU,FGB,KLK1,VWF,F5,F13B,F10,F11,SERPINF2,PLAT,SERPINB2,SERPINE1,F8,F7,FGA,PLG,F5,F10
Calcium Regulation in the Cardiac Cell (WP536);CACNB1,CALM1,CAMK2G,RYR2,RGS6,ADCY4,GNG2,ADCY1,CAMK2A,PRKCB1,CACNA1E,GNG13,RGS1,ATP2B1,PRKACA,GNAI2,ATP2A3,ATP2B3,GJA5,PLCB3,ADRA1A,GNB4,PLN,RGS20,GJA10,CALM2,PRKACB,RYR1,CAMK4,ADCY5,PKIB,ARRB2,RGS10,ADRA1D,ADRB1,RGS14,CACNA1S,CHRM4,CHRM2,CACNA1C,GJA7,KCNB1,ADCY2,GJA1,ITPR2,PRKAR1B,CACNA1D,CAMK2D,GNB3,CACNA1A,KCNJ3,RGS5,YWHAB,GNB5,KCNJ5,YWHAZ,YWHAH,GJA3,ITPR1,ATP2B2,GJB3,GJB4,SFN,PRKD1,GNG12,GNAQ,GNG11,PRKCD,GNG7,GJB6,GNAI3,PRKCE,RGS18,RGS7,GRK5,GNG8,PKIA,RYR3,ITPR3,ADCY8,CHRM1,RGS19,ADRA1B,CALM3,FKBP1A,GJB1,GJA8,RGS17,Calsequestrin,ADCY3,YWHAE,ANXA6,GNA11,GNG5,ADCY9,RGS16,SLC8A1,YWHAQ,ADCY7,GNAZ,PLCB3,ADRB3,GJB5,Calreticulin,RGS11,CASQ1,GNGT1,PRKCZ,PRKAR1A,GNB2,PKIG,RGS4,PRKCH,PRKAR2B,PRKCQ,GNG3,PRKCA,GJA12,GNB1,CASQ2,GNAO1,SLC8A3,PLN,ATP2A2,RGS2,ARRB1,GNAS,GJB2,CACNA1B,GNAI1,CHRM3,CALR,RGS9,CHRM5,PRKCH,CAMK2B,GJA4,GNG4,YWHAG,CAMK1,CACNB3,PRKCG,ADCY6,GRK4,PRKAR2A,ADRB2,RGS3,CX36,GRK6,ATP1A4,ATP1B1,FXYD2,ATP1B2,ATP1B3
G1 to S cell cycle control (WP45);RB1,E2F2,E2F1,POLE,CDKN1B,CDK6,PCNA,CDK4,CDKN1A,CDC45L,CDKN2A,CDK1,CDK2,TP53,PRIM2A,CDKN1C,CCND2,CCNE1,CDK2,CREB3L4,CDKN2B,MDM2,CDK7,CCNG2,RPA2,CDK4,CDK2,TP53,CDKN2D,CDK7,CREB3,CREB3L3,MYT1,TFDP2,CCNB1,CCND3,CCND1,CCNH,MYC,RPA3,MCM4,MCM3,CREBL1,ORC1L,MCM6,MCM7,MCM2,ORC3L,CDKN2C,POLE2,MNAT1,ORC6L,CDC2A,MCM5,ORC2L,E2F3,CDK6,RPA1,CREB1,TFDP1,WEE1,ATM,CREB3L1,GADD45A,POLA2,ORC4L,CCNE1,PRIM1,CDC25A,CCNE1,CCNA1,ORC5L,CCNE2,CCND1,CDK4,CDK6,CCND1,CDK4,CDK6,RB1,E2F2,E2F1,E2F3,TFDP2,TFDP1
Cell Cycle (WP179);CDC7,CDK7,PLK1,CDKN2A,MAD2L2,PCNA,CDK2,GSK3B,ESPL1,MCM2,TP53,CDC25B,CDC14B,CCNA1,CCNA2,RB1,HDAC1,MAD1L1,RBL2,RBL1,CDC45,ATM,TGFB1,CCNH,PTTG1,CHK2,CDK1,PKMYT1,CDC20,SMAD4,CCNE1,CDC25C,ABL1,RB1,CCNE2,ATR,SFN,HDAC2,PTTG2,FZR1,SKP1,YWHAB,CDK2,GADD45A,CDK6,CDC6,EP300,CDKN1C,SKP2,CCND2,BUB3,YWHAE,RB1,YWHAH,CCNB3,YWHAQ,CDC14A,YWHAZ,DBF4,MCM3,WEE1,MCM4,MCM5,CDK4,MCM6,PRKDC,MCM7,ANAPC10,ORC1,CDKN1A,ORC2,CCNA2,ORC3,SMAD3,ORC4,SMC3,ORC5,MDM2,ORC6,SMAD2,BUB1,TGFB2,CCND3,TGFB3,CCNB2,RBL1,YWHAG,E2F4,CCNB1,E2F5,CDK1,TFDP1,CHK1,TFDP2,CDKN2A,MYC,CCNA1,ZBTB17,CDKN2B,CDKN2C,CDKN2D,CCND1,CDKN1B,CUL1,RBX1,E2F1,E2F2,TFDP1,E2F3,TFDP2,E2F4,E2F5,TFDP1,TFDP2,GADD45B,GADD45G,CDC25A,TTK,MAD1L1,SMC1B,SMC1A,STAG1,STAG2,RAD21,WEE2,ANAPC13,ANAPC2,ANAPC4,ANAPC5,ANAPC7,ANAPC11,ANAPC1,CDC23,CDC16,CDC27,CDC20,ANAPC10,ANAPC13,ANAPC2,ANAPC4,ANAPC5,ANAPC7,ANAPC11,ANAPC1,CDC23,CDC16,CDC27,SKP1,CDK6,CUL1,RBX1,ORC1,ORC2,ORC3,ORC4,ORC5,ORC6,MCM2,MCM3,MCM4,MCM5,MCM6,MCM7
Exercise-induced Circadian Regulation (WP410);MYF6,KLF9,HERPUD1,SF3A3,CBX3,AZIN1,PSMA4,ZFR,SUMO1,HIST1H2BN,PURA,CRY2,PER1,PER2,CRY1,PPP1R3C,CEBPB,PPP2CB,NCOA4,ETV6,CAST,HLA-DMA,HSPA8,DNAJA1,UCP3,GSTM3,UGP2,CLDN5,PIGF,TUBB3,GFRA1,MAP3K7IP2,SUMO3,GSTP1,NCKAP1,VAPA,GENX-3414,DAZAP2,IDI1,TOB1,RBPMS,G0S2,ARNTL,NR1D2,CLOCK,BTG1,EIF4G2,QKI,PER1,PER2,CRY1,CRY2,CRY2,CRY1,PER2,PER1
Fatty Acid Omega Oxidation (WP206);ADH1C,ALDH1A1,ADH7,CYP2E1,ADH1B,CYP3A4,CYP2D6,CYP1A1,ADH6,ALDH2,ADH4,ADH1A,CYP4A11,CYP1A2,CYP2A6
G13 Signaling Pathway (WP524);RTKN,PKN1,CFL2,RHPN2,RHOA,PFN1,ARHGEF1,CYFIP1,GNA13,IQGAP2,IQGAP1,PIK3CD,ARHGDIB,PIK3CB,SH3MD2,LIMK1,MYBPH,RAC1,TNK2,PAK3,PIP5K2A,MAPK10,CALM1,WASL,PIK3R2,PPP1CB,WAS,MAP3K4,MYL1,CIT,ARHGDIG,ROCK1,DIAPH1,PIK3CA,CDC42,RPS6KB1,ROCK2,CFL1
GPCRs, Class A Rhodopsin-like (WP455);CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,ADRA1B,ADRA1A,ADRA1D,ADRA2C,ADRA2B,ADRA2A,ADRB1,ADRB2,ADRB3,DRD1,DRD5,DRD2,DRD3,DRD4,HRH1,HRH2,HRH3,HTR1E,HTR1F,HTR1D,HTR1B,HTR1A,HTR2B,HTR2C,HTR2A,HTR4,HTR5A,HTR6,HTR7,AGTR1,AGTR2,NMBR,BRS3,GRPR,BDKRB2,BDKRB1,C3AR1,GPR77,FPRL2,FPR1,FPRL1,AGTRL1,IL8RA,IL8RB,CCR1,CCR2,CCR3,CCR4,CCR5,CCR6,CCR8,CCR9,CCBP2,CCRL2,CXCR3,CXCR4,BLR1,CX3CR1,CCKAR,CCKBR,CCR10,CCRL1,CCR7,XCR1,EDNRA,EDNRB,MC1R,MC2R,MC4R,MC5R,MC3R,NPY1R,NPY2R,PPYR1,NPY5R,NPY6R,GPR83,NTSR2,NTSR1,OPRD1,OPRK1,OPRM1,OPRL1,SSTR1,SSTR2,SSTR3,SSTR4,SSTR5,F2R,AVPR2,AVPR1A,AVPR1B,OXTR,GALR1,GALR3,GALR2,F2RL1,F2RL2,F2RL3,HCRTR2,HCRTR1,GPR74,GPR147,GPR37,GPR37L1,GPR32,CMKLR1,GPR44,GPR30,NMUR2,NMUR1,FSHR,LHCGR,RHO,OPN1MW,OPN1LW,OPN1SW,OPN3,OPN4,RRH,Rgr,OR7A17,OR7C1,OR7A10,OR7A5,OR1Q1,OR1I1,OR1F1,OR1E2,OR1E1,OR1D4,OR1A1,OR1D2,OR1C1,OR1A2,OR7C2,OR1G1,OR2J1,OR10A5,OR10A4,OR2N1P,OR5V1,OR2W1,OR2S2,OR2H2,OR2B3,OR2J3,OR2J2,OR2B2,OR2B6,OR2C1,OR2D2,OR2F1,OR2F2,OR2H1,OR2A4,OR3A1,OR3A3,OR3A4,OR8B8,OR8D2,OR5F1,OR5I1,OR6B1,OR11A1,OR6A2,OR10H2,OR10H3,OR10H1,OR10J1,OR2T1,OR5U1,PTGER1,PTGER2,PTGDR,PTGER3,PTGER4,PTGFR,PTGIR,TBXA2R,ADORA1,MLNR,GPR50,MTNR1A,MTNR1B,P2RY13,GPR87,P2RY12,P2RY14,GPR27,GPR85,GPR173,MAS1,CMKOR1,GPR1,GPR31,GPR24,GPR25,GPR12,GPR4,ADORA2A,ADORA2B,ADORA3,P2RY2,P2RY1,P2RY6,P2RY4,LTB4R,GPR92,P2RY11,GPR174,GPR23,P2RY5,P2RY10,GPR35,SUCNR1,CNR2,CNR1,PTAFR,TRHR,GHSR,GPR22,GPR15,GPR10,GPR8,GPR7,GPR6,GPR3,GPR52,GPR17,GPR21,GPR19,GPR20,GPR63,OR2AG1,OR12D3,OR1D5,OR3A2,GPR45,CYSLTR1,CYSLTR2,GPR43,GPR42,GPR40,GPR41,GPR18,GPR68,GPR34,GPR171,GPR109B,MAS1L,GPR65,GPR161,GPR75,GPR81,GPR39
GPCRs, Class C Metabotropic glutamate, pheromone (WP501);GRM1,GRM5,GRM2,GRM3,GRM8,GRM4,GRM7,GRM6,CASR,GABBR1,GPR51,GPRC5D,GPRC5C,GPRC5B,GPRC5A
GPCRs, Other (WP117);GPR84,RLN3R1,TAAR3,TAAR2,GPR77,GPR55,GPR145,GPR88,GPR62,GPR135,GPR,TAAR5,VN1R1,HRH4,CCR5,OR7E24,CELSR3,GNRHR,OR8G2,OR8G1,FSHR,F2R,ADORA2A,EDG1,OR10A5,NTSR1,LGR6,HTR1F,HTR2A,IL8RB,IL8RA,OR7A17,OR10A2,UTS2R,GPR143,LTB4R2,GPR61,GPR56,GPR116,P2RY13,GPR132,GPR73L1,GPR133,GPR18,OR10A1,CCR2,ADRA1D,ADORA3,ADRB2,OR7E18P,OR7E19P,OR7E35P,HTR7,LGR7,OR2M4,OR5D3P,OR5E1P,OR3A4P,OR2A20P,OR2B6,OR1F1,OR2A9P,OR1N1,OR1E1,OR1G1,OR1E3P,OR1R1P,OR2F1,OR3A1,OR2H1,OR2A5,OR3A3,GPR17,CELSR2,CELSR1,OR51A1P,GRM8,OR2A4,GRPR,OR1J5,CNR1,CHRM3,CHRM2,CCKBR,CXCR3,GHRHR,GRCA,GPR83,GRM1,DRD3,DRD4,EMR2,EBI2,EDNRA,EMR3,FY,ALG6,P2RY11,MASS1,LPHN3,LPHN2,PTGFR,SSTR2,SMO
G Protein Signaling Pathways (WP35);GNAI1,PDE1B,PDE1C,PDE4A,PDE4B,PDE4C,PDE4D,PDE7A,PDE7B,PDE8A,PDE8B,GNB1,GNB2,GNB5,GNGT1,GNGT2,GNG3,GNG4,GNG5,GNG7,GNG8,GNG10,GNG11,GNG12,GNG13,GNAS,GNAZ,GNAI2,GNAI1,GNAO1,GNAI3,ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,KCNJ3,GNAQ,GNA11,GNA14,GNA15,PLCB3,ITPR1,HRAS,NRAS,KRAS,RRAS,PPP3CA,PPP3CC,PPP3CC,PRKCD,PRKCG,PRKCE,PRKCI,PRKCH,PRKD1,PRKCQ,PRKCZ,PRKCB1,PRKD3,GNA12,GNA13,ARHGEF1,RHOA,SLC9A1,PRKAR2A,PRKAR2B,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PDE1A,GNB3,GNAL,GNAO1,CALM1,PRKCA,AKAP1,AKAP2,AKAP3,AKAP4,AKAP5,AKAP6,AKAP10,AKAP9,AKAP8,AKAP7,AKAP11,AKAP12,AKAP13
Glycogen Synthesis and Degradation (WP500);PYGM,PPP2CB,PHKB,GYS2,PPP2R5B,PHKG2,PPP2R5C,CALM1,PHKA1,PPP2R2C,PYGB,UGP2,GYS1,GSK3A,PPP2R3A,GYG,PPP2R1A,CALM3,PPP2R5E,PPP2CA,UGP2,GYG2,PPP2R5D,PPP2R2B,AGL,PPP2R5A,CALM2,PPP2R3B,PHKA2,PPP2R2A,GSK3B,PHKG1,PPP2R1B,GBE1,PGM1,PPP2R4,PYGL
Glycolysis and Gluconeogenesis (WP534);TPI1,PFKP,FBP1,ALDOA,LDHAL6B,PKM1,ALDOC,SLC2A2,GOT1,GAPDH,DLD,PC,PFKM,GOT2,PGK1,MDH1,PKLR,SLC2A5,PDHA1,MDH2,LDHA,HK1,SLC2A1,PGAM2,DLAT,PFKL,ENO3,ENO1,LDHC,HK3,LDHB,MPC2,MPC1,ENO2,G6PC,HK2,PCK1,PGK2,SLC2A4,FBP2,SLC2A3,GCK,PGAM1,PKM2,ALDOB,GPI
Heme Biosynthesis (WP561);ALAS2,FECH,PPOX,CPOX,HMBS,ALAS1,ALAD,UROS,UROD
IL-2 Signaling Pathway (WP49);IL2RA,HRAS
MAPK Signaling Pathway (WP382);TRAF6,MEF2C,SRF,RPS6KA3,MAP2K3,ELK4,RAP1A,CRK,IL1A,PDGFB,AKT3,ECSIT,MAP3K13,RASGRP4,MAP3K7,MAPK9,GRB2,MKNK1,DUSP1,STMN1,ELK1,EGFR,PPP3CB,PPP3CC,MAP4K1,NFATC1,ARRB2,MAPT,RASGRP1,RAP1B,CD14,IKBKG,BDNF,DAXX,MAPK10,TNF,MOS,STK4,MAPK14,IKBKB,ARRB1,LRRK2,CASP3,FLNA,PRKACA,MAPKAPK2,TNFRSF1A,MAP3K14,HSPB1,ZAK,GNA12,TGFB1,MAP3K1,MAP3K2,MAX,DUSP10,RASGRF2,MAP4K4,PDGFRB,TAB1,MAP3K4,GADD45A,MAP2K5,CDC25B,IL1R1,RAC2,PRKCD,PPP5C,MAP2K1,RAC1,PTPN7,IL1R2,TAB2,TGFBR1,MAPK1,PTPRR,PTPN5,PLA2G4D,BRAF,NTRK1,ATF2,MAP2K4,FOS,PRKCG,MYC,SOS2,TGFB2,ELK1,MAPK7,DUSP4,HSPA8,MAPK12,MAPK8IP1,PPM1A,IL1B,ELK4,TRAF2,MAPK13,TAOK1,MAP2K6,DUSP8,AKT2,MAPKAPK5,RASA2,DUSP7,PPP3R2,FGFR1,TGFB3,PPP3CA,EGF,DDIT3,MAP3K6,MAP3K8,NGF,CRKL,TAOK2,MAPK3,MAPK8,NR4A1,PRKCA,ATF4,NTF4,PDGFA,ATF4,NTRK2,FASLG,PDGFRB,PPM1B,FGFR2,CDC42,FGFR3,MP1,FGFR4,JUN,SOS1,JUND,RRAS,HRAS,RPS6KA5,MAP3K12,TP53,RRAS2,NFKB1,GNG12,PLA2G4C,NF1,RASGRP2,AKT1,RASGRP3,RASGRP4,RASA1,RASGRF1,HSPA6,NTF3,RAPGEF2,PRKACB,HSPA1A,PRKACG,STK3,DUSP3,MAP4K3,CHUK,TGFBR2,NFKB2,MAP4K2,RELA,MAP2K7,RELB,PPP3R1,DUSP9,NLK,DUSP2,DUSP16,FAS,MKNK2,PLA2G4A,NFATC3,MAP3K5,MAP3K11,TAOK3,DUSP6,MAP2K2,PPP5D1,MAPK11,RPS6KA4,MAPKAPK3,RAC3,MAPK8IP2,MAPK8IP3,FLNB,FLNC,HSPA1B,HSPA1L,HSPA2,MRAS,NRAS,KRAS,RAF1,PLA2G4F,PLA2G4B,PLA2G4E,CACNG2,CACNG5,CACNG4,CACNA2D3,CACNG8,CACNG7,CACNG6,CACNA1A,CACNA1B,CACNA1C,CACNA1D,CACNA1E,CACNA1F,CACNA1S,CACNA2D1,CACNB1,CACNB2,CACNB3,CACNB4,CACNG1,CACNA1I,CACNA1H,CACNA1G,CACNA2D2,CACNA2D4,FGF4,FGF1,FGF2,FGF3,FGF4,FGF5,FGF6,FGF7,FGF8,FGF9,FGF10,FGF11,FGF12,FGF13,FGF14,FGF20,FGF21,FGF22,FGF23,FGF18,FGF17,FGF16,FGF19,PAK2,PAK1
Monoamine GPCRs (WP58);HRH1,ADRA2C,HTR4,DRD3,HRH2,CHRM3,ADRA1A,DRD5,HTR5B,DRD4,ADRB3,ADRA1B,CHRM2,HTR6,HTR1D,CHRM1,HTR1E,HTR7,CHRM4,DRD2,CHRM5,ADRA2A,HTR2A,HTR1F,DRD1,HTR5A,ADRB1,ADRA2B,HTR2C,HTR2B,HTR1A,ADRA1D,HTR1B,ADRB2
Nuclear Receptors (WP170);THRA,THRB,THRB,RARA,RARB,RARG,RARG,PPARA,PPARD,PPARG,PPARG,NR1D2,NR0B1,ROR1,RORA,RORC,NR1H2,NR1H3,VDR,HNF4A,RXRA,RXRB,RXRG,NR2C2,NR2F1,NR2F2,NR2F6,NR2E1,ESR1,ESR2,ESRRA,ESRRB,NR3C1,PGR,AR,NR4A1,NR4A2,NR5A1,NR5A2,NR1I2,NR1I3
Nucleotide GPCRs (WP80);ADORA1,ADORA2A,ADORA2B,ADORA3,P2RY1,P2RY2,P2RY5,P2RY6,LTB4R,GPR23,P2RY4
Ovarian Infertility Genes (WP34);BMPR1B,PRLR,FSHR,LHCGR,ZP3,ZP3,FIGLA,DMC1,ATM,MLH1,MSH5,GDF9,ZP2,SMPD1,DAZL,GJA4,GJA4,INHA,SMAD3,PGR,ESR2,VDR,NR5A1,NCOR1,NRIP1,EGR1,CEBPB,PTGER2,CDKN1B,CCND2,CDK4,SMPD1,CYP19A1,SYNE2,GDF9,INHA
Pentose Phosphate Metabolism (WP134);G6PD,PGLS,RPE,TALDO1,RPIA,TKT,PGD,TKT
Peptide GPCRs (WP24);SSTR2,IL8RA,NPY2R,CXCR3,CCR5,GALR3,TACR1,BDKRB2,FPR1,AGTR2,NMBR,AVPR2,TAC4,BLR1,AGTR1,SSTR4,BDKRB1,NTSR2,CXCR4,NPY5R,CCR7,FPRL1,ATP8A1,FPRL2,OPRM1,AVPR1A,GALR1,CCKAR,MC3R,LHCGR,CCKBR,EDNRA,CX3CR1,GHSR,CCR8,CCR-9,SSTR3,GRPR,EDNRB,MC4R,FSHR,TSHR,TACR3,GNRHR,BRS3,TRHR,AVPR1B,CXCR6,MC2R,NPY1R,SSTR5,TACR2,MC5R,MC1R,PPYR1,CCR2,OXTR,OPRK1,CCR1,SSTR1,NTSR1,GALR2,IL8RB,OPRD1,OPRL1,CCR10,NPY6R,C3AR1,AGTR1,C5R1,CCR3,FY,CCR1,CCR4,CCR6,HCRTR1,HCRTR2
Prostaglandin Synthesis and Regulation (WP98);CYP11A1,ANXA5,EDNRB,PTGER4,S100A10,S100A6,PTGFR,PTGIS,PTGER2,PTGER1,HPGD,PTGS2,PRL,ANXA8,PLA2G4A,ANXA4,SCGB1A1,PTGDS,EDN1,ANXA3,HSD11B1,ANXA1,PTGDR,PTGIR,HSD11B2,PTGS1,ANXA6,EDNRA,TBXAS1,PTGER3,ANXA2,ABCC4,HPGDS,MITF,PTGES,PPARG,PPARGC1A,PPARGC1B,SOX9,AKR1C3,CBR1,AKR1C1,AKR1C2,AKR1C1,TBXA2R,PTGFRN
Proteasome Degradation (WP183);PSMB10,UBC,HIST1H2AB,UCHL3,PSMA2,HLA-G,PSME1,PSMB1,PSMA5,HLA-E,PSMD12,PSMD9,PSMC5,UBE2B,PSMB8,PSMD7,PSMB4,UBE2D3,PSMD11,UBE1,RPN1,PSMC3,H2AFZ,PSMB2,HLA-H,PSMB9,IFNG,PSMA3,UCHL1,HLA-A,PSMD10,HLA-J,HLA-F,PSMD3,PSMD13,UBE2D2,RPN2,H2AFX,PSMD6,PSMA7,PSMA1,UBE1L,PSMB6,PSMA6,PSMB5,PSME3,PSMC1,PSMD5,UBE2D1,NEDD4,PSMC6,PSMC4,PSMD4,UBB,HLA-C,PSMA4,PSME2,PSMB7,PSMD1,PSMC2,HLA-B,PSMB3,PSMD2,PSMD8,PSMC5
Eukaryotic Transcription Initiation (WP405);POLR2A,POLR3B,CDK7,GTF2A2,ILK,GTF2F2,GTF2B,POLR2K,POLR3K,TAF12,GTF2H2,TBP,POLR2B,POLR2E,POLR2C,ERCC3,POLR3H,GTF2H4,TAF13,Polr1e,GTF2H3,TAF5,POLR2G,POLR1B,POLR3D,ERCC2,POLR2I,GTF2H1,POLR2J,TAF6,POLR1A,GTF2E1,CCNH,POLR3E,POLR2H,POLR1D,TAF9,MNAT1,GTF2E2,POLR2F,TAF7
Regulation of Actin Cytoskeleton (WP51);DIAP3,PIP5K2B,MAPK1,C3orf10,CHRM3,PIP5K1B,GSN,SSH1,PAK1,PFN1,PIK3C3,FGF5,PDGFA,FGD1,PIK3R5,RAC1P4,SOS2,BAIAP2,IQGAP1,VCL,FGF10,ARHGEF1,ARHGEF7,GNA13,RDX,MYH10,ABI2,PFN1,CHRM2,CHRM1,Pik3c2b,FGF9,EGFR,VCL,ENAH,SSH2,GRLF1,RAC3,WASF2,PAK7,PIP5KL1,MRAS,MAP2K1,LIMK1,BDKRB1,FGF7,VIL1,GNA12,NCKAP1,FGF14,ACTB,PIK3R2,RAC1P2,PAK2,FGFR4,FGF3,CHRM5,FGF12,CDC42,TMSB4X,PIK3C2G,EGF,ARHGEF4,BCAR1,MYLK,SSH3,ACTB,FGF4,PIK3R1,PAK3,DOCK1,CHRM4,CFL2,CD14,PDGFRB,ARPC5,PIK3CA,PTK2,FGF20,FGF17,ARPC5,RHOA,ACTB,SLC9A1,FGFR3,PIK3C2A,FGF23,PIK3CB,BDKRB2,ROCK2,FGF15/19,FGF18,PIP5K2A,FGF21,NRAS,FGF2,PIK3R3,VIL2,ROCK1,ACTG1,FGF22,FN1,FGF16,PIK3CG,ARHGEF6,MYL1,RAC1,BRAF,PPP1R12A,WAS,RRAS2,PIK3R4,BAIAP2,RRAS,ACTG1,APC,C11orf13,PDGFRA,KRAS,FGF13,PIP5K1A,WASF1,PAK4,ACTN1,GNG12,DIAP1,PIP5K1C,SOS1,MSN,CRK,ITGA1,RAF1,CSK,PIP5K2A,PIP5K2C,MAPK3,PDGFB,CYFIP2,MYL3,ACTG1,MAP2K2,ARHGEF6,PXN,RAC2,FGFR2,PIK3CD,MAPK6,PAK6,Apc2,GIT1,CFL1,MOS,FGF6,FGF1,F2,F2R,FGFR1,FGF11,FGF8,VAV1,MAPK4
Signal Transduction of S1P Receptor (WP26);SPHK1,SPHK2,ASAH1,SMPD2,S1PR1,EDG5,EDG3,EDG8,PLCB1,PLCB2,PLCB3,MAPK3,MAPK1,MAPK6,MAPK4,MAPK7,MAPK12,GNAI1,GNAI2,GNAI3,AKT1,AKT2,AKT3,PIK3C2B,RACGAP1
Small Ligand GPCRs (WP247);CNR1,CNR2,EDG1,EDG2,EDG3,EDG5,EDG6,MTNR1A,PTAFR,PTGDR,PTGER1,PTGER2,PTGER3,PTGER4,PTGFR,PTGIR,TBXA2R,MTNR1B,GPR50
Myometrial Relaxation and Contraction Pathways (WP289);RAMP1,IGFBP6,GNG13,RGS11,PRKCZ,ADCY5,RYR1,ATP2A3,ATF4,GUCY2E,PRKAR2B,PRKCG,ADCY2,PRKCE,IGFBP5,GRK4,GNB3,GNG3,PKIB,FOS,GRK5,OXTR,MYLK2,GNG12,RGS2,GNG2,RGS6,JUN,ADCY3,GNG7,PRKACB,CREBL1,ACTA2,RAMP2,ADMR,CALCA,ADCY8,ADCY1,ARRB2,ATF1,NOS1,GRK5,RGS17,PRKCH,RYR2,RGS18,YWHAB,IL6,GRK6,RCP9,LGR7,CNN1,YWHAH,CAMK2G,RGS7,MYL4,RGS1,PRKCB1,MYLK2,EDG2,RAMP3,CAMK2D,PRKCQ,NOS3,CALD1,GSTO1,CRH,PRKCA,YWHAZ,GRK4,CNN2,PRKAR2A,ARRB2,GNB2,GNG11,OXTR,IGFBP4,RYR3,RGS10,DGKZ,RGS5,ATP2A2,IGFBP2,RGS20,GNAQ,GNB5,YWHAE,OXT,PRKAR1A,RGS9,SFN,ADCY7,ATF5,PLCG2,IL1B,GNG5,ADM,RGS16,ITPR3,PRKD1,ACTG1,GNG8,LGR8,GNB4,PRKAR1B,RGS19,ACTB,CORIN,GABPB2,PRKCD,SP1,GABPA,ADCY6,GUCA2A,ITPR1,CAMK2B,CRHR1,RLN1,PDE4D,GRK6,ETS2,ATF3,ADCY4,PLCD1,RGS4,RGS14,SLC8A1,GUCA2B,ARRB1,GJA1,ARRB1,YWHAG,CACNB3,CMKOR1,IGFBP1,PKIG,PDE4B,GNGT1,PKIA,YWHAQ,CREB3,ACTC,IGFBP3,PLCG1,GNAS,MAFF,PRKACA,CALM3,ATF2,GNG4,CALM2,ADCY9,CALM1,ACTA1,GNB1,MYL2,RGS3,ITPR2,PLCB3,CAMK2A,NFKB1,CREB1,GUCY1A3
Steroid Biosynthesis (WP496);HSD17B4,HSD3B1,CPN1,HSD17B2,HSD3B1,HSD3B1,HSD3B1,HSD3B1,F13B,HSD3B2,HSD3B1,HSD3B1,CYP17A1,HSD3B1,HSD3B1,CYP17A1,HSD3B1,HSD3B1,HSD3B2,HSD3B2,HSD17B1,HSD3B1,HSD3B1,HSD17B3,HSD3B1,HSD3B1,HSD3B1,HSD3B1,HSD17B7,HSD3B1,HSD3B1,HSD3B2,HSD3B1,HSD3B1,CPN1
TGF-beta Receptor Signaling (WP560);TGFBR3,ZFHX1B,TGFB1,SMAD9,JAK1,MAPK9,SMAD1,RUNX2,TGIF,SKI,SMAD4,BMP4,TNF,FST,FKBP1A,SPP1,WNT1,TGFBR2,THBS1,LIF,NOG,LEF1,ENG,SMAD6,BMP4,SKIL,ZNF423,MAPK3,RUNX3,TGFBR1,NFKB1,SMAD3,BAMBI,EP300,SERPINE1,SMAD1,INHBA,LTBP1,SMAD2,STAT3,TGFBR2,MIR302A,ZFYVE9,IFNG,TGFB1,JUN,SMAD2,SMAD7,FOXH1,HRAS,CTNNB1,TNF,FOS,TFE3,EGF,STAT1,CREBBP,TGFBR1,SMAD5,ITGB6,LEFTY1,LEFTY2
TNF alpha Signaling Pathway (WP231);KRAS,NRAS,HRAS
Triacylglyceride Synthesis (WP325);GPD1,GK,GPAM,GNPAT,AGPS,AGPAT1,AGPAT2,AGPAT3,AGPAT4,AGPAT5,PPAP2A,PPAP2B,PPAP2C,DGAT1,GK2,DGAT2,MOGAT1,MOGAT2,LPL,LIPE,LIPC,LIPF,PNPLA2,MOGAT3
Tryptophan metabolism (WP465);CYP4F12,INDO,CYP2E1,GCDH,ALDH9A1,HRMT1L2,ALDH2,ALDH1A2,ASMT,CYP1A1,OGDH,MAOB,ALDH3A2,MAOB,DDC,HADH2,ALDH9A1,CAT,HADHSC,CYP3A4,ALDH3A2,DDC,DDC,ALDH2,MAOB,CYP7B1,AADAT,ACAT1,INDO,ALDH1A2,KYNU,AFMID,CYP1B1,AANAT,AOX1,DHCR24,AADAT,ACMSD,INDO,KYNU,CYP1A2,CYP2C18,WARS,CYP2A13,INMT,CYP19A1,HRMT1L2,ALDH1A1,CYP2J2,HAAO,HRMT1L2,ABP1,MAOB,KYNU,ECHS1,TDO2,CYP2F1,GCDH,TPH1,ALDH1A1,ASMT
Wnt Signaling (WP428);DVL3,RHOA,RAC1,PLAU,PRKCB,CAMK2D,FRAT1,GSK3B,CSNK2B,APC,WNT3A,PPP3R1,PPP3R2,FZD3,MAPK9,LEF1,CSNK1E,CCND1,FZD8,TCF7L1,WNT7A,TCF7L2,WNT11,WNT1,PRKCA,JUN,LRP5,FZD10,FZD7,PPP3CC,WNT5B,PPP3CA,CTNNB1,WNT2,CSNK1A1,WNT2B,FZD4,PRKCG,CAMK2B,DVL2,WNT6,CCND3,WNT5A,ROR1,FZD1,LRP6,KREM1,WNT16,FZD6,CAMK2G,RYK,WNT4,CAMK2A,WNT3,CSNK2A1,AXIN1,WNT10B,FZD5,WNT7B,DVL1,CHD8,PPP3CB,WNT10A,CSNK1A1L,CSNK2A3,FOSL1,MAPK9,MYC,CSNK2A2,CCND2,FZD9,MAP3K7,TCF7,WNT16,FZD2,ROR2,CTNNB1,CTNNB1,DKK1,DKK2,DKK4,SOST,SERPINF1,FRAT2,CTNNB1,SFRP1,SFRP2,SFRP4,SFRP5,NOTUM,CER1,WIF1,PORCN,WNT5B,WNT5A,FZD3,FZD8,FZD10,FZD7,FZD4,FZD1,FZD6,FZD5,FZD9,FZD2,PLCB1,PLCB2,PLCB3,PLCB4,NFATC1,NFATC2,NFATC3,NFATC4,NFATC1,NFATC2,NFATC3,NFATC4,FZD3,FZD8,FZD10,FZD7,FZD4,FZD1,FZD6,FZD5,FZD9,FZD2,GPC4,VANGL1,VANGL2,WNT11,DVL3,DVL2,DVL1,INVS,PRICKLE1,PRICKLE2,NKD1,NKD2,DAAM1,DAAM2,ROCK2,MAPK8,CXXC4,SENP2,NLK,CTNNBIP1,SOX17,CTBP1,CTBP2
mRNA Processing (WP411);PRPF4,SNRPA1,RBM17,SNRPD3,NCBP2,DNAJC8,RNGTT,SNRPD1,SF3A2,SNRPD2,XRN2,DHX16,HNRPM,HNRPA1,CUGBP2,SPOP,HNRPA2B1,PHF5A,SF3B5,HNRPR,C20orf14,NSEP1,SFRS9,SF4,SSFA1,SF3B3,FNBP3,PSKH1,SNRPB2,HNRPH2,WDR57,HNRPU,PCBP2,LSM7,DDX1,SRPK1,U2AF1,SFRS10,SRPK2,HNRPA3P1,HNRPK,SSFA1,SUPT5H,SRP54,PRPF4B,CUGBP1,SFRS1,HEAB,SNRPF,METTL3,SFRS6,NXF1,SF3B2,SFPQ,RBM5,PRPF3,SSFA1,FUSIP1,CSTF3,PAPOLA,HNRPD,CPSF3,HNRPAB,SFRS16,POLR2A,DICER1,PABPN1,RNU2,HRMT1L2,CPSF4,SFRS8,SFRS3,SF3A1,CD2BP2,LSM2,FUSIP1,TMP21,CPSF2,CPSF1,SFRS2,PPM1G,NUDT21,SF3B4,CSTF2,DHX38,HNRPC,SFRS12,SFRS4,CLK2,PRPF8,SF3A3,SNRPN,CLK4,SF3B1,PRPF4,HRMT1L1,DDX20,NONO,BRUNOL4,SFRS5,PRPF18,CSTF2T,PTBP1,SNRPN,CSTF1,HNRPL,U2AF2,SFRS7,DHX9,SFRS14,SRRM1,RNMT,SNRPE,CDC40,SNRPG,RBMX,SNRPB,SMC1L1,SNRP70,PRPF8,TXNL4A,NCBP1,CDC40,DHX8,CLK1,CLK3,PTBP2,U5-116KD,LSM2,RNPC2,SNRPA,HNRPH1,FUS,RNPS1,DHX15
DNA Mismatch Repair (WP531);RFC1,MLH1,PCNA,EXO1,PCNA,RPA1,PCNA,MSH6,EXO1,MSH2,MSH6,POLD1,LIG1,MSH2
Osteoclast Signaling (WP12);AIMP2,MAPK8
Fatty Acid Beta Oxidation (WP143);HADHA,ACADM,HADHB,PNPLA2,CPT2,ACADS,ACADM,HADHB,DCI,ECHS1,GCDH,HADHB,HADHB,HADHSC,HADHB,HADHB,HADHB,ACADVL,HADHB,HADHB,GPD2,HADHA,HADHSC,HADHA,ACSL5,DLD,HADHA,ACAS2,HADHSC,TPI1,GK2,HADHB,ECHS1,ACSL1,DECR1,LIPC,SLC25A20,ACADL,ACADL,CRAT,LIPE,ECHS1,ACSL6,DCI,HADHSC,HADHB,CPT1A,CPT1B,HADHA,HADHA,HADHA,HADHSC,ECHS1,HADHA,HADHB,ACSL4,ACADS,GK,LIPF,HADHA,ACADL,HADHB,HADHA,HADHA,CHKB,ECHS1,HADHA,ACAT1,ACSL3,HADHA,ACADL,LPL,ACADM
Amino acid conjugation of benzoic acid (WP521);GLYAT,GLYATL2,Acyl-CoA synthetase,GLYATL1
Oxidation by Cytochrome P450 (WP43);CYP1A1,CYP1A2,CYP1B1,CYP2A6,CYP2A7,CYP2A13,CYP2B6,CYP2C8,CYP2C9,CYP2C18,CYP2D6,CYP2E1,CYP2F1,CYP2G1P,CYP2J2,CYP2R1,CYP2S1,CYP2U1,CYP2C19,CYP3A4,CYP2W1,CYP4A11,CYP3A43,CYP3A7,CYP3A5,CYP4F3,CYP4F2,CYP4B1,CYP4A22,CYP4F22,CYP4F12,CYP4F11,CYP4F8,CYP4V2,CYP4X1,CYP4Z1,CYP51A1,CYP7A1,CYP7B1,CYP8B1,CYP11A1,CYP11B1,CYP11B2,CYP17A1,CYP19A1,CYP20A1,CYP21A2,CYP24A1,CYP26A1,CYP26B1,CYP26C1,CYP27A1,CYP27B1,CYP27C1,CYP51A1,CYP39A1,CYP46A1,CYP,CYP,CYP,CYP,POR,CYP,CYB5R1,CYB5R2,CYB5R3,CYB5R4,CYB5A,CYB5B,CYB5A,CYB5B,CYB5B,CYB5A
MAPK Cascade (WP422);MAPK14,JUN,NRAS,RAF1,MAP2K7,MAP3K3,MAP3K1,MAPK3,ELK1,MAP2,MAP2K4,HRAS,MAP3K12,MAPK10,MAP2K2,MBP,MAPK12,MAP2K6,SIPA1,MAPK1,RASA3,RRAS,ARAF,KRAS,MAP3K2,BRAF,MAP2K1,MAP2K3,MAP2K4,PLCB3
Hypertrophy Model (WP516);WDR1,EIF4EBP1,IL1R1,NR4A3,IL1A,IFNG,EIF4E,VEGF,ATF3,TCF8,JUND,GDF8,ADAM10,CYR61,ANKRD1,DUSP14,HBEGF,IFRD1,MYOG,IL18
Phytochemical activity on NRF2 transcriptional activation (WP3);ERK,C/EBP-beta,MAF,PI3K,GCLC,JNK,P38,NRF2,PKC,NRF2,KEAP1,HO-1,SLC7A11,NQO1,GSTA2,GCLM,KEAP1,C/EBP-beta,NRF2,KEAP1,NRF2
Toll-like Receptor Signaling Pathway (WP75);LY96,MAPK12,IRAK1,NFKB1,CD80,JUN,IFNA10,TLR1,TIRAP,TLR9,STAT1,IRAK4,TLR5,PIK3R1,NFKB1,TICAM1,IFNA8,MAPK14,TRAF6,AKT2,CCL5,TOLLIP,IL12B,PIK3CB,PIK3CG,IFNA16,TRAF3,TLR6,MAPK10,PIK3R5,IFNA2,CHUK,TBK1,AKT3,TAB2,NFKBIA,IL12A,IFNA7,IFNA21,TRAF6,TNF,CD40,IFNA17,IFNB1,CASP8,TIRAP,SPP1,CCL3,TLR2,CXCL10,TLR4,IFNA14,TLR7,IFNA4,IKBKE,IFNA1,IRF7,MAP2K4,IL1B,MYD88,IRAK1,TLR8,MAP3K7,MAP2K6,TICAM2,IRF3,CHUK,IL6,CD86,MAPK3,IRAK4,PIK3CD,MAPK13,IFNA13,CD14,IFNB1,IFNAR1,MYD88,MAPK8,RIPK1,LBP,MYD88,IRF5,TAB1,IL8,MAPK1,MAP2K1,FADD,IFNB1,MAP2K2,IFNAR2,TRAF6,IFNA5,PIK3R3,MYD88,MAP3K8,RAC1,TLR2,PIK3R2,MAP2K7,CXCL9,TLR3,IFNA6,AKT1,MAPK11,MAP2K3,RELA,CCL4,IKBKG,NFKB2,IKBKB,FOS,PIK3CA,CXCL11,MAPK9,TAB3
Interferon type I signaling pathways (WP585);CRK,PTPN6,JAK1,PIAS1,FYN,PTPN11,Zap70,PTPRC,PIAS3,Lck
Senescence and Autophagy in Cancer (WP615);RB1,TP53,E2F1,IGFBP3,HRAS,IFNB1,IFNG,IRF5,IRF7,PLAU,SERPINE1,GSK3B,IFI16,RAF1,CDKN2A,MDM2,SERPINB2,CREG1,CDKN2A,MAP2K1,MAPK1,COL1A1,MAPK14,CDKN1A,MAP2K3,CDKN1B,MAP2K6,CDC25B,TGFB1,IRF1,IGF1,IGF1R,CDKN2A,CXCL1,CXCL14,IL6,IL3,IL8,FN1,THBS1,SPARC,VTN,GSN,ULK1,ATG14,ATG12,ATG5,LAMP2,FRAP1,BECN1,PTEN,ING1,CD44,COL3A1,IGFBP5,PCNA,SMAD3,SMAD4,CDKN2A,CDK2,CDK4,CDK6,CDK2,BMI1,MLL,IGFBP7,BRAF,CDKN1A,CXCR2,IL6R,NFKB,CDKN1A,RNASEL,JUN,BCL2,PIK3C3,AMBRA1,UVRAG,SRC,SH3GLB1,ATG10,ATG7,ATG16,MAP1LC3A,ATG7,ATG3,GABARAPL1,SQSTM1,MAP1LC3B,MAP1LC3C,RSL1D1,SLC39A3,SLC39A2,SLC39A1,SLC39A4,GABARAPL2,GABARAP,INS,ING2,C/EBP-beta,IL24,IL1A,IL1B,CCL3,MMP14,TNFSF15,INHBA,PLAT,BMP2,IL6ST,COL10A1,HMGA1,LAMP1,FKBP8,MLST8,ATG16L1,PIK3C3,RB1CC1,ATG13,AKT1S1
Type II interferon signaling (IFNG) (WP619);IFNG,IFNG,IFNG,IFNGR1,IFNGR2,JAK1,JAK2,JAK2,IFNGR2,IFNGR1,JAK1,IFNG,JAK2,IFNGR2,IFNGR1,JAK1,IFNGR2,IFNG,JAK1,JAK2,IFNGR1,SOCS3,SOCS1,PTPN11,STAT1,STAT1 [P],STAT2 [P],STAT2,STAT1,STAT2,STAT1,IRF9,(ISGF3),IRF9,STAT1,STAT1,IRF9,STAT1,STAT1,STAT1,STAT1,PRKCD,PTP,IRF4,SPI1,STAT1,STAT1,STAT1,STAT1,STAT2,STAT1,IRF9,(ISGF3),STAT1,STAT1,IRF9,IFNA,IFNB1,HLA-B,NOS2A,GBP1,HIST2H4,PSMB9,TAP1,OAS1,CXCL10,CIITA,CYBB,IL1B,IFIT2,EIF2AK2,G1P3,IRF1,ICAM1,CXCL9,G1P2,IRF8 [P],IRF8,IRF2
ErbB Signaling Pathway (WP673);GSK3,NRG4,MDM2,PIK3R3,ERBB4,AKT3,PLCG1,BTC,MAPK8,p53,ERBB3,NRG1,ERBB1,ERBB2,MYC,ARAF,BAD,AREG,GAB1,ELK,TGFA,SOS1,ERBB2,SRC,BIM,GRB2,NRG3,EREG,ERBB2,GRB2,Myc,p21,MAP2K1,JUN,ERBB4,HBEGF,EGF,eIF-4EBP,ERBB2,ERBB1,CRK,ERBB2,ERBB4,ERBB3,PRKCA,p27,CAMK2A,PDK1,mTOR,HRAS,STAT5A,KRAS,CBL,CCND1,PAK4,NCK1,MAP2K7,ERBB1,MAPK1,ERBB3,FAK,ABL1,NRG2,FOXO1,ELK,PLCG2,CAMK2B,CAMK2D,CAMK2G,PRKCB,PRKCG,CBLB,STAT5B,CRKL,ABL2,NCK2,PAK1,PAK2,PAK3,PAK5,PAK6,BUB1B-PAK6,MAP2K4,MAPK9,MAPK10,SHC3,SHC4,SHC1,SHC2,SOS2,NRAS,STAT5A,STAT5B,BRAF,RAF1,MAP2K2,MAPK3,PIK3R2,PIK3R1,PIK3CD,PIK3CB,PIK3CA,AKT2,AKT1,RPS6KB1,RPS6KB2
Polyol Pathway (WP690);KHK,ALDOB,ALR2,SORD
Tamoxifen metabolism (WP691);CYP2D6,CYP2D6,CYP3A4,CYP3A5,CYP3A5,CYP3A4,CYP2C9,CYP2C19,CYP3A4,CYP3A4,CYP3A4,FMO1,FMO3,CYP1A1,CYP1A2,CYP2A6,CYP2C19,CYP2C9,CYP2C8,CYP3A4,CYP2E1,CYP2D6,SULT2A1,SULT1A1,SULT1E1,SULT2A1,CYP3A4,UGT1A4,UGT1A4,UGT2B7,UGT1A8,UGT1A10,SULT1E1,SULT2A1,SULT1A1,UGT1A4,CYP2C19,CYP2D6,CYP1B1,UGT2B15
Arylamine metabolism (WP694);UGT1A9,UGT1A4,CYP1A2,NAT1,SULT1A2,NAT1,NAT2,SULT1A1,NAT2
Glucuronidation (WP698);UGP2,PGM3,PGM5,PGM2,HK1,UGDH,PGM1,UGT2B17,UGT1A4,UGT1A8,UGT2A3,UGT1A6,UGT2B15,UGT2B4,UGT2B10,UGT1A10,UGT1A5,UGT2A1,UGT1A1,UGT1A9,UGT2B28,UGT2A2,UGT2B7,UGT2B11,UGT1A3,UGT1A7
Methylation Pathways (WP704);COMT,NNMT,HNMT,INMT,PNMT,TPMT,MAT1A,MAT2A,MAT2B
Estrogen signaling pathway (WP712);C-FOS,SP1,ERE,ER-AF1,ELK,MAPK1,ER,ER-AF2,GPR30,c-Jun,PI3K,NFKB,Non-ERE,BCL2 Apoptotic switch,GFRs,GNGT1,GNB1,PKB/Akt,CREB,MAPKKK,JNKs,ER,GSA,p38,MAP2K1,PKACA,NFKB,CREB,CHUK,ER,TF,IKBKB,IKBKG
Monoamine Transport (WP727);TSC2,SCAMP2,RBL2,AMPH,STX1A,SYN1,PVRL2,TNF,SLC5A7,FBXO32,SLC6A2,ITGB3,CDC25C,NOS1,ACHE,DBH,TDO2,TNFRSF11B,AGT,SLC6A3,TPH2,HRH3,MAPK14,TGFB1I1,SLC6A1,IL1R1,UNC13B,ADORA2A,TH,PPP2CB,IL1B,SLC6A4
Serotonin Receptor 4/6/7 and NR3C Signaling (WP734);NR3C1,EGR1,ELK4,ATF1,SRF,CREB1,ELK1,MAPKAPK2,RPS6KA5,MAPK3,MAP2K2,MAP2K1,BRAF,RAP1A,GNAS,HTR4,HTR7,HTR6
AMP-activated Protein Kinase (AMPK) Signaling (WP1403);TP53,HMGCR,ADRA1B,INS-IGF2,ELAVL1,CCNA2,CCNA1,p21,CCNB1,ADRA1A,AKT2,PIK3R3,CAMKK2,ADIPOR2,RPS6KB1,4E-BP1,AMPKy3,GYS1,TSC2,AMPKa1,AKT1,ACC1,LEP,SREBF1,INSR,PIK3C3,AMPKy2,mTOR,AMPKy1,PIK3R1,STRADA,AMPKb2,TSC1,PIK3CB,PIK3CA,STRADB,ADIPOR1,PPARGC1B,LIPE,AMPKb1,PLCB1,BORCS8-MEF2B,EEF2K,CPT1B (muscle),GLUT4,FASN,RPS6KB2,CPT1A (liver),Torc2,HNF4A,LEPR,PFK2,PIK3CG,SLC2A4RG,GYS2,CAMKK1,STK11,eEF2,MO25,CPT1C (brain),PRKACB,PIK3CD,AMPKa2,Raptor,PIK3R2,ADIPOQ,PRKACG,ACC2,GLUT4,GLUT4
Sphingolipid pathway (WP1422);CerS1,ASAH2,CerS6,SGPP2,CerS5,CerS4,SPT2,GAL3ST1,FVT1,KDSR,SPT3,COL4A3BP,B4GALT6,ACER1,ASAH1,ASAH1,ACER1,CERK,SPHK2,CerS3,PPAP2A,CerS2,SGPP2,PPAP2A,SPHK1,SPHK2,ASAH2,SPT1,SPHK1,COL4A3BP,GAL3ST1,CERK,B4GALT6,CerS1,CerS6,CerS5,CerS4,CerS3,CerS2,COL4A3BP,SGPL1
Ganglio Sphingolipid Metabolism (WP1423);B3GALT4,B4GALNT1,ST6GALNAC6,SLC33A1,ST6GALNAC6,B4GALNT1,SLC33A1,ST6GALNAC6,FUT1,ST8SIA5,A3GALT2,ST3GAL2,ST3GAL5,B3GALT4,ST6GALNAC6,ST8SIA5,ST8SIA5,ST8SIA3,B4GALNT1,B4GALNT1,ST3GAL1,ST8SIA5,B4GALNT1,B3GALT1,ST3GAL1,ST3GAL5,ST3GAL1,ST8SIA1,B3GALT4,ST8SIA1,FUT1,ST8SIA1,B3GALT4,B3GALT4,ST3GAL2,ST8SIA5,ST6GALNAC6,ST3GAL1,B4GALNT1,ST3GAL2,B4GALNT1,ST3GAL2,ST8SIA5
Bone Morphogenic Protein (BMP) Signalling and Regulation (WP1425);BMP2,BMPR2,BMPR1A,SMURF1,SMAD6,SMAD1,SMURF1,TOB1,SMAD1,SMAD1,SMAD4,SMURF1,SMAD1,RUNX2,SMURF1,SMAD6,BMPR1B,TOB2,SMAD1,NOG
Osteopontin Signaling (WP1434);RELA,RELA,IKK-alpha,PLAU,ERK2,IKK-beta,MEK1,RELA,NFKB1,RELA,NIK,ITGAV,ITGB3,NFKB1,MMP-9,NIK,NFKB1,SPP1,ERK1,NFKB1
Regulation of toll-like receptor signaling pathway (WP1449);LY96,MAPK12,RNF31,IRAK1,MIR105-1,MIRLET7I,PELI1,NFKB1,RNF41,CD80,JUN,IFNA10,TLR1,TIRAP,TLR9,STAT1,IRAK4,TLR5,PIK3R1,NFKB1,TICAM1,IFNA8,MAPK14,TRAF6,AKT2,CCL5,PELI2,TOLLIP,IL12B,PIK3CB,TLR2,PIK3CG,IFNA16,TRAF3,PELI3,TLR6,MAPK10,IRAK2,PIK3R5,MBL2,IFNA2,CHUK,CYLD,TBK1,AKT3,TAB3,NFKBIA,IL12A,IFNA7,SIGIRR,IFNA21,TRAF6,TNF,CD40,IFNA17,IFNB1,CD180,CUEDC2,CASP8,TIRAP,SYK,SPP1,CCL3,TLR2,CXCL10,OTUD5,TLR4,IRAK3,SARM1,PLK1,IFNA14,TLR7,IFNA4,IKBKE,MIR146A,IFNA1,IRF7,MAP2K4,IL1B,MIRLET7E,RBCK1,MYD88,IRAK1,TLR8,MAP3K7,MAP2K6,SOCS1,CTNNAL1,RNF41,TICAM2,TRAFD1,CISH,MIR155,IRF3,CHUK,USP7,BTK,IL6,CD86,MAPK3,IRAK4,PIK3CD,MAPK13,IFNA13,CD14,TNFAIP3,TIFA,TMED7,hsa-mir-98,NEU1,IFNB1,MLST8,RNF216,IFNAR1,MYD88,MYD88,MAPK8,RIPK1,SMAD6,LBP,MYD88,IRF5,TAB2,MAP3K7IP1,IL8,MAPK1,SQSTM1,MAP2K1,SFTPA2,PTPN6,FADD,IFNB1,MAP2K2,IFNAR2,TRAF6,IFNA5,PIK3R3,MYD88,MAP3K8,RAC1,TLR2,PIK3R2,MAP2K7,CXCL9,SFTPD,TLR3,IFNA6,AKT1,MAPK11,MAP2K3,TREM1,TLR4,ZMYND11,RELA,CCL4,IKBKG,NFKB2,IKBKB,FOS,PIK3CA,CXCL11,MAPK9,FBXW5
Target Of Rapamycin (TOR) Signaling (WP1471);PRKAB1,PRKAG3,TSC2,PRKAB2,ULK1,MLST8,RRAGC,RAC1,DDIT4,CDC42,RHEB,PRKAG1,MTOR,HMGCR,PRR5,RPTOR,RRAGD,RPS6KB1,MLST8,ULK3,RRAGB,PRKAA2,RRAGA,AKT1,FKBP1A,ULK2,PRKAA1,DDIT4L,IDI1,AKT1S1,PRR5L,TSC1,MAPKAP1,PRKCA,PRKAG2,EIF4EBP1,MTOR,RICTOR
Physiological and Pathological Hypertrophy  of the Heart (WP1528);MKK3,MEF-2,p38a,PKCb,LIFR,JNK,CamK,CTF1,C-JUN,CalNB,PKCE,Rac1,ET-1,FOS,p38b,RhoA,NFAT3,JNK,CalNA,STAT3,p38,GATA-4,erk,Ang II,gp130
miRNA Regulation of DNA Damage Response (WP1530);RAD51,APAF1,CCNB2,RAD52,RB1,GADD45B,CDKN1A,ABL1,ATR,CDK2,CCND3,GADD45A,CDKN1B,RAD17,RFC,CHEK1,PIDD,TP53AIP1,CCND1,BID,CASP9,GADD45G,CCND2,PML,NBN,CHEK2,FANCD2,CDK5,TLK2,TLK1,GADD45G,SFN,MIR15A,BRCA1,GADD45B,DDB2,PMAIP1,RB1,RPA2,GADD45A,MDM2,FAS,CCNE2,RAD1,PRKDC,CASP8,CCNG1,BAX,CASP3,CDK6,ATM,SESN1,E2F1,CDK4,SMC1A,CYCS,MIR20A,TP53,MIR145,HUS1B,CCNE1,CCNB3,BBC3,RAD50,c-Myc,E2F1,RRM2B,CDK1,CREB1,MRE11,CDC25C,ATRIP,RAD9A,TNFRSF10B,H2AFX,MIR24-1,CCNB1,CDC25A
Angiogenesis (WP1539);MAPK1,ARNT,PI3K,sTIE2,NOS3,SMAD1,PLCG1,MMP9,FGF2,CBP,PDGFB,TIE2,p38 MAPK,HIF1A,TIMP2,MMP9,SRC,PDGFB,FLT1,VEGFR2,MMP9,HIF1A,FGFR2,MMP9,FGF2,AKT1
Energy Metabolism (WP1541);PPARG,TFAM,PPP3CA,PPARGC1A,PPARA,PPARGC1A,PPARGC1A,PPP3R1,PPP3CB,PRKAG3,EP300,PPARGC1A,GSK3B,PPARGC1A,PRKAB1,PPARGC1A,RXRA,PPARA,PPARD,TFB1M,MEF2D,CREB1,PPARGC1A,TFB1M,PRKAB2,TFB2M,TFB2M,UCP2,TFB1M,NRF1,PRKAA1,PPARG,PPARGC1A,MAPK14,MEF2A,FOXO1,GABPA,HDAC1,MEF2B,PPARGC1A,ESRRA,PPARGC1A,MYBBP1A,PPARGC1A,FOXO3,PPARGC1A,PPARA,CREB1,PPARGC1A,PRKAG1,ATF2,PPARGC1A,CAMK4,HDAC1,PPARGC1A,MEF2C,PPRC1,TFB2M,MED1,PPP3CC,PPARGC1A,SIRT1,FOXO3,UCP3,PPARGC1B,TFAM,PPARG,CAMK2G,PRMT1,SIRT3,PRKAG2,PPARD,PPARGC1A,PPP3R2,CAMK4,PRKAA2,NCOA1
MicroRNAs in cardiomyocyte hypertrophy (WP1544);MIR199A1,MIR15B,WNT3A,MIR103A2,STAT3,ERK1,MIR15B,MIR125B2,MIR23A,LIF,LRP5,MIR23A,MLCK3,MIR30E,MIR195,RCAN1,MIR125B2,MIR195,PKC-beta,MIR30E,MIR21,PKC-beta,MIR15B,MIR195,MIR15B,MAPKKK,MIR125B2,MIR130B,MIR103A2,MIRLET7B,MIRLET7B,MIR30E,Rac1,HDAC 4,HDAC 9,PDK,MIR195,IGFI,MIR199A2,MIR195,JNK,ERK2,MIR133B,IKKa,MIR125B1,CDK 7,MIR199A1,MIR199A1,MIR130B,MIR23A,MIR195,MIR195,MIR140,MIR133A1,Beta-catenin,MIR21,MIR15B,IKKg,MIR199A1,Ang II,MIR23A,Dvl1,NFAT3,MIR140,GSK3-beta,MIR199A2,ERK5,PIK3CA,CT-1,MIR195,MIR199A1,MEK2,MIR208A,PIK3R1,MIR27B,MIR199A2,ERK1,PIK3R2,MIR15B,MIR30E,MEK4,NF-kappa-B,MIR195,MIR133A2,MIR133A2,MIR27B,MIR199A1,MIR195,MIR195,MIR103A1,MIR27B,MIR199A1,IGF-1 R,NIK,MIR125B1,MIR15B,HDAC 7,MIR27B,MIR125B2,MIR27B,SOCS,NFAT3,MIR140,HDAC 4,NFAT3,MIR15B,MIR30E,MIR15B,ERK2,ROCK1,MIR27B,MIR27B,PDK1,MIR185,CDK 9,PKG I,PIK3CD,PLC,I-kappa-B,p38,FGFR2,MAPKKK,MLCK1,MIR214,RAF1,MIR199A2,MIR208A,MIR27B,MIR199A2,ET-1,MIR27B,MIRLET7B,MIR23A,MIR15B,HDAC 9,IKKb,HDAC 7,MIR133A1,gp130,FZD2,LRP6,MIR199A2,MIR23A,MIR125B1,MEK7,PIK3CB,MIR15B,GSK3-beta,PIK3R3,Neuregulin,MIR199A2,EGF,MIR21,MEF-2,JNK,CalNB,MIR195,AKT2,TGF-beta,MIR125B1,mTOR,FGF2,MEK3,Ang II,MAPKKKK,MEK5,MIR15B,ANP,MIR21,MAPKKK,PLA2,MIR23A,PIK3CG,STAT3,TNF-alpha,MIR133B,ROCK2,MIR30E,p38,MIR15B,MIR30E,MEK1,MIR208A,BNP,MIR133A2,HDAC 5,MIRLET7B,RhoA,MIR30E,WNT5A,GATA4,MIR103A1,eIF2B,MIRLET7B,MIR185,AKT1,CalNA,CamK,MIR30E,TAK1,MIR133B,MEK6,FZD1,HDAC 5,MIR27B,MIR133A1,NF-kappa-B,MIR195,MIR130B
miRNAs involved in DNA damage response (WP1545);MIR18A,MIR371A,E2F1,c-Myc,MIRLET7F1,ATM,MIR542,MIRLET7D,MIR106B,c-Myc,MIR372,MIR424,MIR223,MIR29B1,MIR210,MIR3074,MIR374B,MIR450B,ABL1,CDK6,MIR27B,CDKN1A,MIR143,CCND1,MIR29C,MIR23A,MIR15A,CCNE1,MIR503,MIR195,MIR450A2,MIRLET7A1,MIR16-1,MIR21,MIR25,CDKN1B,MIR221,MIR19A,MIR181A1,H2AFX,MIR93,MIR29A,CCND3,MIR181B1,MIR100,MIR203A,MIR145,MIR34B,MIR19B1,CREB1,MIRLET7B,MIR373,MIR34C,MIR497,CDC25A2,MIR222,MIR421,MIR23B,CCND1,MIR449A,TP53,MIR27A,MIR15B,MIR17,MIR20A,MIR92A1,E2F1,MIR449B,RAD52,MIR330
Type II diabetes mellitus (WP1584);KCNJ11,TNF,INSR,MAPK1,MAFA,SLC2A4,SLC2A2,PRKCZ,INS-IGF2,PIK3R5,ADIPOQ,PHKA2,MAPK8,GK,IKBKB,CACNA1A,INS-IGF2,SOCS4,MAPK8,IRS1,MTOR,PDX1,PRKCD,SURF1,IRS1
Nicotine Metabolism (WP1600);CYP2B6,FMO3,CYP2A6,CYP2A6,UGT1A4,AOX1,CYP2A6,UGT1A9
Fluoropyrimidine Activity (WP1601);UPP1,TK1,SLC22A7,ABCC5,DHFR,CDA,TDG,ABCC3,UPP2,DPYD,MIR29C,UPP1,FPGS,ABCC4,SMUG1,TYMS,TYMP,MTHFR,DPYS,RRM1,UMPS,UCK1,XRCC3,ERCC2,CES1,UCK2,GGH,CYP2A6,ABCG2,TP53,RRM2,SLC29A1,UPB1,UPP2,TYMP,PPAT,ABCC4,CES2
Nicotine Activity on Chromaffin Cells (WP1603);CACNA1G,CHRNB4,CHRNA3,CACNA1C
TP53 Network (WP1742);CDKN1A,BID,ABL1,BOK,BAX,PMAIP1,MYC,BCL2,TP53,CDKN2A,BBC3,TP73,GADD45A,TMEM212-IT1,TP63,ATM,OTX2,MDM2,TNFSF10
Apoptosis Modulation and Signaling (WP1772);MIR29B1,CASP2,AIFM1,CASP4,CASP1,HSPA1A,PIDD,TP53,PRKD1,NAIP,XIAP,AIFM2,RIPK1,PEA15,RIPK1,MIR29B2
Integrated Cancer Pathway (WP1971);ATF1,CDC25B,CDC25A,BACH1,PLK1,MYC
SRF and miRs in Smooth Muscle Differentiation and Proliferation (WP1991);CAMK2D,MYOCD,KLF4,SRF,MEF2D,NKX2-5,CCND2,MYOCD,ELK1,MEF2A,KLF4,ELK1,SRF,SRF,MEF2B,MEF2C,SRF
Effects of Nitric Oxide (WP1995);NOS3 (endothelial),HBA1,deoxy-myoglobin,NOS1 (neuronal),COX1,NOS2 (inducible),XDH
Iron metabolism in placenta (WP2007);SLC40A1,IREB2,HEPHL1,ACO1,STEAP3,STEAP3,STEAP3,SLC11A2,MCOLN1,MCOLN1,SLC11A2,TFR2
miRs in Muscle Cell Differentiation (WP2012);ELSPBP1,MYOD1,MYF5,MYOD1,PAX7,MIR486-1,MIR214,MEF2C,SRF,MEF2D,MEF2A,EZH2,ID2,MEF2B,MIR133A1,MIR133A2,PRKAR1B,PRKAR2A,PRKACA,PRKAR2B,PRKACB,PRKAR1A,PRKACG,PRKD3,PRKCA,PRKCI,PRKCB1,PRKCQ,PRKD1,PRKCG,PRKCE,PRKCH,PRKCZ,PRKCD,MIR486-2
Cell Differentiation (WP2023);MIR155,TLX1,MIR221,MIR206,MIR150,MIR223,SOX2,STAT3,MIR143,MIR181C,MIR133A2,MIR223,MIR3074,MIR486-1,MIR155,MIR451A,MIR26A1,SRF,MYOD1,MIR150,SRF,MEF2B,MIR302C,TLX3,SRF,MIR222,EZH2,MIR133B,MIR146B,TLX2,HDAC5,MIR145,MIR9-3,MIR128-1,MIR302E,LEFTY2,MIR199A1,MIR9-2,ID2,MIR1-1,MIR181A1,MEF2C,KLF4,MIR133A1,MIR199A2,MIR26A2,MIR203A,LEFTY1,PAX7,MEF2D,MIR222,MIR181B1,MIR192,MIR302D,MIR1-1,MIR221,MIR146A,MIR181B2,MIR106A,MEF2A,MIR296,MIR3074,MIR124-1,MIR20A,MIR3591,SRF,MIR17,MIR181D,RUNX2,MIR24-2,MIR9-1,MIR16-2,MIR214,MIR16-1,MIR181A2,MIR17,MIR302A,MIR302B,MIR133A1,MIR133A2,MIR133B,MIR1-1,MIR133A2,MIR133A1,MIR133B,MEF2C,MEF2B,MEF2A,MEF2D,MYOD1,MIR181A2,MIR181A1,MIR133A2,MIR133A1,MIR133B,MIR1-1,MIR133A2,MIR133A1,MIR133B,MIR1-1,MIR486-2
Cell Differentiation (WP2029);MIR155,TLX1,STAT3,MIR223,TLX3,SRF,TLX2,HDAC5,LEFTY2,LEFTY1,MIR20A,MIR17,MIR133A2,MIR133A1,MIR133A2,MIR133A1,MIR133A2,MIR133A1,MIR223,MIR155,MIR17
Human Thyroid Stimulating Hormone (TSH) signaling pathway (WP2032);CCND3,CCND3,MAP2K1,MAPK3,PIK3R2,STAT1,TSHB,CGA,HRAS,RAF1,BRAF,GNB1,GNG2,SCRIB,KCNIP3,TSHR,STAT3,PDPK1,PIK3CA,PIK3R1,CDK2,SRC,MAP2K3,MAP2K6,AKT1,PRKCZ,RPS6KB1,MAPK1,RB1,CREB1,PDE4D,GNAI1,GNA13,GNAI2,GNA12,GNAO1,GNAQ,GNAI3,MYL12B,RALGDS,GNAS,JAK2,JAK1,RPS6,MTOR,ADCY2,ADCY3,CDK2,CDK4,RPS6KA1,PLD1,PLCB1,RAP1B,RAP1A,RHOA,CCNE1,MAPK14,CDKN1B,CCND3,CDK4,RAP1GAP,APEX1,APEX1
Prolactin Signaling Pathway (WP2037);PRL,PPIB
IL17 signaling pathway (WP2112);TRAF6,IL17RD,IKBKG,MAPK1,RELA,GSK3B,SP1,NFKB1,IL17RE,IL17A,AKT1,IL17F,TRAF3IP2,JAK2,IKBKB,IL17D,STAT3,NFKBIB,IL17C,IL25,IL17RC,MAP3K7,CEBPB,IL17RA,IL17RB,MAP3K14,IL17B,CEBPD,MAPK1,JAK1,TRAF3,TRAF3IP2,MAP3K7,TRAF6,TRAF3IP2,NFKB1,RELA,MAPK3
Metastatic brain tumor (WP2249);E2F3,TP53,CDC42,MIR29A,CDK6,MYC,MIRLET7A1,MIR29C,MIRLET7A3,MIRLET7C,MIRLET7D,MIRLET7E,MIRLET7F1,MIRLET7G
Signaling Pathways in Glioblastoma (WP2261);FGFR1,PIK3C2B,SPRY2,CCND1,MAP2K1,RB1,PTEN,IGF1R,AKT1,CCNE1,CDKN2A,PDPK1,IRS1,FOXO1,ERRFI1,PIK3R1,TSC1,ERBB3,GRB2,PIK3C2A,PIK3C2G,PIK3R2,PIK3CA,PIK3CB,PIK3CD,AKT2,AKT3,SRC,GAB1,PIK3CG,FOXO3,FOXO4,PDGFRA,PDGFRB,ERBB2,EGFR,FGFR2,MET,CBL,NF1,NRAS,KRAS,HRAS,ARAF,BRAF,RAF1,PLCG1,PRKCZ,PRKCQ,PRKCH,PRKCG,PRKCD,PRKCI,PRKCB,PRKCA,PLCG2,MAP2K2,MAP2K3,MAP2K4,MAP2K5,MAP2K6,MAP2K7,MAPK1,MAPK3,CDKN1B,CDK2,CDKN1A,TSC2,CDKN2C,CDKN2B,CCND1,CCND2,CCND2,CDK4,CDK6,E2F1,CDKN2A,MDM2,MDM4,TP53,EP300,ATM,BRCA1,BRCA2,BRCA1,MSH6
Synaptic Vesicle Pathway (WP2267);SYN1,RAB3A,SYN2,SYN3,SYT1,VAMP2,STX1B,STX2,STX1A,STX3,SNAP25,RIMS1,STXBP1,RAB3A,UNC13C,UNC13B,UNC13A,CPLX3,CPLX2,CPLX1,NAPA,NSF,CACNA1A,CACNA1B,RAB3A,SYP,DNM1,DNM1L,DNM2,DNM3,CLTA,CLTC,CLTCL1,AP2S1,AP2A1,AP2A2,AP2B1,AP2M1,SLC32A1,SLC17A8,SLC17A7,SLC17A6,SLC18A1,SLC18A2,SLC18A3,SLC32A1,SLC22A3,SLC38A1,PARK7,SLC1A3,CLN8,SLC6A4,SLC25A4,ATP1A2
Pathogenic Escherichia coli infection (WP2272);TUBB6,KRT18,ARHGEF2,ARPC5,TUBB8,OCLN,TUBA8,EZR,ABL1,ITGB1,TUBB3,WASL,TUBB2B,FYN,CDC42,TUBB2C,TUBA4A,TUBA3C,TUBB4,TUBA1C,ACTG1,TLR5,TUBA3E,PRKCA,TUBA1A,YWHAZ,ACTB,CLDN1,LY96,CTTN,actin-related protein 2/3 complex subunit 1B-like,NCL,WAS,TUBA3D,HCLS1,ROCK1,TUBA1B,ARPC1A,ARPC4,CTNNB1,ARPC3,RHOA,TUBAL3,ARPC5L,ROCK2,TUBB4Q,occludin-like,TUBB1,ARPC2,CD14,TUBB,CDH1,NCK1,NCK2,YWHAQ,TUBB2A,TLR4,ARPC1B,TUBB6,TUBB1,TUBB4Q,TUBB8,TUBB2B,TUBB4,TUBB2C,TUBB,TUBB2A,TUBB3
RalA downstream regulated genes (WP2290);ZONAB,SEC5,EXOC84,RALBP1,CDC42,RAC3,RAC2,RAC1,HRAS,KRAS,NRAS,RalA
Allograft Rejection (WP2328);GDNF,C5,CCL19,VEGFA,MICA,BHMT2,LRRK2,PECR,GDNF,PDGFRA,STAT1,IL21,C5,CXCL11,IL2,CXCR5,GNLY,HARS,BHMT2,CXCL9,CCL19,CXCL9,CXCL13,CSNK2A2,C3,TUBA1B,PDGFRA,GDNF,CXCL12,CCL21,GABPA,AGTR1,CXCL11,CSNK2A2,C3,CCL21,IL1A,C4A,COL5A1,CXCL8,HARS,IFNG,CXCL11,CXCL9,VIM,IL21,IFNG,ABCB1,CD28,IFNG,IL13,IL4,IL12B,HLA-B,TRBV,IL10,HLA-G,HLA-F,PRF1,HLA-C,IL2,IL21,FOXP3,IL22,HLA-E,GZMB,TGFB1,IL10,TNF,TRAV,IL5,IL17A,IL4,IL12A,IFNG,IL5,CD40LG,CD40,FAS,HLA-A,FASLG,BOLA class I histocompatibility antigen,CTLA4,C2,C9,C8B,C6,CD55,C1QA,C1QB,C4A,C7,C8A,C4B,C1QC,C3,CD55,CD40LG,CD40,CASP8,CASP7,CASP3,CASP9,PRKCZ,IL2RA,IL1B,HLA-DRB3,HLA-DRA,HLA-DMB,HLA-DRB1,HLA-DQA2,HLA-DPA1,HLA-DOB,HLA-DRB4,HLA-DOA,HLA-DQA1,HLA-DQB1,HLA-DRB5,CD80,HLA-DMA,HLA-DPB1,CD28,CD80,HLA-E,HLA-G,HLA-F,HLA-B,HLA-C,HLA-A,CD86,GZMB,PRF1
Interleukin-11 Signaling Pathway (WP2332);IKBKB,PIK3R2,IL6ST,IL11RA,IL11RA,IL6ST,YES1,JAK2,STAT3,IL11,IL11,PIK3R1,PPP2R4,RAF1,HRAS,PTPN11,GRB2,FYN,RPS6,RPS6KA1,AKT1,MAPK3,MAPK1,STAT1,CREB1,ATF1,CHUK,RELA,BIRC5,BCL2,SOCS3,RUNX2,BGLAP,IBSP,ICAM1,SOCS3,SRC,JAK1,STAT3,TYK2,MAP2K1,MAP2K2,RPS6KB1,RELA,FES,TGFB1,PIAS1,PIAS3,PIAS1,PIAS3,ITGA2,STAT1,PDPK1
Parkin-Ubiquitin Proteasomal System pathway (WP2359);UBE1,UBCH8,UBCH7,UBE2J1,UBE2J2,UBE2G1,UBE2G2,Cullin 1,Cyclin E,Caspase-1,Septin 5,TUBA4A,TUBAL3,TUBB8,PSMD11,PSMD8,HSPA8,FBXW7,Parkin,Synphilin 1,CASK,Caspase-8,CHIP,PAELR,Alpha-synuclein,SIAH1,DORFIN,SIAH2,TUBA3E,TUBA3D,TUBA3C,TUBA1C,TUBA1B,TUBA1A,TUBA8,TUBA4B,TUBB6,TUBB4Q,TUBB4,TUBB3,TUBB2C,TUBB2B,TUBB2A,TUBB1,TUBB,PSMD10,PSMD1,PSMC6,PSMC5,PSMC4,PSMC3,PSMC2,PSMC1,PSMD7,PSMD6,PSMD5,PSMD4,PSMD3,PSMD2,PSMD14,PSMD13,PSMD12,PSMD9,HSPA7,HSPA6,HSPA5,HSPA4,HSPA2,HSPA1L,HSPA1B,HSPA1A,HSPA14,HSPA9
Gastric Cancer Network 2 (WP2363);MTDH,CD48,LMNB2,UBE2C,COL9A3,PLAC8,TP53,COL9A1,UBE2T,RNF144B,FANCI,SNURF,RAD17,DSCC1,RFC3,CHTF18,TOP2A,LBR,OTUD5,CACYBP,S100A6,AHCTF1,CTNNB1,FAM91A1,ATAD2,CEBPZ,MYC,BRIX1,CHTF8,RFC4,EGFR
Spinal Cord Injury (WP2431);TNFSF13B,TNFSF13,LTB,CSPG4,PTPRZ1,LTB4R,PDYN,PLXNA2,CD47,NGFR,AIF1,APEX1,AQP1,C1QB,LGALS3,FECHP1,CDC42,LEP,MIF,ZFP36,FCGR2A,PRB1,PTPRA,IL1B,ZFP36,NOS2,TNF,NR4A1,IL4,BTG2,BTG2,CDK2,NOS1,IL2,TNF,IL6,TLR4,FOS,IL1B,TGFB1,TLR4,TNF,EGR1,FOS,MMP12,IFNG,MBP,RTN4,C5,CXCL1,CXCL8,AQP4,IL1B,NOS2,TNF,ARG1,EPHA4,EFNB2,CXCL10,CCNG1,MMP9,NCAN,SLIT1,SLIT2,SLIT3,NTN1,RGMA,MMP9,MMP9,MMP9,CCR2,IL1R1,IL1A,CXCL1,CXCL2,CCL2,PLA2G6,PLA2G5,PLA2G2A,ANXA1,ICAM1,SELP,KLK8,GFAP,CDK4,TACR1,E2F5,RB1,PRKCA,E2F1,MAPK1,CCND1,MYC,GADD45A,MAPK3,TP53,CHST11,VCAN,COL4A1,XYLT1,COL2A1,ACAN,BCAN,SOX9,TP53,GRIN1,VIM,PPP3CA,GAP43,FKBP1A,IL2,MAG,RTN4,RHOA,RHOC,RHOB,ROCK2,OMG,RTN4R,LILRB3,PTGS2,ROS,NOX4,CDK1,GDNF,SEMA6A,GJA1,BDNF,RAC1,FOXO3,CDKN1B,EGFR,CASP3
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) (WP2453);DLST,DLD,ACO1,FH,MDH1,OGDH,IDH1,PCK1,ACLY,IDH1,CS,SUCLG2,PDHA1,IDH3A,SDHA,PC,DLAT,OGDH,PDHA1,DLD
NAD Biosynthesis II (from tryptophan) (WP2485);TDO2,AFMID,KMO,KYNU,HAAO,QPRT,NMNAT1,NADSYN1
Nanomaterial induced apoptosis (WP2507);BCL2,CASP7,CASP9,BAK1,BID,CASP8,CFLAR,FADD,FAS,FASLG,APAF1,CYCS,AIFM1,DIABLO,CASP6,CASP3,BAX,PRF1,ENDOG,HTRA2
Nanoparticle triggered regulated necrosis (WP2513);TNFRSF1A,CASP8,TRADD,TICAM1,RIPK1,FADD,PARP1,PLA2G4A,MAPK8,RIPK3
ATM Signaling Pathway (WP2516);CDC25A,Cyclin B,GADD45A,CREB1,CDKN1A,TP73,CDC25C,CDK1,ATM,RAD9A,PIDD1,RAD51,CDC2,CCNE1,ABL1,MAPK9,TP53,ATF2,JUN,TP53BP1,ATM,ATM,ATM
Trans-sulfuration and one carbon metabolism (WP2525);PHGDH,PSAT1,MAT2B,MAT1A,MAT2A,DNMT1,DNMT3A,DNMT3B,DNMT3L,PSPH,AHCY,AHCYL1,AHCYL2,SHMT1,SHMT2,AMT,TYMS,DHFR,DHFRL1,MTHFD1,MTHFD2,MTHFD2L,MTHFD1L,MTHFD1L,MTHFD1,MTHFD2,MTHFD2L,MTR,BHMT,SHMT1,SHMT2,AMT,MTHFR,CBS,CTH,GSS,GCLC,GCLM,GSS
PDGF Pathway (WP2526);RASA1,PDGFRB,MAPK3,MAP2K4(JNKK1),PLCG1,PDGFA,MAPK1,PDGFB,H-Ras-1(Ras),PDGFA,NFkB,PLA2G4A
Sulindac Metabolic Pathway (WP2542);MSRA,MSRB2,CYP1B1,MSRB3,CYP1A2,CYP1A2
Gene regulatory network modelling somitogenesis (WP2854);FGF8,TBX6,RIPPLY2,MESP2,EPHA4,HES7,HES1,NICD,LFNG,NOTCH1,DLL1,WNT3A,NOTCH1,DLL1,WNT3A,FGF8,FGF8
Apoptosis-related network due to altered Notch3 in ovarian cancer (WP2864);NET1,ERBB3,TNF,SERBP1,APOE,CUL5,SQSTM1,TNFRSF10B,RIPK2,CUL1,CDKN1A,AKT1,HSPB1,CTNNA1,HSPD1,HELLS,ANXA5,HDAC1,NFKB1,TRAF1,NGFRAP1,RNF7,PTK2,ETS1,MAPK1,CDKN1B,RPS6KB1,AXIN1,SMAD7,VIM,PKN1,IER3,CSDA,CARD14,NQO1,GCLC,JUND,F2R,BIRC5,THBS1,TNFRSF21,APP,CASP7,NRG1,ABL1,PAK2,SOCS3,IL7R,PTK2B,VAV3,ERN1,HSPA5
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer (WP2868);STAT3,ERK1,JAK1,ERK2,EGFR,STAT3,EGFR,JAK1,STAT3
Aryl Hydrocarbon Receptor Pathway (WP2873);EP300,HSP90AA1,SRC,AIP,AHR,EGFR,HSP90AA1,TNF,ARNT,CDC37,AHR,ARNT,AIP,SRC,SRC,CDC37,AHR,ARNT,AHR,PTGES3,PTGES3,NCOA1,UGT1A3,SLC7A5,UGT1A4,MYOF,IFNG,SERPINB2,TGFB1,CAP2,UGT1A9,POLK,UGT1A7,IL12A,CES3,IL17B,IL1B,JUNB,IL12B,MGST1,UGT1A6,AHRR,CDKN1B,CYP1B1,UGT1A1,ALDH3A1,GSTA2,JUND,NQO1,IGFBP1,NFE2L2,BAX,JUN,CYP1A2,IL2,HES1,CYP1A1
Constitutive Androstane Receptor Pathway (WP2875);NR1I3,RXRA,PTPA,HSP90AA1,NR1I3,HSP90AA1,RXRA,NR1I3,DNAJC7,DNAJC7,NCOA6,SP1,NCOA1,PPARGC1A,NCOA2,SMC1A,CYP2C9,ABCB1,UGT1A1,ABCC2,CYP2A6,CYP4A11,CYP2C19,SULT1A1,GSTA2,CYP3A5,SULT2A1,CYP3A4,ALAS1,EHHADH,CYP2B6,ABCC3,UGT1A4,UGT1A6,UGT1A9,UGT1A3,FOXO1
PPAR Alpha Pathway (WP2878);PPARA,RXRA,PPARA,RXRA,ACAA1,UGT1A9,NR1H3,SCP2,CPT1A,APOC3,FABP1,CCND1,PLTP,DBI,APOA2,CPT2,APOA1,CYP4A11,ACADM,CDK4,CYP7A1,MYC,SLC27A1,KLK15,APOA5,CDK1,CYP8B1,EHHADH
Estrogen Receptor Pathway (WP2881);SP1,ESR1,JUN,ESR1,ESR1,ESR1,ESR1,ESR1,ESR1,ESR1,PDK4,STAT3,ACOX1,GPAM,PCK1,CYP1A1,PPARA,CYP1A2,NR0B2,CYP1B1
miRNA targets in ECM and membrane receptors (WP2911);LAMA4,SDC2,MIR30C1,MIR30D,COL3A1,THBS2,COL4A2,COL4A1,COL5A3,COL6A1,COL6A2,COL1A2,COL5A2,COL6A3,COL5A1,TNXB,LAMB2,THBS1,LAMC1,FN1,MIR30C2,MIR141,MIR148B,MIR200A,MIR25,MIR532,MIR589,MIR548AA1,MIR548AA2,MIR141,MIR30B,MIR92A2,MIR200C,ITGB6,ITGB5,ITGA11,ITGA1,MIR200B,MIR200C,MIR200B,MIR429
DDX1 as a regulatory component of the Drosha microprocessor (WP2942);ATM,DDX1,NBN,DGCR8,MRE11,RAD50,DROSHA,DDX1,DDX1
Overview of nanoparticle effects (WP3287);CDH3,PTK2,CRP,PTGS1,PTGS2,HMOX1,ITGAD,PIK3CD,AKT3,FN1,COL4A1,NFRKB,BAX,IL6,CXCL8,BCL2,TNF,CCND3,LAMA3
let-7 inhibition of ES cell reprogramming (WP3299);MYC,TRIM71,EGR1,MIRLET7A1,SOX2,KLF4,OCT4,MIRLET7A2,MIRLET7A3,MIRLET7C,MIRLET7D,MIRLET7E,MIRLET7F1,MIRLET7F2,MIRLET7G,MIRLET7I
MFAP5-mediated ovarian cancer cell motility and invasiveness (WP3301);TNNC1,CREB1,MFAP5,ITGB3,TNNC1,RYR3,PLCG1,PTK2,PRKCQ,ITPR3,JUN,ITGAV,MAPK1,PTK2,PRKCQ,PLCG1,TNNC1,CREB1,CREB1,MAPK1,JUN,MAPK3,MAPK3
FTO Obesity Variant Mechanism (WP3407);ARID5B,IRX3,IRX5,UCP1,PRDM16,PPARGC1A,TBX1,FTO,FTO
NOTCH1 regulation of human endothelial cell calcification (WP3413);NOTCH1,LPAR1,SOX6,ALPL,SAT1,CALU,FGFR3,ITGA1,GJA5,VEGFA,DLL1,DLL3,DLL4,JAG1,JAG2
Initiation of transcription and translation elongation at the HIV-1 LTR (WP3414);NFATC4,NFATC3,NFATC2,EP300,CREBBP,CDK9,CCNT1,HEXIM1,NELFA,NELFB,SUPT4H1,SUPT5H,SP1,PPP3CA,PPP3CB,PPP3CC,PPP3R1,PPP3R2,HDAC1,NFKBIA,NFATC1,RELA,NFATC4,NFATC3,NFATC2,NFATC1,NFKB1,NFATC4,NFATC3,NFATC2,NFATC1,NFKBIA,RELA,NFKB1,RELA,NFKB1,RELA,NFKB1,RELA,NFKB1,NFATC4,NFATC3,NFATC2,NFATC1,NFKB1,NFKB1,CREBBP,EP300,CDK9,CCNT1,NELFCD,NELFE,CDK9,CCNT1,SP1,SP1,HDAC2,HDAC3,HDAC4,HDAC5,HDAC7,HDAC8,HDAC9
Preimplantation Embryo (WP3527);H2AFY2,BARX2,TEAD4,DDIT3,IRX5,NR3C2,SIX3,E2F5,KHSRP,DPPA3,ZFP36L2,NLRP5,CELF3,NANOGNB,BATF3,FOXD1,PADI6,NKX2-1,GATA3,ELAVL1,ZAR1,ZSCAN4,EGR1,ARGFX,HNRNPAB,ESRRA,GATA2,MYBL1,IRF4,TPRX1,DPRX,MOS,LEUTX,ZFP36,DLX2,MXD1,FOXQ1,TFAP2B,HMGA1,PBX1,SOX11,TCF7L1,FOSB,MTA3,SOX8,SOX2,POU5F1,NANOG,KLF4,DPPA3,DNMT3L,KLF4,ZFP42,TBX3,CDX2,SMARCA4,CDH1,ATP1A1,AQP3,AQP9
Zinc homeostasis (WP3529);MTF1,SLC30A1,SLC39A13,SLC39A9,SLC39A10,SLC39A12,SLC39A8,SLC39A5,SLC39A4,SLC39A3,SLC39A2,SLC39A1,MT1A,SLC30A1,MT1B,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,MT2A,MT3,MT1L,MT4,SLC39A7,SLC39A11,SLC39A9,SLC30A9,SLC30A4,SLC39A8,SLC30A10,SLC30A3,SLC30A4,SLC30A2,SLC39A14,SLC30A5,SLC30A2,SLC30A7,SLC30A4,SLC30A6,SLC39A6,SLC30A8
Methionine De Novo and Salvage Pathway (WP3580);MAT2A,MAT2B,AHCY,MTR,BHMT,CHDH,MSRA,MSRB2,MSRB3,AMD1,TAT,IL4I1,ODC1,SRM,SMS,MTAP,MRI1,APIP,ADI1,ENOPH1,ADI1,MAT1A
MECP2 and Associated Rett Syndrome (WP3584);NCOR1,MYT1,POU4F1,DLX5,MTOR,APOC2,FGF4,HDAC1,BDNF,NF1,SST,NREP,FUT8,TET3,MECP2,POU3F2,FGF3,DLX6,SMC3,GRIN1,MEF2C,TAP1,UBE3A,RBFOX1,CNP,TET2,SGK1,FKBP5,RPS6,EZH2,GAMT,AKT1,MPP1,OPRK1,ARHGEF26,SIN3A,IGF2,SP1,GAD1,TAF1,HNRNPH1,CSRP1,DLX5,GRID1,CDON,MYT1,CEBPD,CAMK2A,MBP,BCL6,GABRR2,CTCF,SP3,PRPF38A,E2F1,GRIA1,FGF5,REST,MAG,FGF2,GPRIN1,TET1,HNRNPF,YBX1,MECP2,MECP2,MECP2,SP1,CREB1,RPS6,BDNF,GAMT,MECP2
mir-124 predicted interactions with cell cycle and differentiation (WP3595);SIX4,STRADB,STK11,PRKAA1,PTBP1,CTDSP1
Transcription factor regulation in adipogenesis (WP3599);INSR,RXRA,LPIN1,PCK2,CEBPA,SLC2A4,PPARG,CREB1,CEBPB,CEBPD,NR3C1,NRIP1,IRS1,IRS2,ADIPOQ,LEP,MAPK8,FOXO1,TWIST1,PPARGC1A,TNF,IL6,NRIP1
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling (WP3612);GCLM,GCLC,GSTP1,JUN,ABCG2,FOS,ABCC3,ABCC2,KEAP1,ABCC4,ABCC6,HMOX1,MAPK12,MAPK13,MAPK11,NFE2L2,MAPK14,MAPK8,KEAP1,NFE2L2,NFE2L2,EPHX1,CES1,NQO2,SRXN1,NQO1
Photodynamic therapy-induced HIF-1 survival signaling (WP3614);ARNT,PFKL,SLC16A1,LDHA,HIF1AN,PKM2,PGK1,SLC2A1,EGLN1,HK1,SLC2A3,HIF1A,HIF1A,SERPINE1,EDN1,NOS2,PTGS2,ANGPT1,VEGFA,IGFBP1,IGFBP2,VEGFA,TGFA,TGFB3,IGFBP3,TGFB3,TGFA,EPO,ANGPT2,BIRC5,PTGS2,BCL2A1,MCL1,BCL2L1,BNIP3,BNIP3L,BID,PMAIP1,TP53,BAX,BAK1
Caffeine and Theobromine metabolism (WP3633);CYP1A2,XDH,CYP1A2,NAT2,XDH,CYP1A2,CYP2A6,XDH
NAD+ metabolism (WP3644);NT5E,NADK,NMNAT1,NAMPT,NMNAT2,PARP1,NMNAT3,NRK,CD38,NAMPT,SIRT1,SIRT2,PARP1,NAMPT,SIRT1,SIRT2,SIRT5,SIRT6,SIRT7,SIRT3,SIRT4,SIRT5
Hypothetical Craniofacial Development Pathway (WP3655);TFAP2A,TP63,IRF6,TGFB3,WNT1,RHOA,ARHGAP29,FGD5P1,RHOA
Metabolism of Dichloroethylene by CYP450 (WP3666);CYP2E1,CYP2E1,CYP2E1
Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway (WP3670);SIRT1,ECSIT,LOXL4,NQO1,NRF1,TGFB1,NFE2L2,CDC37,BMP2,COL2A1,SUV39H1,EXOC6,PKD1,FN1,ANXA5,FGF7,DDR1,IGFBP7
Tgif disruption of Shh signaling (WP3674);TGIF2,SHH,NKX2-1,FGF8,SMAD2,MIR34A,FOXG1,TGIF1,GLI3,NODAL
Amplification and Expansion of Oncogenic Pathways as Metastatic Traits (WP3678);VCAM1,SRC,POSTN,VHL,VEGFA,CYTIP,JAG1,PIK3CG,TCF7,TNC,NOTCH1,CXCR4,EPAS1,PIK3CG,TCF7L1,TCF7L2,LEF1
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities (WP3844);TSC2,NOS3,GRB10,RPTOR,FOXO3,AKT1,TFEB,FOXO1,RB1CC1,PTEN,BAD,ULK1,PDK1,EIF4EBP1,MTOR,CDKN1B,MTOR,GSK3B,ATG13,RHEB,GSK3B,RICTOR,FOXO4,PIK3CA,PIK3CB,PIK3R1,PIK3R2,PIK3R3,PIK3CG,HRAS,NRAS,KRAS
MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ (WP3849);RRAS,RAF1,MAPK1,TRAF6,NFKB1,IKBKB,CHUK,IKBKG,NFKB1,MAPK1
TLR4 Signaling and Tolerance (WP3851);TIRAP,IRF3,IRAK1,TRAF6,MYD88,TRAF3,NFKB1,TBK1,IFNB1,TAB2,TRAM1,TLR4,TAB1,IL6,IRAK4,IRF3,NFKB1,IRF7,IRF7
Toll-like Receptor Signaling (WP3858);TLR5,TLR7,TLR8,TLR9,MYD88,IRAK4,IRAK1,TIRAP,TLR4,TLR1,TLR2,TLR2,TLR6,TOLLIP,TIRAP,TRAF6,TLR4,TLR3,TICAM2,TICAM1,TRAF3,IKBKE,TBK1,IRF3,IRF7,IKBKB,NFKB1,NFKB2,RELA,RELB,c-REL,MAPK1,MYD88,MYD88,CHUK,IKBKG
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection (WP3863);PTPN6,PLCG1,NFKBIA,PRKCQ,RAF1,TNF,IL2,GRB2,NCK1,MAP3K14,PTPRC,RRAS,LCP2,CBL,MAP3K8,AKT1,JUN,CHP1,GRAP2,IL4,DLG1,TRAJ10,IKBKG,JUN,MAPK3,MAP2K2,MAP2K1,IKBKB,CD8A,LAT,IL10,MALT1,PDK1,FYN,PIK3CA,LCK,CTLA4,MAP2K7,CD3D,AHSA1,NFKB1,CD40LG,MAPK9,ITK,IFNG,CD4,CARD11,PDCD1,IL5,BCL10,FOS,PAK1,CSF2,TRBJ1-4,GSK3B,SOS1,CD28,MAP3K7,CDK4,ICOS,NFATC2,ZAP70,CHUK,GRB2,RRAS
Valproic acid pathway (WP3871);ABAT,HDAC1,CYP2A6,UGT1A3,CYP2B6,ACADSB,ACSM1,IVD,EHHADH,HSD17B10,HADHA,HADHB,CYP2C9,ACADSB,CYP2A6,CYP2B6,CYP2C9,CYP2A6
Canonical and Non-Canonical TGF-B signaling (WP3874);TGFBR1,TGFB1,TGFBR2,GREM1,BMP1,BMPR2,BMPR1A,SMAD4,SMAD2,SMAD3,MAPK8,MAPK9,MAPK14,LOX,LOXL1,LOXL2,LOXL4,LOXL4,LOXL2,LOXL1,LOX,LOX,LOXL1,LOX,LOXL1,LOXL1,LOXL4,LOXL1,LOXL4
BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation (WP3876);SFRP1,DCN,SMAD9,BMP2,SST,BCL2L11,WNT4,SMAD5,FOXO1,LEFTY2,SMAD1
4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression (WP3879);MKNK1,EIF4E,MAP2K6,RAF1,MAP3K11,MAP2K2,AKT1,MAP3K5,EIF4EBP1,MAP2K1,PBK,MKNK2,MAPK1,TSC1,MAPK3,MAP2K3,MTOR,EIF4EBP1
Benzene metabolism (WP3891);Microsomal Epoxide Hydrolase,CYP2E1,NQO1,MPO,CYP2E1,NQO1,Glutathione S-transferase,MPO
Development of pulmonary dendritic cells and macrophage subsets (WP3892);ID2,IRF4,RUNX2,FLT3LG,IKZF1,STAT3,IRF8,CSF2,SPI1,TPO,SPI1,IRF8,CSF1,CSF1,FLT3LG,SPI1,CSF1,STAT3,FLT3LG,SPI1,STAT3,SPI1,TCF4,FLT3LG,FLT3LG,CSF1,IRF8,BATF3,CSF1,IRF8,BATF3,FLT3LG,IRF4,CSF1,CSF2
Development and heterogeneity of the ILC family (WP3893);IL15,IL12A,ID2,GATA3,TNF,IL1B,TBX21,TNF,AHR,IFNG,IL6,IL7,BCL11B,GFI1,HNF1A,NFIL3,IL13,NFIL3,IL4,ZBTB16,GATA3,IL17A,IL18,TOX,IL25,IL23A,IL22,AREG,EOMES,IL15,IFNG,IFNG,ID2,TOX,RORA,IL33,TSLP,IL25,IL5,IL9,ID2,NFIL3,TBX21,TBX21,IL7,IL12B,IFNG,IL12A,IL12B,IFNG,IL22,IL17A,IL23A,IL1B
Hfe effect on hepcidin production (WP3924);HFE,TMPRSS6,HFE2,HAMP,BMP6,SMAD7,ID1,HFE,HFE
Amino Acid metabolism (WP3925);GLUL,GCLM,GSS,GLUD1,ALDH18A1,ALDH18A1,GLS,AC007325.2,EPRS,OGDH,SUCLG1,SDHA,FH,MDH2,ACLY,ACO2,IDH1,AC068533.7,RARS,ASS1,ODC1,SRM,CAD,SMS,LDHA,PKM,PCK1,PC,MDH1,ASNS,CS,PDK4,ALDH7A1,GPT2,GOT1,ACAA1,MCCC1,AUH,BCAT1,ACADM,EHHADH,HADH,HIBADH,EHHADH,HMGCS2,BCAT1,BCAT1,ACADM,ACADM,EHHADH,AP002884.2,PYCR1,PPM1L,PDHA1,FARSB,TAT,OAT,DDC,MAOA,ALDH7A1,ARG1,ARG2,GOT2,P4HA2,CPS1,CAD,DLST,DLD,ACSS1,ALDH1A1,ADH1C,ADH7,ADH5,ADH4,IARS,VARS,WARS,LARS2,TAT,TPO,DBH,PNMT,TH,FAH,MAOA,TDO2,MAOA,DDC,TPH1,SDS,CTH,CBS,MPST,SDS,BHMT,MARS2,GSR,GPT2,HAL,HDC,HNMT,AOC3,HMGCL,HIBCH,DDC,PDHX,PDHA1,FTCD,MUT,OTC,G6PC2
BMP Signaling Pathway in Eyelid Development (WP3927);FGF10,FGFR2,INHBB,TGFA,SHH,BMP4,SFRP1,SMAD1,SMAD5,SMAD4,PITX2,DKK2,FOXC1,FOXC2,NOTCH1,MAP3K1,MAPK9,JUN,EGFR,MAPK3
Chemokine signaling pathway (WP3929);CXCR5,CCR6,CXCR2,CXCR3,CXCR4,CCR1,CCR9,CCR1,CCR3,CCR2,CCR4,CCR2,CCR7,CCR8,CCR10,CX3CR1,CXCR2,XCR1,CXCR6,CCL19,CCL27,CXCL3,CXCL10,XCL1,CXCL9,CCL21,CCL1,CCL11,CCL7,CCL17,CCL20,CCL22,CCL25,CCL27,CCL3,CCL4,CCL5,CCL15,CCL7,CCL15,CXCL3,CXCL5,CX3CL1,CXCL12,CCL19,CCL26,CXCL13,CXCL11,CCL24,PF4,CCL28,CXCL14,PPBP,CCL21,CXCL16,JAK2,JAK3,PTK2,CSK,FGR,HCK,LYN,PXN,PIK3CA,PIK3CD,PIK3R1,PIK3R2,PIK3R3,PIK3CG,PIK3R5,PIK3CB,PLCB1,PLCB2,PLCB3,PLCB4,SHC1,SHC3,SHC2,SHC4,GNAI1,GNAI2,GNAI3,GNG5,GNB1,GNB2,GNB3,GNB4,GNB5,GNGT1,GNG10,GNG12,GNG2,GNG3,GNG4,GNG5,GNG7,GNG8,GNGT2,GNG13,GNG11,GRB2,BCAR1,ELMO1,CRK,CRKL,GRK2,GRK4,GRK5,GRK1,GRK6,ARRB1,ARRB2,ROCK1,ROCK2,VAV1,VAV2,VAV3,ITK,CDC42,ADCY4,ADCY3,ADCY6,ADCY7,ADCY8,ADCY9,ADCY2,ADCY5,ADCY1,RASGRP2,RAP1A,RAP1B,WAS,WASL,PRKCB,PRKCD,PARD3,PRKCZ,TIAM1,TIAM2,NCF1,PRKACG,PRKACB,PRKX,PTK2B,PAK1,STAT1,STAT2,STAT3,STAT5B,MAPK1,MAPK3,AKT1,AKT2,AKT3,HRAS,KRAS,NRAS,MAP2K1,BRAF,RAF1,DOCK2,RAC1,RAC2,PRKCZ,NFKB1,RELA,CHUK,IKBKB,IKBKG,NFKBIA,NFKBIB,PREX1,SOS1,SOS2,FOXO3,GSK3B,AC006486.9
Kennedy pathway from Sphingolipids (WP3933);CEPT1,PEMT,CHKB,SGPL1,PTDSS1,CHKA,PCYT1B,PCYT2,ETNK1,PCYT1A,ETNK2,CHPT1,PTDSS2
Leptin Insulin Overlap (WP3935);JAK2,PDPK1,LEPR,SOCS3,STAT3,PIK3R3,AKT1,SOCS2,PIK3CG,INSR,SOCS1,INS,JAK2,DGKZ,STAT3,LEP,IRS1,PIK3CG,IRS2,JAK2,STAT3,IRS4
miR-222 in Exercise-Induced Cardiac Growth (WP3938);HMBOX1,CDKN1B,HIPK1,HIPK2
One carbon metabolism and related pathways (WP3940);ETNK2,GPX5,SOD1,CSAD,CHPT1,DHFR2,PCYT1A,MAT2A,GSR,PCYT1B,ETNK1,CEPT1,SOD3,MAT1A,GPX7,CTH,GSS,CHDH,DNMT3A,BHMT2,MTHFR,DNM1,PLD1,SOD2,GPX6,CHKB,GAD1,CDO1,GAD2,GNMT,BHMT,SHMT1,PCYT2,SARDH,GPX4,GPX2,GPX1,MTR,GCLM,GPX3,AHCYL1,CBSL,DMGDH,BAAT,SHMT2,CHKA,TYMS,GCLC,PEMT,BCAT1,AGXT2,GCLC,GSS,BCAT2,GCLM
Robo4 and VEGF Signaling Pathways Crosstalk (WP3943);ROBO4,SLIT2,KDR,RAC1,VEGFA,SRC
TYROBP Causal Network (WP3945);GIMAP2,TCIRG1,DPYD,SAMSN1,IL13RA1,GPX1,LGALS9C,ITGAM,BIN2,PPP1R18,IGSF6,PYCARD,NCKAP1L,SLC1A5,FKBP15,NPC2,CXCL16,TYROBP,HLX,CD4,ABCC4,SLC7A7,RBM47,APBB1IP,C1QC,ITGB2,ADAP2,TMEM106A,CAPG,STAT5A,ELF4,RPS6KA1,SPP1,CREB3L2,ZFP36L2,RUNX3,PLEK,NRROS,LYL1,LOXL3,C3,NCF2,GAPT,CD37,TGFBR1,GAL3ST4,CD84,ITGAX,RNASE6,HCLS1,IL10RA,SH2B3,CYTL1,TNFRSF1B,RGS1,IL18,KCNE3,SFT2D2,MAF,LHFPL2
GPR40 Pathway (WP3958);PLCH1,PLCD3,PLCG2,PKD1,ITPR3,PLCD1,PLCZ1,PLCB1,GNA11,PLCE1,PLCL1,PLCB2,PLCB3,FFAR1,PLCG1
DNA IR-Double Strand Breaks (DSBs) and cellular response via ATM (WP3959);ATM,RAD9A,ATF2
Lipid Metabolism Pathway (WP3965);AKT3,PLIN1,HILPDA,PNPLA2,LIPE,ACACA,PRKAG3,PDHA1,PRKAG1,ABHD5,BCKDHA,FASN,ACLY,PRKAA1,ACSS2,PRKAB2,AKT2,PRKAB1,PRKAA2,AKT1,PRKAG2,ACSBG1,PRKACG,PRKACA,PRKAR1A,PRKAR2B,PRKAR2A,PRKAR1B,PRKACB
Role of Osx and miRNAs in tooth development (WP3971);MIR145,RUNX2,SP7,KLF4,DMP1,DSPP,BMP7,NOTCH1,NOTCH2,NOTCH3,NOTCH4,ALPL,DKK1,SOST,HNF1A,CTNNB1,MIR338,MIR32,MIR586,MIR885,MIR29A,MIR34AHG,MIRLET7A1,MIR204,MIR211,MIRLET7A2,MIRLET7C,MIRLET7D,MIRLET7E,MIRLET7F1,MIRLET7F2,MIRLET7G,MIRLET7I,MIR29B1
miRNA regulation of prostate cancer signaling pathways (WP3981);MAP2K1,CREBBP,NFKB1,PDGFA,AR,TP53,NFKBIA,BCL2,KLK3,CCND1,PDGFRB,PIK3CA,GRB2,SOS1,KRAS,RAF1,MAPK1,AKT3,CASP9,BAD,FOXO1,CDKN1A,CDKN1B,MDM2,GSK3B,IKBKG,MTOR,AR,CREB3L1,CTNNB1,TCF7,MAP2K2
Prion disease pathway (WP3995);RFX5,ELK1,FGFR1,TBP,BCL11A,STAT3,CASP12,MAPK3,HSP90B1,RAD21,NCAM1,PDIA3,CTCF,PAX5,FYN,PRNP,PRNP,POU2F2,MEF2C,NFKB1,CASP3,BATF,SPI1,EP300,EBF1,BCL2,IRF4,SMC3,RXRA,MAPK1,PTK2,CASP12,CHD2,PRNP,HSPA5,NFKB1,FYN,PTK2
Fibrin Complement Receptor 3 Signaling Pathway (WP4136);AKT1,IL6,IKBKB,PI3K,PLG,NF-kB,SYK,TLR3,MYD88,IFNB1,RHOA,IRAK1,PLAT,CXCL10,RASSF5,TIRAP,TRAF6,TICAM1,CD14,TYROBP,CXCL3,PLG,IRAK4,LY96,LBP,TLR4,SRC,TICAM2,IRF3,ITGAM,ITGB2,TICAM1,MYD88,TNF,SYK,IRF3,CCL2,NFKB1,CHUK,IKBKG,PI3K,IRAK2,IL12B,NOS2
PTF1A related regulatory pathway (WP4147);PDX1,RBPJ,NKX6-1,CTNNB1,HES1,PROX1,RBPJ,NOTCH1,FGF10,KAT2B,RBPJL,PTF1A
Splicing factor NOVA regulated synaptic proteins (WP4148);CAV2,EPB41L2,MAPK4,CDH2,SNW1,CLSTN1,KCNJ6,CLASP1,KCNMA1,CASK,NCDN,GABRG2,MAPK9,ATP2B1,PLCB4,RAP1GAP,STX2,CAMK2G,CADM1,NEO1,CAV2,CASK,GPHN,DAB1,APLP2,KCNQ2,STXBP2,EPB41,EPB41L3,CHL1,NTNG1,TERF2IP,EFNA5,GRIN2B,GRIN1,CHL1,CDH2,ANK3,CASK,DAB1,GRIK2,CASK,PRKCZ,GABBR2,PLCB4,ANK3,ANK3,MAPK9,EPB41,EPB41,GRIK2,KCNMA1,PRKCZ,GABBR2,GPHN,PLCB4,EPB41L1,CADM3
Wnt Signaling in Kidney Disease (WP4150);NPHP3-ACAD11,RHOA,CTNNB1,INVS,LRP5,LRP6,WNT1,WNT10A,WNT10B,WNT7A,WNT16,WNT6,WNT5A,WNT2B,WNT11,WNT4,WNT3A,WNT5B,WNT9B,WNT2,WNT3,WNT7B,FZD1,FZD8,FZD4,FZD2,FZD7,FZD9,FZD5,FZD6,FZD3,FZD1,FZD8,FZD4,FZD2,FZD7,FZD9,FZD5,FZD6,FZD3,DVL2,DVL3,DVL1,MAPK9,MAPK10,MAPK8,DVL2,DVL3,DVL1
Degradation pathway of sphingolipids, including diseases (WP4153);GLB1,GLB1,GLB1
Endometrial cancer (WP4155);EGF,FOS,EGFR,GRB2,SOS1,SOS2,HRAS,KRAS,NRAS,ARAF,BRAF,RAF1,MAP2K1,MAP2K2,MAPK1,MAPK3,ELK1,PTEN,PIK3CA,PIK3CB,PIK3CD,PIK3R1,PIK3R2,PIK3R3,PDPK1,ILK,AKT1,AKT2,AKT3,FOXO3,BAD,CASP9,CDH1,CTNNB1,CTNNA1,CTNNA2,CTNNA3,AXIN1,AXIN2,APC,APC2,GSK3B,CTNNB1,CTNNB1,TCF7,LEF1,TCF7L1,TCF7L2,CCND1,MYC,ERBB2,BAX,CDKN1A,DDB2,GADD45A,GADD45B,GADD45G,BAK1,POLK,TP53,FGFR2,FGF1,FGF2,FGFR1,FGFR3
GABA receptor Signaling (WP4159);ALDH9A1,AP2A1,GPHN,AP2A2,SLC32A1,AP2S1,AP2M1,SLC6A11,AP2B1,ALDH9A1,GPHN
PI3K-Akt Signaling Pathway (WP4172);GYS2,CCND2,CCNE1,CCNE2,GYS1,TSC2,ITGA5,TSC1,PIK3CA,CSF3,GRB2,JAK3,JAK2,EPO,COL4A2,CHAD,ITGB7,TNR,COL4A5,LAMB3,IFNA1,CSH1,COMP,COL1A2,ITGB4,FN1,THBS2,IL3RA,PIK3R1,COL6A3,AKT1,RELN,PTK2,LAMC3,IL2RB,IFNA4,LAMC2,IFNAR1,LAMB1,ITGA7,ITGB6,ITGA2B,ITGA9,ITGA2,PIK3R2,COL4A6,ITGA1,OSMR,DDIT4,ITGA3,TNC,COL6A6,LAMA4,ITGA8,COL4A1,LAMA3,LAMC1,LAMB2,THBS4,COL2A1,JAK1,PIK3CB,THBS3,ITGA10,ITGAV,PRLR,IL7R,ITGA6,LAMA5,IL6R,ITGB1,IBSP,COL6A2,VWF,TNXB,ITGB5,TNN,SPP1,PTEN,LAMA2,CSF3R,IL2RA,EPOR,COL6A1,IL4R,LAMA1,SOS1,ITGB3,PIK3CD,ITGB8,VTN,THBS1,AKT3,COL1A1,COL4A3,PIK3R3,COL6A5,IL2RG,IFNA2,IFNAR2,COL4A4,AKT2,ITGA4,GHR,ITGA11,PIK3R5,EFNA1,FGF1,FGF11,FGF10,EFNA2,EGF,FGF12,CSF1,ANGPT4,ANGPT2,ANGPT1,VEGFA,EFNA3,EFNA4,EFNA5,FGF14,FGF5,FGF19,FGF17,FGF18,FGF2,FGF3,FGF4,FGF6,FGF7,FGF8,FGF9,VEGFD,HGF,IGF1,IGF2,INS,KITLG,FLT3LG,VEGFC,VEGFB,PDGFB,PGF,PDGFA,NGF,PDGFC,FGF21,FGF23,FGF22,PDGFD,FGF20,FGF13,FGFR2,KDR,INSR,FGFR3,IGF1R,KIT,FGFR1,EPHA2,EGFR,CSF1R,FGFR4,FLT1,FLT4,NGFR,MET,PDGFRA,PDGFRB,TEK,IFNA5,IFNA6,IFNA7,IFNA8,IFNA10,IFNA14,IFNB1,IL2,OSM,PRL,IFNA13,CHRM1,LPAR1,F2R,CHRM2,LPAR5,LPAR2,LPAR3,LPAR6,LPAR4,GNB2,GNB1,GNB4,GNGT1,GNG10,GNG12,GNB3,GNG2,GNG3,GNG4,GNG5,GNG7,GNG8,GNGT2,GNG13,GNG11,PIK3CG,NRAS,KRAS,HRAS,PRKAA1,PRKAA2,MLST8,RHEB,MTOR,RPTOR,THEM4,CDC37,HSP90AB1,PHLPP1,TCL1A,PDPK1,PPP2CB,PPP2CA,PPP2R2A,PPP2R5D,PPP2R5B,PPP2R2B,PPP2R1B,PPP2R3B,PPP2R3A,PPP2R5C,PPP2R5E,PPP2R2C,PPP2R1A,PPP2R2D,PPP2R5A,PPP2R3C,HSP90AA1,HSP90B1,PHLPP2,TCL1B,RAF1,MAP2K2,MAP2K1,MAPK1,MAPK3,GSK3B,FOXO3,IKBKB,BAD,CASP9,MDM2,IKBKG,CDKN1B,CDKN1A,ATF2,CREB3,CREB1,ATF4,CREB3L2,CREB3L3,ATF6B,CREB3L1,CREB3L4,CREB5,RPS6KB1,RPS6KB2,EIF4EBP1,EIF4B,RPS6,EIF4E,EIF4E2,EIF4E1B,IRS1,PIK3R6,CSH2,GH1,GH2,IFNA16,IFNA17,IFNA21,IL3,IL4,IL6,IL7,GNB5,CD19,PIK3AP1,BCR,SYK,TLR2,TLR4,RAC1,SOS2,LAMB4,COL9A1,COL9A2,COL9A3,TP53,CHUK,NFKB1,RELA,BCL2L1,MYB,FGF19,NTF3,NTF4,BDNF,TGFA,FLT3,NTRK1,NTRK2,STK11,BCL2,MCL1,BCL2,BCL2L1,RBL2,CDKN1B,FASLG,BCL2L11,CDK2,CDK4,CDK6,CCND1,CCND3,PCK1,PCK2,G6PC,G6PC2,G6PC3,MYC,BRCA1,NOS3,PRKCA,PKN1,PKN2,PKN3,C8orf44-SGK3,SGK1,SGK2,SGK3
Somatroph axis (GH) and its relationship to dietary restriction and aging (WP4186);FOXO1,IGF1R,SIRT1,MTOR,AKT1
Caloric restriction and aging (WP4191);MTOR,NAMPT,PRKAB2,SIRT1,IGF1,PPARGC1A,FOXO1B,AKT1,TP53
Tumor suppressor activity of SMARCB1 (WP4204);RBBP4,DPF1,PTCH1,SMARCC2,SMARCB1,ARID1A,SMARCA4,RB1,SMARCC1,SMO,GLI1,GLI2,GLI3,GLI4,SUZ12,EED,EZH2,H3F3B,H3F3A,CDKN2A,CDK4,CDK6,ACTL6A,ACTL6B,DPF2,DPF3,SMARCE1,SMARCD1,SMARCD2,SMARCD3,ARID1B
MET in type 1 papillary renal cell carcinoma (WP4205);HGF,PIK3CA,STAT3,MAPK8,CBL,PLCG1,MET,GAB1,GRB2,SOS1,SOS2,HRAS,KRAS,NRAS,CRK,CRKL,RAPGEF1,PTPN11,RAP1A,RAP1B,ARAF,RAF1,BRAF,RAC1,CDC42,PAK4,BUB1B-PAK6,PAK1,PAK2,PAK3,PAK6,PAK5,MAP2K1,MAP2K2,MAPK1,MAPK3,PIK3CB,PIK3CD,PIK3R1,PIK3R2,PIK3R3,PIK3R3,AKT1,AKT2,AKT3,BAD,ETS1,JUN,ALK,STRN,INSL3,JAK3,ELOA,RPL11,C8orf34,CRK,PTK2,SRC,MET,TFE3,PRCC,CDKN1A
Phosphodiesterases in neuronal function (WP4222);PDE1B,PDE4D,CREB1,PDE10A,PPP1R1B,GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIA1,DRD1,DRD2,ADORA2A,PDE5A,PDE3A,PDE3B,NOS1,GUCY1A2,GUCY1A3,GUCY1B3,GUCY1B2,ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ADCY10,PDE1A,PDE1C,PDE11A,PDE12,PDE2A,PDE3A,PDE3B,PDE4A,PDE4B,PDE4C,PDE5A,PDE6A,PDE6B,PDE6C,PDE6D,PDE6G,PDE6H,PDE7A,PDE7B,PDE8A,PDE8B,PDE9A,CHRNA7,PDE10A,PDE4D,PDE1B,DRD2,GRIN1,GRIN2D,GRIN2C,GRIN2A,GRIN2B,GRIA1,GUCY1A3,GUCY1A2,GUCY1B2,GUCY1B3,PDE1B,CREB1,GRIA1,GRIN1,GRIN2D,GRIN2C,GRIN2A,GRIN2B,DRD1,CREB1,GUCY1A2,GUCY1B3,GUCY1A3,GUCY1B2,GRIN2A,GRIN2C,GRIN1,GRIN2B,GRIN2D,DRD1,DRD2,GRIA1,ADORA2A,GUCY1B2,GUCY1A3,GUCY1B3,GUCY1A2,PDE1B,PDE10A,PDE4D,ADCY2,ADCY1,ADCY2,ADCY1,ADCY2,ADCY1,PPP1R1B,ADCY2,ADCY1,PPP1R1B
Ras Signaling (WP4223);PLA2G4B,GRIN1,PLA2G16,RRAS,GRIN2A,GRIN2B,HTR7,CSF1R,EGFR,EPHA2,FGFR1,FGFR3,FGFR2,FGFR4,FLT1,FLT3,FLT4,IGF1R,INSR,KDR,KIT,MET,NGFR,NTRK1,NTRK2,PDGFRA,PDGFRB,TEK,CALM1,CALM2,CALM3,CALML3,CALML4,CALML5,CALML6,RASGRF1,RASGRF2,PRKACA,PRKACB,PRKACG,GNB5,GNB1,GNB2,GNB3,GNG3,GNG4,GNG5,GNG7,GNG10,GNG11,GNGT1,GNGT2,GNG13,GNG2,GNG12,GNB4,GNG8,PLCG1,PLCG2,RASGRP1,RASGRP2,RASGRP3,RASGRP4,ZAP70,LAT,GRB2,SHC1,SHC2,SHC3,SHC4,GAB1,GAB2,PTPN11,SOS1,SOS2,RRAS2,MRAS,HRAS,KRAS,NRAS,RRAS,RRAS2,MRAS,HRAS,KRAS,NRAS,NF1,RASA4B,RASA4,RASA3,RASA1,RASA2,RASAL3,RASAL1,SYNGAP1,RASAL2,RASSF1,RASSF5,STK4,STK4,TIAM1,RAC1,RAC2,RAC3,PAK4,BUB1B-PAK6,PAK1,PAK2,PAK3,PAK6,PAK5,RHOA,AKT1,AKT2,AKT3,CHUK,IKBKB,IKBKG,NFKB1,RELA,BAD,BCL2L1,FOXO4,FASLG,AFDN,SHOC2,RAF1,KSR1,KSR2,MAP2K1,MAP2K2,MAPK1,MAPK3,BRAP,ETS1,ETS2,ELK1,PLA2G4E,PLA2G4F,PLA2G2D,PLA2G4D,PLA2G2E,PLA2G2C,PLA2G3,PLA1A,PLA2G1B,PLA2G2A,PLA2G4A,PLA2G5,PLA2G2F,PLA2G12A,PLA2G6,PLA2G10,PLA2G12B,PLA2G4C,JMJD7-PLA2G4B,RAPGEF5,RAP1A,RAP1B,RALGDS,RGL1,RGL2,RALA,RALB,MAPK8,MAPK9,MAPK10,EXOC2,TTBK1,REL,PLD1,PLD2,RALBP1,RAC1,RAC2,RAC3,CDC42,PLCE1,PRKCA,PRKCB,PRKCG,RIN1,RALBP1,ARF6,RAC1,RAB5A,RAB5B,RAB5C,ABL1,ABL2,PIK3CA,PIK3CB,PIK3CD,PIK3R1,PIK3R2,PIK3R3
Regulation of sister chromatid separation at the metaphase-anaphase transition (WP4240);MAD1L1,ESPL1,CDC20,SMC1A,MAD2L1,BUB1,BUB1B,BUB3,CENPE,ANAPC2,ANAPC11,PTTG1,ESPL1,PTTG1,SMC3,RAD21,STAG1,ESPL1
Type 2 papillary renal cell carcinoma (WP4241);FH,EPAS1,SETD2,TFE3,PRCC,CDKN1A,TFE3,SFPQ,TFE3,DVL2,CTSK,BIRC7,DIAPH1,HIF1A,CTSK,TFEB,TFEB,COL21A1,CADM2,HIF1A,EGLN1,EGLN2,EGLN3,ELOC,ELOB,VHL,RBX1,CUL2,ARNT,ARNT2,CREBBP,EP300,SLC2A1,VEGFA,TGFB1,TGFB2,TGFB3,PDGFB,TGFA
Ethanol metabolism resulting in production of ROS by CYP2E1 (WP4269);MAPK8,CYP2E1,CYP2E1,SP1,MAP2K2,MAFF,MAFG,MAP2K1,MAFK,NFE2L2,SP1,CYP2E1,NFE2L2
Genotoxicity pathway (WP4286);LCE1E,LRRFIP2,ARRDC4,USP41,NLRX1,RBM12B,DAAM1,PHLDA3,E2F8,B3GNT2,SMAD5,SEMG2,PTGER4,EI24,HIST1H2BG,CCP110,PLK3,TP53I3,TOPORS,PRKAB1,TM7SF3,PRKAB2,HIST1H1E,HIST1H2BC,DDB2,MEX3B,FBXO22,CDKN1A,CEBPD,HIST1H2BI,SEL1L,ACTA2,E2F7,DCP1B,SERTAD1,CENPE,HIST1H2BB,HIST1H2BN,HIST1H2BM,HIST1H3D,PPM1D,PCDH8,ITPR1,IKBIP,GADD45A,AEN,RRM2B,TNFRSF17,TIGAR,COIL,MDM2,ID2,BRMS1L,CBLB,BLOC1S2,AMER1,GXYLT1,RPS27L,BTG2,TRIAP1,RAPGEF2,TRIM22,ITPKC,DUSP14
Methionine metabolism leading to Sulphur Amino Acids and related disorders (WP4292);ADK,CBS,CTH
Viral Acute Myocarditis (WP4298);SOCS1,IFNG,TGFB1,JAK1,STAT1,IL10,IL6,STAT3,EIF4G2,ACTB,BAX,SGCB,CD4,FYN,MMP9,RAC2,ABL1,BCL2L1,CASP2,CASP6,CASP7,CCR5,TLR3,CYCS,PTCRA,CHRAC1,AIF1,CCND1,SOS1,MAPK1,RASA1,SGCA,DFFB,GSK3B,AKT1,CD55,SGCD,HLA-DMA,ENDOG,TLR4,PYCARD,DFFA,PIK3R1,Cd28,ITGAL,LAMA2,CREB1,CXCR4,ITGB2,NFKB2,CASP3,IL12A,KRT8,MYH6,RAC3,DMD,BCL2,EIF4G2,DAG1-B,TLR5,CASP9,CCR3,DAG1,EIF4G1,SGCG,CD40LG,BNIP2,ABL2,MAPK3,CD80,CAV1,PTCRA,CAAP1,PARP1,PABPC1,MAPK1,IL12B
Extracellular vesicles in the crosstalk of cardiac cells (WP4300);KDR,PTEN,HSPB1,MIR455,mir-19a,EGF,CD63,GATA4,SPP1,BIRC5,SORBS2,CD81,TLR4,SOD1,MMP9,STAT3,IL6,EGFR,PDLIM5,MIR320A,IGF1,ETS2,SOD1
The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome (WP4320);MBD3,LEF1,KDM1A,HDAC2,CBX3,CHD3,RBBP4,E2F1,MBD2,CBX1,MTA2,CHD4,HDAC1,MTA3,INPP5K,SREBF1,CBX5,MTA1,RBBP7,SUV39H1,CBX1,CBX3,CBX5,SUV39H1,RB1,TP53
Thermogenesis (WP4321);BMP8A,PRDM16,PLIN1,SLC25A20,RHEB,RPTOR,ZNF516,FGF21,KDM3B,GRB2,PPARGC1A,PRKAG2,PRKG1,RPS6KA1,CPT1A,FRS2,ARID1B,TSC1,PNPLA2,RPS6KB1,CREB3,UCP1,RPS6KA6,MGLL,FGF21,ADRB3,PRKAG3,KDM1A,MAP3K5,UCP1,SLC25A29,ATF2,PPARG,ACSL1,SIRT6,GNAS,HRAS,CPT2,PRKACA,RPS6KA2,ACTL6B,RPS6,RPS6KA3,GCG,ADCY1,ADCY2,ADCY3,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ADCY4,ADCY10,CNR1,NPR1,KLB,FGFR1,SOS1,SOS2,KRAS,NRAS,TSC2,MTOR,MLST8,AKT1S1,RPS6KB2,PRKG2,LIPE,PRKACB,PRKACG,MAP2K3,MAPK14,MAPK11,MAPK13,MAPK12,CREB1,CREB3L4,CREB3L2,CREB3L3,CREB3L1,CREB5,KDM3A,ACTB,SMARCA2,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD1,SMARCD2,SMARCD3,SMARCE1,ACTG1,DPF3,DPF1,ARID1A,ACTL6A,UCP1,ACSL3,ACSL4,ACSL5,ACSL6,CPT1B,CPT1C,PRKAA1,PRKAA2,PRKAB1,PRKAB2,PRKAG1,BMP8B
miRNAs involvement in the immune response in sepsis (WP4329);TLR4,TLR7,MAP3K7,IRAK1,IL1A,MYD88,ICAM1,MIRLET7I,MIR146B,MIR223,IRAK4,TRAF6,TAB2,TAB1,MIR146B,MIR155HG,IKBKG,CHUK,IKBKB,MIR223,MIR16-1,MIR16-2,MIR199A1,MIR199A2,MIR126,MIR9-1,IRAK1,IRAK4,TRAF6,IRAK1,IRAK4,TRAF6,TRAF3,TLR8,MYD88,MIR146B,MIR149,MIR200B,MIR200C,MIR203A,MIR203B,MIR758,MAPK14,MAPK8,IRF5,IRF1,IRF7,RELA,NFKB2,RELB,c-REL,NFKB1,RELA,NFKB2,RELB,c-REL,NFKB1,CXCL8,CCL3,CCL4,VCAM1,ELANE,LCN2,GZMB,IL6,MIR21,MIR145,MIR155,TNF,IL10,IL10,MIR16-1,MIR16-2,MIR106A,MIR106B,MIR4461,MIR16-1,MIR16-2,MIR19A,MIR125B1,MIR125B2,MIR155,MIR187,MIR122,TNF,IL6,MIRLET7I,MIR187
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma (WP4337);JAK1,RELA,IL6,IL6ST,NFKB1,MIR21,IL11RA,STAT3,IL11,IL6R,JAK2,JAK3,JAK1,JAK2,JAK3,IL6,IL11,STAT3,ZEB1,SOX4,MIR200A,MIR200B,MIR200C,MIR21,SOX4,UCA1,IL6
Non-genomic actions of 1,25 dihydroxyvitamin D3 (WP4341);CAMK2A,CAMK2B,CAMK2G,PLCB1,PLCB2,PLCB3,PLCB4,PLCD1,PLCD1,PLCD1,PLCD1,PLCE1,TLR2,TLR8,PRKCE,PRKCH,PRKCQ,RXRB,STAT1,STAT2,JAK1,IFI44L,ISG15,OAS1,OAS2,OAS3,RSAD2,IKBKB,MED1,PLCG2,IFI27L2,CYP27B1,SP3,PRKCG,PRKCB,PRKCA,RXRG,CD40LG,PRKCD,VDR,RXRA,CAMK2D,ETS1,TLR4,VDR,CD40,CYP27B1,VDR,TYK2,STAT2,STAT1,VDR,VDR,VDR,SP1,VDR,JUN,KRAS,HRAS,NRAS,MAPK3,MAPK1,MAPK7,MAPK8,MAPK9,PRKCZ,VDR,NFKB1,RELB,NFKB2,NFKB1,RELB,NFKB2,MAPK8,MAPK9,TNFRSF1A,TNF,MAPK11,MAPK14,MAPK13,MAPK12,MAPK11,MAPK14,MAPK13,MAPK12,CYP24A1,CAMP,DEFB4A,NOD2,VDR,CCL2,CXCL8,IL6
NRF2-ARE regulation (WP4357);GSK3B,ERK,CEBPB,MAF,PI3K,GCLC,JNK,P38,NRF2,PKC,HO-1,SLC7A11,NQO1,GSTA2,GCLM,CEBPB,NRF2,KEAP1,NRF2,FYN,SRC,YES1,NRF2,INSR,PGAM5,NRF2,KEAP1,CUL3,RBX1,KEAP1,KEAP1,CUL3,RBX1,FYN,SRC,YES1
Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors (WP4397);CCR2,MSMP,CTCF,CCR2,MSMP
LTF danger signal response pathway (WP4478);IL1A,IL1B,IL6,IL8,TNF,IFNA,IFNB,IRAK1,TRAF6,TLR4,LTF,TREM1,IRAK4,TLR2,CD14,MAPK1,RAGE,NFkB,MYD88
Role Altered Glycolysation of MUC1 in Tumour Microenvironment (WP4480);IkKB,TNF,IkKA,IkKG,IkBA,RELA,IL6,MUC1,NFkB1,NFkB1,RELA,MUC1,RELA,NFkB1,IkBA
Vitamin D in inflammatory diseases (WP4482);NFkB,IkKA,IkKB,IkKG,RELA,IkBA,IL6,TNF,RXR,SMAD4,PPP3CA,PPP3R1,MAP2K3,SMAD3,NFAT,MKP1,p38,MAP2K6,MAP3K1,VDR,VDR,Med14,GCR,VDR,SMAD3,NFAT,RELA,NFkB,IkBA,RXR
Cells and Molecules involved in local acute inflammatory response (WP4493);C3,C5,C6,C7,IL1A,KNG1,IL6,IL8,TNF,SELPLG,SELP,ICAM1,ITGAL,ITGB2,C5,C3,VCAM1,ITGB1,ITGA4
IL-10 Anti-inflammatory Signaling Pathway (WP4495);BLVRA,BLVRB,IL10RA,IL10RB,IL1A,IL6,JAK1,STAT1,STAT2,STAT3,TNF,IL10,HMOX1,HMOX1
Metabolic pathway of LDL, HDL and TG, including diseases (WP4522);LPL,LCAT,CETP,PCSK9,ABCA1,LPL
Intraflagellar transport proteins binding to dynein (WP4532);WDR35,IFT122,IFT140,WDR19,IFT22,HSPB11,IFT27,IFT43,IFT46,IFT80,IFT81,DYNLL2,TCTEX1D2,DYNLT1,DYNC1LI1,WDR34,DYNC1H1,DYNLRB1,DYNC2H1,DYNC2LI1,DYNLL1,DYNC1I2,DYNC1I1,DYNLRB2,WDR60,DYNLT3,DYNLL2,DYNLT1,DYNLRB1,DYNLL1,DYNLRB2,DYNLT3,DYNC1LI2
Hippo-Yap signaling pathway (WP4537);YWHAQ,LATS2,CXCL10,STK3,STK38L,SAV1,LATS1,YY1AP1,MINK1,TNIK,NF2,NDRG1,RASSF1,TAZ,MST1,MAP4K1,MAP4K2,MAP4K4,MAP4K3,TEAD1,YY1AP1,TAZ,YY1AP1,TAZ,TEAD2,TEAD3,TEAD4
Cell migration and invasion through p75NTR (WP4561);EFNB2,TIAM1,STAT3,MMP8,TRIO,EFNA5,MMP2,MMP9,NGFR,EFNB3,TWIST1,ARF1,EFNA2,EFNA4,EFNA1,EFNA3,TWIST1,EFNB1,BDNF,PARD3,RAC1,KIDINS220,JUN,NTRK2,ADAMTS13,PAK1,RHOA,AKT2,AKT1,EFNB2,EFNB3,EFNB1,STAT3,STAT3,MMP2,MMP9,CDH11,RAC1,RAC1,NGFR,NTRK2,BDNF,AKT3,AKT2,AKT1,AKT3,CDH11
Neural Crest Cell Migration during Development (WP4564);AKT2,AKT3,CDH11,NGEF,FOS,EPHB1,MMP9,MMP2,PIK3CA,PIK3CB,PIK3CD,PIK3R3,PIK3R4,PIK3R5,PIK3R6,TIAM1,TRIO,MMP8,TWIST1,PIK3CG,ARF1,RAC1,PAK1,AKT1,BDNF,F2RL2,JUN,RHOA,STAT3,CDH11,AKT3,AKT1,AKT2,NGFR,NGFR,EPHB2,EPHB3,EPHB4,EPHB6,BDNF,STAT3,MMP2,TWIST1,MMP9,RAC1,PAK2,PAK3,PAK4,PAK5,PAK6
Angiopoietin Like Protein 8 Regulatory Pathway (WP3915);PIK3CD,PIK3C3,PTP,IRS1,GLUT1,FBP,GS,RHEB,G6PC,PIK3R3,PIK3R1,PEPCK,IRS2,PIK3C2G,PIK3R2,INSR,RPS6KB2,SOS1,PIK3CG,IRS4,TSC2,PIK3CB,SIN1,Chrebp,GLUT4,CIP42,TSC1,Raptor,RPS6KB1,SREBF1,LPL,mlst8,Rictor,PIK3R4,RAS,LXR,SOS2,Exo70,RAF1,SREBF2,mTOR,SEST3,mTOR,PIK3C2A,PIK3CA,DIO2,RXRA,THRA,THRB,SLC16A2,SLCO1C1,RXRA,ANGPTL8,SHC2,SHC3,SHC1,GSK3A,GSK3B,PDK,AKT1,AKT2,EIF4E,EIF4EBP1,mlst8,mTOR,SIN1,Rictor,mlst8,FOXO1A,FOXO3A,INSR,CAP1,CBL,FLOT1,FLOT2,CRK,RAPGEF1,RHOQ,Rictor,RXRA,ABCG8,FASN,ABCG5,CYP3A4,CYP7A1,CYP2B6,SCD,MAP2K1,MAP3K7,MAPK14,MAPK1,MAP2K2,RPS6KA5,MAP3K2,MAP3K6,MAPK8,MAP4K1,MAP3K11,MAP4K3,MAPK10,RPS6KA6,MAP2K7,MAP3K4,MAP3K1,MAP3K12,MAPK4,RPS6KA4,MAPK11,MAP4K5,MAPK6,MAP4K4,MAPK3,MAP3K14,MAPK12,MAP2K5,MAP2K4,MAPK13,RPS6KA1,RPS6KA2,MAP3K5,RPS6KA3,MAPK9,MAPK7,MAP3K3,MAP3K9,MAP3K8,MAP2K6,MAP3K13,MAP4K2,MAP2K3,MAP3K10,MINK1,AKT1,AKT2,CBLC,CBLB,FOXO1A,FOXO3A,INSR,AMPKy3,AMPKa1,AMPKy2,AMPKy1,AMPKb2,AMPKb1,AMPKa2
ApoE and miR-146 in inflammation and atherosclerosis (WP3926);NFKB2,APOE,RELA,MIR146A,SPI1,IRAK1,TLR4,TRAF6,TLR2,RELA,NFKB2
EDA Signalling in Hair Follicle Development (WP3930);EDAR,EDARADD,DKK4,DKK1,BMP1,SOSTDC1,SHH,GLI1,PTCH1,LTB,RELB
ESC Pluripotency Pathways (WP3931);FZD6,AKT3,DVL3,ACTR2,SMAD1,GSK3B,SMAD5,HRAS,BMPR1A,BRAF,PDGFA,WNT3,FGF1,SMAD7,WNT5B,FGF16,PDGFB,FGF6,FGF19,ACVR1,FGFR1,MAP2K1,CTNNB1,FZD4,FGF22,DVL1,JAK1,BMPR2,JUN,FGF10,PIK3CD,FGF9,FZD8,STAT3,SOS1,FGF20,AKT2,RAF1,FGF11,WNT7A,FZD9,SMAD1,IL6ST,FGFR3,WNT5A,MAPK7,FZD2,FGF17,SMAD5,FZD5,WNT16,FGF18,FZD7,FZD1,EGFR,MDM2,WNT10A,FGFR4,FGFR2,PDGFRA,MAPK1,SMAD5,NOG,ARAF,MTOR,SMAD4,STAT3,WNT7B,SMAD9,MAP2K3,SELENOP,LIF,LIFR,WNT2,MAP2K5,PIK3R2,SMAD1,LRP5,WNT9B,AXIN1,ELK1,FGF14,WNT3A,BMPR1B,MAPK6,SMAD9,PTPN11,CTNNB1,FGF23,FGF5,GAB1,PTEN,WNT11,STAT3,GRB2,DVL2,APC,AKT1,HNF1A,WNT4,SMAD6,FGF2,WNT1,MAPK4,CTNNB1,FGF12,FGF21,WNT6,EGF,MAPK12,FZD3,WNT10B,PDGFRB,FOS,FGF3,FGF13,SMAD9,MAP2K6,MAP2K2,FGF7,BMP4,FGF8,STAT3,ERAS,FGF4,WNT2B,LRP6,SMAD4,SMAD1,SMAD5,SMAD9,SMAD4,STAT3,STAT3,PTPN11,JAK1,HRAS
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway (WP3932);NOS2,NOS3,ITGA5,TSC1,PIK3CA,CSF3,GRB2,JAK3,JAK2,EPO,COL4A2,CHAD,ITGB7,TNR,STK11,COL11A2,LAMB3,IFNA7,CSH1,COMP,ITGAE,COL1A2,ITGB4,FN1,ITGAX,ITGAD,THBS2,IL3RA,PIK3R1,COL5A1,AKT1,RELN,PTK2,PIK3IP1,LAMC3,IL2RB,IFNA7,LAMC2,IFNAR1,LAMB1,ITGA7,ITGB6,ITGA2B,ITGA9,ITGA2,ITGB2,PIK3R2,COL4A6,PELO,OSMR,DDIT4,ITGA3,TNC,COL5A2,LAMA4,ITGA8,COL4A1,LAMA3,LAMC1,LAMB2,THBS4,COL2A1,JAK1,PIK3CB,THBS3,ITGA10,ITGAV,PRLR,IL7R,ITGA6,LAMA5,IL6R,ITGB1,IBSP,COL6A2,VWF,TNXB,ITGB5,TNN,SPP1,PTEN,LAMA2,CSF3R,IL2RA,EPOR,COL3A1,ITGAL,IL4R,LAMA1,SOS1,ITGB3,TSC2,PIK3CD,ITGB8,VTN,THBS1,AKT3,COL1A1,COL11A1,PIK3R4,COL5A3,IL2RG,IFNA7,IFNAR2,COL4A4,AKT2,ITGA4,GHR,ITGA11,PIK3R5,EFNA1,FGF1,FGF11,FGF10,EFNA2,EGF,FGF12,CSF1,ANGPT4,ANGPT2,ANGPT1,VEGFA,EFNA3,EFNA4,EFNA5,FGF14,FGF13,FGF19,FGF17,FGF18,FGF2,FGF3,FGF4,FGF6,FGF7,FGF8,FGF9,VEGFD,HGF,IGF1,INS,INS,KITLG,VEGFC,VEGFB,PDGFB,PGF,PDGFA,NGF,PDGFC,FGF21,FGF22,PDGFD,FGF20,FGF16,FGFR2,KDR,INSR,FGFR3,IGF1R,KIT,FGFR1,EPHA2,EGFR,CSF1R,FGFR4,FLT1,FLT4,NGFR,MET,PDGFRA,PDGFRB,TEK,AKT1S1,IFNA7,IFNA7,IFNA7,IFNA7,IFNA7,IFNA7,IFNB1,IL2,OSM,PRL,IFNA7,IFNA7,CHRM1,LPAR1,F2R,CHRM2,LPAR5,LPAR2,LPAR3,LPAR6,LPAR4,GNG5,GNB2,GNB1,GNB4,GNGT1,GNG10,GNG12,GNB3,GNG2,GNG3,GNG4,GNG5,GNG7,GNG8,GNGT2,GNG13,GNG11,PIK3CG,NRAS,KRAS,HRAS,STRADA,CAB39,CAB39L,PRKAA1,PRKAA2,MLST8,RHEB,MTOR,RPTOR,HIF1A,ULK1,CRTC2,CDC37,HSP90AB1,PHLPP1,TCL1A,PDPK1,PPP2CB,PPP2CA,PPP2R5D,PPP2R5B,PPP2R2B,PPP2R1B,PPP2R3A,PPP2R5C,PPP2R5E,PPP2R2C,PPP2R1A,PPP2R2D,PPP2R5A,PPP2R3C,HSP90AA1,HSP90B1,PHLPP2,TCL1B,TCL1B,RAF1,MAP2K2,MAP2K1,MAPK1,MAPK3,GSK3B,FOXO3,FOXO1,IKBKB,BAD,CASP9,MDM2,IKBKG,CDKN1B,CDKN1A,ATF2,CREB3,CREB1,ATF4,CREB3L2,CREB3L3,ATF6B,CREB3L1,CREB3L4,CREB5,TBC1D1,RAB8A,RAB2A,RAB10,RAB11B,RAB14,SLC2A4,SLC2A1,SLC2A3,SLC2A2,PPARGC1A,GYS1,GYS2,PFKFB2,PFKFB1,PFKFB3,PFKFB4,LIPE,SREBF1,FOXA1,ACACA,ELAVL1,NOS1,EPAS1,HIF3A,RPS6KB2,EIF4EBP1,EIF4B,RPS6KB1,RPS6,EIF4E,EIF4E2,EIF4E1B,PIK3C2B,PIK3C2A,IRS1,IRS4,IRS2
Leptin and adiponectin (WP3934);LEP,ADIPOQ,LEPR,ADIPOR2,ADIPOR1,PRKAA1,PRKAG1,PRKAB1,ACACA,CPT1A
Microglia Pathogen Phagocytosis Pathway (WP3937);HCK,C1QA,TYROBP,SYK,PIK3R1,SIGLEC7,TREM1,FCER1G,FCGR1A,ITGAM,TREM2,ITGB2,LYN,PTPN6,PLCG2,LAT,RAC1,RAC2,RAC3,VAV1,VAV2,VAV3,NCKAP1L,ARPC1B,NCF4,NCF2,NCF1,CYBB,CYBA,NCF1,NCF4,NCF2,RAC1,RAC2,RAC3,CYBB,CYBA,C1QB,C1QC,PIK3CG,PIK3CA,PIK3CD,PIK3CB,PIK3R2,PIK3C3,PIK3C2A,PIK3R6,PIK3R3
Oxidative Damage (WP3941);PCNA,C1QC,CDKN1C,C1QB,C5AR1,TNFRSF1B,C5,TRAF3,BCL2,CR2,BAD,APAF1,MAP3K9,MAPK13,CDC42,TRAF2,C4B,CDKN1A,C1S,C1R,TDP2,CYCS,TNK2,C3AR1,MAP2K4,BAG4,C2,CDKN1B,TRAF1,NFKBIE,NFKB1,TNF,GADD45A,MAP3K1,MAPK10,TRAF6,C1QA,CASP3,BAK1,CASP9
PPAR signaling pathway (WP3942);ACAA1,PPARD,PPARG,PCK2,CYP4A11,CYP8B1,UCP1,SLC27A1,HMGCS2,CYP4A11,RXRB,AQP7,SCD,ACOX1,CYP4A11,SCD,SCD,NR1H3,RXRA,ACSBG2,FABP1,CYP4A11,RXRG,RXRB,ACSL6,ANGPTL4,CYP27A1,ACSL3,FABP7,ACADM,CPT1B,CPT1C,RXRA,CYP4A11,FABP3,CYP4A11,FABP2,ACSL4,DBI,SLC27A2,SLC27A4,APOA2,CD36,SLC27A1,FABP1,ME1,ADIPOQ,APOC3,ACSL5,FABP4,PPARA,FADS2,RXRG,CYP7A1,PLTP,GK3P,PLIN1,SLC27A5,ACOX3,APOA5,ACOX2,PCK1,CPT2,ACSL1,FABP6,RXRB,MMP1,OLR1,SLC27A4,CYP4A11,CD36,MMP1,SLC27A6,CYP4A11,ACSBG1,SCP2,SCD,LPL,ILK,APOA1,GK2,FABP3,RXRG,CPT1A,RXRA,SORBS1,FABP4,FABP5,EHHADH,PDPK1,ACADL,ACAA1
Serotonin and anxiety-related events (WP3944);HTR2A,ARC,HTR2C,HTR1A,FOS,PLEK,PPP3CA,PRKCB,PLCD4,GRIN2D,NLGN1,CRHR1
Serotonin and anxiety (WP3947);PLCD4,PLEK,POMC,GRM1,TRPV1,PRKCB,CAMK2B,FMR1,CRH,PPP3CA,GABRA1,ARC,HTR2C,FOS,HTR1A,ADRA1A,ARC,HTR2A,GRM1,ARC
Mevalonate pathway (WP3963);ACAT2,PMVK,MVD,HMGCS1,MVK,FDPS,HMGCR
H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity (WP3969);H2AFY,CDK4,CTNNB1,CCND1,E2F1,CDK8,CDK8,MED1,CSRP2,JAG1,SOX4,CDH1,TULP3,PMAIP1,RB1,E2F1,RB1
PDGFR-beta pathway (WP3972);PIK3CA,PDGFRB,PLCG1,PRKCA,MAPK3,PIK3R1,JAK1,PRKCB,STAT6,JAK2,EIF2AK2,STAT3,STAT1,STAT5A,GRB2,HRAS,SOS1,SHC1,RASA1,MAP3K1,MAP2K1,STAT5B,MAPK8,MAP2K4,RAF1,ELK1,SRF,FOS,JUN
miRNA regulation of p53 pathway in prostate cancer (WP3982);ATM,CHEK2,MIR4482,TP53,MIR548C,MIR1305,MIR548B,MDM2,SIAH1,PTEN,DDB2,SESN3,SERPINE1,SHISA5,EI24,BAX,TNFRSF10B,MIR548C,PMAIP1,BBC3,MIR1305,CASP8,MIR27B,PERP,ZMAT3,SIAH1,MIR4491,MIR548C,MIR1305,BID,MIR548B,MIR27B,MIR320A,MIR182,MIR4482,MIR548C,MIR1305,MIR27B,MIR320A,MIR548C,MIR1305,TP53AIP1,CYS1,APAF1,MIR548C,CASP9,CASP3
Ethanol effects on histone modifications (WP3996);ELP3,AHCY,TYMS,DHFR,MTHFR,EHMT2,ATF2,HDAC2,KAT2B,MTR,MAT1A,HDAC1,HAT1,SLC19A1,ACSS2,ADH1B,CYP2E1,ADH1A,ALDH1A1,ALDH2,ADH1C,ALDH1A2,ALDH1A3,HDAC3,HDAC4,HDAC5,HDAC6,HDAC7,HDAC8,HDAC9,HDAC10
Prader-Willi and Angelman Syndrome (WP3998);SLC45A2,GABRD,HERC2,E2F1,SNORD116@,OCA2,MAGEL2,CYFIP1,GABRA5,GABRB3,PCSK1,TUBGCP5,NHLH2,GABRG3,SNORD115@,NIPA2,NIPA1,ATP10A,SNORD107,SNURF,PWRN1,SNRPN,NDN,UBE3A,MKRN3,NPAP1,SNORD64,SNORD109A,SNORD109B,SNRPN,PCSK1,MKRN3,UBE3A,E2F1,UBE3A,E2F1,GABRB3,GABRA5,OCA2,GABRG3,MSX1,DLX5,MAGEL2,NDN,PCM1,FEZ1,BBS4,NGF,FEZ1,PRKCZ,BBS4,HTR2C,SNORD115@,GABRR1,GABRR2,GABRR3
Pathways in clear cell renal cell carcinoma (WP4018);DEPTOR,ACACA,KCNJ2,EFCAB3,FASN,ENPP3,HK3,PDGFRA,FLT1,STAT3,EGFR,CAMK1,AKT1,MLST8,SQSTM1,MTOR,RPTOR,TSC1,EP300,GRB10,PTEN,SLC2A1,VEGFA,RHEB,VHL,HIF1A,ARNT,PBRM1,SETD2,BAP1,KDM5C,TSC2,ARNT,HIF1A,HIF1A,ARNT,HIF1A,PDGFB,TGFB1,TGFB2,TGFB3,CREBBP,EP300,CREBBP,AKT1S1,ACACB,ACLY,MDH1,ME1,HK1,HK2,GPI,PFKL,PFKP,PFKM,ALDOA,ALDOB,ALDOC,TPI1,GAPDH,PGK1,PGK2,PGM1,PGM2,ENO1,ENO2,ENO3,PHGDH,PSAT1,PSPH,SHMT1,SHMT2,SDS,SDSL,PKLR,LDHA,LDHB,LDHD,LDHC,PKM,HIF1A,PKM,PDGFRB,KDR,BHLHE41,CDH13,CEP290,KSR1,PGBD5,PLOD2,SSPN,RAPGEF5,ZEB1,TOX2
Pyrimidine metabolism (WP4022);CDA,DPYS,TYMS,TK2,CAD,CTPS1,DPYD,DHODH,CMPK1,PNPT1,TYMP,ENPP1,DTYMK,DUT,RRM2,DCTPP1,CAD,UMPS,DCTD,DTYMK,CAD,UPB1,RRM1,UPRT,UCK1,UCK2,NT5C,CDA,NT5C,NT5C,NT5C,TK1,TK2,TK1,CMPK2,CMPK1,CMPK2,CMPK1,CMPK2,DCK,ENPP3,RRM2B,RRM2,RRM1,RRM2B,ENPP1,ENPP3,ENPP1,ENPP3,ENTPD3,ENTPD1,ENTPD3,ENTPD1,NME1-NME2,NME1,NME2,NME3,NME4,NME6,NME7,NME1,UPP1,UPP1,CTPS2,UCKL1,UCK1,UCK2,UCKL1,NT5M,NT5M,NT5M,ZNRD1,POLR1A,PRIM2,POLA1,POLR2A,POLR2G,POLR2K,POLR3D,POLR3H,POLR1B,POLR1C,POLR1D,POLR1E,POLR2B,POLR2C,POLR2D,POLR2E,POLR2H,POLR2J1,POLR2J2,POLR2J3,POLR2L,POLR3A,POLR3B,POLR3C,POLR3E,POLR3F,POLR3G,POLR3GL,POLR3K,POLR2I,TWISTNB,POLD1,POLD3,POLE1,POLE3,PRIM1,POLA2,POLD2,POLD4,POLE2,POLE4,UMPS,NT5C,NT5M,TYMP,DPYD,UPB1,ENTPD3,ENTPD1,NT5M,ENTPD3,ENTPD1
SCFA and skeletal muscle substrate metabolism (WP4030);FFAR3,PPARD,SLC2A4,FFAR2,GCG,PYY,FFAR3,FFAR2
Macrophage markers (WP4146);CD14,CD83,CD68,F3,CD163,CD86,CD74,RAC2,LYZ
White fat cell differentiation (WP4149);CREB1,STAT5A,STAT5B,DDIT3,CEBPB,RARA,NR1H3,GATA3,GATA2,PPARG,CEBPA,CEBPD,FOXO1,KLF5,KLF15,EGR2,EBF1,WNT10B,RORA,SREBF1,KLF4,IRF3,NR2F2,CTNNA1,ZNF423,TCF7L1,MECOM,TLE3,INS,NR3C1,IRF4,KLF2
Hormonal control of Pubertal Growth Spurt (WP4194);GnRH,GRH,SRIF
The human immune response to tuberculosis (WP4197);IRF9,PSMB8,OAS1,MX1,IRF1,SOCS1,STAT1,PIAS1,STAT1,IFITM1,IRF9,PSMB8,IFNGR1,IRF9,PTPN2,TAP1,IFI35,IFIT1,IFITM1,IFI35,TYK2,JAK1,IFIT3,STAT1,STAT1,STAT1,STAT1,STAT2,STAT1,STAT2,JAK2,PTPN2,JAK1,JAK2,JAK1,STAT1,STAT2,PTPN2,IFNGR2,IFNGR1,IFNGR2,IFNAR1,IFNAR2
Hereditary leiomyomatosis and renal cell carcinoma pathway (WP4206);TP53,PDK1,PRKAB1,EGLN1,NFE2L2,PDHA1,LDHA,PRKAA1,PRKAG1,SLC11A2,RPS6,ACACA,ACACB,PRKAB1,PRKAA1,PRKAG1,PDHA2,PDHB,NFE2L2,KEAP1,KEAP1,CUL3,HIF1A,SLC2A1,VEGFA
Transcriptional cascade regulating adipogenesis (WP4211);GATA2,GATA3,CEBPA,CEBPG,KLF5,SREBF1,CEBPD,CEBPB,PPARG,KLF2,EGR2,DDIT3,KLF15
Chromosomal and microsatellite instability in colorectal cancer (WP4216);ARAF,TGFBR1,SMAD2,MAP2K1,RALA,TCF7,CDKN1A,KRAS,BIRC5,NTN1,CYCS,AKT1,CASP3,DCC,TGFB1,TP53,MLH1,CASP9,BAX,PMAIP1,TGFB2,TGFB3,TGFBR2,SMAD3,TGFBR2,MSH3,MSH6,BCL2,BAD,BBC3,BCL2L11,MSH2,TCF7L2,TCF7L1,LEF1,MYC,CCND1,GSK3B,AXIN1,AXIN2,RALGDS,RAF1,BRAF,AKT2,AKT3,RALB,RAC1,RAC2,RAC3,RHOA,MAPK8,MAPK9,MAPK10,MAPK1,MAPK3,JUN,FOS,MYC,BAD,APPL1,CASP9,CASP3,DDB2,POLK,BAK1,BAX,GADD45A,GADD45B,GADD45G,APC,APC2,CSNK1A1L,CSNK1A1,CTNNB1,EXOC2,TBK1,REL,CTNNB1,PTGS2,SMAD4
Ebola Virus Pathway on Host (WP4217);ITGA2,Filamin A,CLEC10A,ASGR1,ADAM17,ICAM2,ICAM3,RHOB,CD209,CLEC4M,HAVCR1,GAS6,TYRO3,ITGA3,ITGA4,ITGA5,ITGA1,ITGA6,ITGB1,ITGB3,BST2,RAB7A,RAB5A,NPC1,NPC2,CTSB,CTSL,AXL,MERTK,IKBKE,IRF7,KPNA1,CLEC4G,IQGAP1,TBK1,C1QBP,TLR4,TIMD4,TPCN2,TSG101,STAT1,NEDD4,SOCS3,PIK3R1,CDC42,IRF3,CLATHRIN,ITGAV,CLEC6A,MBL2,FOLR1,RHOC,RAC1,EGFR,AKT1,MFGE8,CD300A,PRKRA,DDX58,HAVCR2,IL4,DAB2IP,TFAP2A,RAB9A,EIF2AK2,EIF2S1,VPS33A,VPS18,VPS39,VPS41,VPS11,VPS16,NFKB1,VPS4A,EPS15,RASA2,RHOA,EP300,CREBBP,ACTB,PAK1,TIAM1,VAV2,IGF1R,CLTC,CLTA,CLTB,CLTCL1,CAV1,CAV2,CAV3,PIK3R1,PIK3CA,PIK3CB,PIK3CD,PIK3R3,PIK3R2,TOP1,FLNA,FLNB,FLNC,GSN,SCIN,MAPK1,NFKB1,NFKB2,REL,RELA,ACTN1,ACTN4,ACTB,ACTG1,HLA-A,HLA-B,HLA-C,HLA-DMA,HLA-DMB,HLA-DOA,HLA-DOB,HLA-DPA1,HLA-E,HLA-F,HLA-G,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB3,HLA-DRB4,HLA-DRB5,RELB,Filamin B,Filamin C
Epithelial to mesenchymal transition in colorectal cancer (WP4239);MAP2K1,FMNL2,TWIST1,PROX1,SMAD4,GSK3B,GDF15,PIK3CA,TMPRSS4,RAF1,FOXQ1,TGFBR1,JAG1,TUSC3,CTNNB1,RBPJ,EIF5A2,STRAP,MAPK3,FZD10,MIR9-2,NUBPL,WNT16,NOTCH1,AKT1,CDH1,HRAS,CLDN1,TP53,COL4A1,MEF2D,JUP,TGFB1,NRP2,TRAF6,NR2C2,MAP2K3,MAP2K6,MAP2K4,MAPK14,MAPK8,SHC1,GRB2,SOS1,SOS2,KRAS,MAP2K2,MAPK1,AKT2,AKT3,SNAI1,SNAI2,NOTCH2,NOTCH3,NOTCH4,HIF1A,JAG2,DLL1,DLL3,DLL4,DLK1,CDKL2,TWIST2,CDH2,ZEB2,FOXC2,FOXM1,FN1,SNAI1,SNAI1,SNAI1,CTDSP1,SNAI1,PKD1,PAK1,LATS2,TWIST1,TWIST2,TWIST1,TWIST2,ZEB2,ZEB2,SUZ12,RBBP4,EED,EZH2,ZEB1,TGFBR2,TGFB2,TGFB3,MAPK11,MAPK13,MAPK12,SNAI1,SMAD2,SMAD3,DSP,PKP1,PKP2,CRB3,MPP5,VTN,MMP15,MMP2,MMP9,ID1,ID2,CDH1,OCLN,DSP,CDH2,FN1,VTN,SPARC,ITGA5,CDH1,PKP1,PKP2,CRB3,TJP1,CDH2,VTN,OCLN,CLDN2,CLDN3,CLDN4,CLDN5,CLDN6,CLDN7,CLDN8,CLDN9,CLDN10,CLDN11,CLDN12,CLDN14,CLDN15,CLDN16,CLDN17,CLDN18,CLDN19,CLDN20,CLDN22,CLDN23,CLDN24,COL4A2,COL4A3,COL4A4,COL4A5,COL4A6,WNT1,WNT4,WNT2,WNT3,WNT5A,WNT6,WNT7A,WNT7B,WNT8A,WNT8B,WNT10B,WNT11,WNT2B,WNT9A,WNT9B,WNT10A,WNT5B,WNT3A,WNT3A,FZD2,FZD5,FZD3,FZD1,FZD4,FZD6,FZD7,FZD8,FZD9,LRP5,LRP6,PIK3CB,PIK3CD,PIK3R1,PIK3R2,PIK3R3
Hedgehog Signaling Pathway (WP4249);CSNK1G2,GRK2,FBXL17,GAS1,SUFU,CSNK1A1L,HHIP,ARRB1,PRKACA,GLI1,KIF3A,CSNK1A1,PTCH1,SMO,CSNK1G3,CSNK1D,CSNK1G1,CSNK1E,DHH,SHH,IHH,PTCH2,HHIP,PTCH1,PTCH2,SMURF1,SMURF2,LRP2,CDON,BOC,SMO,EVC2,PRKACB,PRKACG,GRK3,ARRB2,GLI2,GLI3,GLI1,GLI2,GLI3,KIF7,GPR161,GPR161,SUFU,SPOP,SPOPL,CUL3,SPOP,SPOPL,CUL3,GLI1,GLI2,GLI3,PTCH1,PTCH2,CCND1,CCND2,BCL2,SMO
Non-small cell lung cancer (WP4255);EGF,PIK3CA,EML4,PIK3R1,BAK1,TGFA,AKT1,HRAS,KRAS,CDKN1A,BAD,PDK1,RB1,CDKN2A,RASSF1,EGFR,JAK3,FHIT,PRKCA,STK4,RARB,CDK4,TP53,ERBB2,SOS1,SOS2,KRAS,NRAS,ARAF,BRAF,RAF1,MAP2K1,MAP2K2,MAPK1,MAPK3,PLCG1,PLCG2,PRKCB,PRKCG,PIK3CB,PIK3CD,AKT2,AKT3,CASP9,FOXO3,ALK,STAT3,STAT5A,STAT5B,PIK3CA,PIK3CB,PIK3CD,PIK3R2,PIK3R3,CCND1,RASSF5,RXRA,RXRB,RXRG,CDK6,CCND1,E2F1,E2F2,E2F3,BAX,DDB2,GADD45A,GADD45B,GADD45G,POLK
LncRNA involvement in canonical Wnt signaling and colorectal cancer (WP4258);APC2,DVL3,PLAU,RUVBL1,FRAT1,GSK3B,CSNK2B,APC,WNT3A,FZD3,LEF1,HNRNPK,CSNK1E,CCND1,FZD8,TCF7L1,WNT7A,CDK6,TCF7L2,WNT11,WNT1,JUN,LRP5,FZD10,FZD7,MIR34AHG,WNT5B,CTNNB1,WNT2,TCF3,CSNK1A1,WNT2B,FZD4,DVL2,WNT6,CCND3,EZH2,WNT5A,ROR1,FZD1,LRP6,KREM1,WNT16,FZD6,RYK,WNT4,WNT3,CSNK2A1,AXIN1,WNT10B,MAP3K7,FZD5,WNT7B,DVL1,CHD8,WNT10A,CDK8,CSNK1A1L,CSNK2A3,FOSL1,H2AFY2,MYC,CSNK2A2,CCND2,TFAP2A,FZD9,ATF3,TCF7,WNT16,FZD2,ROR2,CTNNB1,DKK1,DKK2,DKK4,SOST,SERPINF1,FRAT2,CTNNB1,SFRP1,SFRP2,SFRP4,SFRP5,NOTUM,CER1,WIF1,PORCN,NKD1,NKD2,CXXC4,SENP2,NLK,CTNNBIP1,SOX17,CTBP1,CTBP2,MIR16-2,MIR16-1,H19,NKD1,HNRNPU,H19,H19,AXIN2
Breast cancer pathway (WP4262);FGF7,FGF6,FGF19,ATM,ERBB2,FGF17,PARP1,TCF7,PTEN,MRE11,RPS6KB1,TP53,FGF5,BRCA1,SKP1,CDK4,HES1,RAD51,FGF23,FGF21,HEY1,FGF16,FGF1,GRB2,CETN3,FGF18,FGF20,FGFR1,IGF1R,IGF1,SHC1,SHC2,SHC3,SHC4,SOS1,SOS2,HRAS,KRAS,NRAS,ARAF,BRAF,RAF1,PIK3CA,PIK3CD,PIK3R1,PIK3R2,PIK3R3,AKT1,AKT2,AKT3,MTOR,RPS6KB2,EGF,EGFR,KIT,JAG2,NOTCH1,NOTCH2,NOTCH3,NOTCH4,DLL1,DLL3,DLL4,LRP5,LRP6,FRAT1,FRAT2,TCF7L2,TCF7L1,LEF1,MYC,CCND1,ERBB2,FLT4,HEY2,HEYL,HES5,CCND1,MYC,ERBB2,CDKN1A,NFKB2,BRCA2,CDKN1A,BAX,DDB2,POLK,BAK1,GADD45G,GADD45A,GADD45B,CDK6,RB1,E2F1,E2F2,E2F3,ESR1,ESR2,PGR,ESR1,ESR2,PGR,ESR1,ESR2,PGR,NCOA3,NCOA1,WNT1,WNT4,TNFSF11,NCOA3,NCOA1,ESR1,ESR2,MYC,CCND1,CCND1,NCOA3,NCOA1,ESR1,ESR2,FOS,JUN,SP1,FGF2,FGF3,FGF4,FGF8,FGF9,FGF10,FGF22,APC2,DVL3,GSK3B,CSNK2B,APC,CSNK1A1,DVL2,CSNK2A1,AXIN1,DVL1,CSNK1A1L,CSNK2A3,CSNK2A2,CTNNB1,AXIN2,CTNNB1,FZD3,FZD8,FZD10,FZD7,FZD4,FZD1,FZD6,FZD5,FZD9,FZD2,WNT3A,WNT7A,WNT11,WNT1,WNT5B,WNT2,WNT2B,WNT6,WNT5A,WNT16,WNT4,WNT3,WNT10B,WNT7B,WNT10A,WNT16,MAP2K1,MAPK1,MAPK3,MAP2K2,ATR,RAD50,NBN
Pancreatic adenocarcinoma pathway (WP4263);DUSP6,ARHGEF6,PRKCD,KRAS,TIAM1,RAC1,RAC2,RAC3,PAK4,BUB1B-PAK6,PAK1,PAK2,PAK3,PAK6,PAK5,RHOA,AKT1,AKT2,AKT3,CHUK,IKBKB,IKBKG,NFKB1,RELA,BAD,BCL2L1,CASP9,RAF1,MAP2K1,MAP2K2,MAPK1,MAPK3,RALGDS,RALA,RALB,PLD1,RALBP1,RAC1,RAC2,RAC3,CDC42,PIK3CA,PIK3CB,PIK3CD,PIK3R1,PIK3R2,PIK3R3,ARAF,BRAF,MAPK8,MAPK9,MAPK10,TGFA,EGF,EGFR,ERBB2,PIK3CA,PIK3CB,PIK3CD,PIK3R1,PIK3R2,PIK3R3,AKT1,AKT2,AKT3,MTOR,RPS6KB1,RPS6KB2,JAK1,STAT1,STAT3,VEGFA,TGFB1,TGFB2,TGFB3,TGFBR1,TGFBR2,SMAD2,SMAD3,SMAD4,BRCA2,RAD51,TP53,CDKN1A,BAX,DDB2,GADD45A,GADD45B,GADD45G,BAK1,POLK,CDKN2A,CDK4,CDK6,CCND1,RB1,E2F1,E2F2,E2F3,RIPK4,PEBP1
Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer (WP4284);TP53,CCNE2
MTHFR deficiency (WP4288);EHMT1,MTHFR,CASP3,DNMT3A,DNMT3B,CASP9,ASMT,EHMT2,COMT,DNMT1
Metabolic reprogramming in colon cancer (WP4290);GOT2,PPAT,PSAT1,GLUD1,G6PD,GLS,SLC1A5,PYCR1,HK3,GPI,TIGAR,PFKL,GAPDH,ALDOB,PGK1,PGAM1,LDHA,ENO1,PKM,SLC16A3,PDHA1,PDHB,ACO2,SUCLG2,DLST,IDH2,FH,MDH2,SDHB,IDH3A,ACLY,FASN,PSPH,SHMT2,PAICS,GART,TALDO1,RPIA,TKT,PGD,PYCR2,SLC2A1
Lamin A-processing pathway (WP4299);ZMPSTE24,LMNA,ZMPSTE24
Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells (WP4301);RAB27A,ARAF,MAPK1,PDCD6IP,HNRNPH1,BRAF,RAF1,RRAS,RRAS2,MRAS,HRAS,KRAS,NRAS,MAPK3,RAB5A,RAB5B,RAB5C,HGS,RRAS,RRAS2,MRAS,HRAS,KRAS,NRAS,PDCD6IP,RAB27A
Rett syndrome causing genes (WP4312);EIF2B2,MECP2,TAF1B,GABRA3,NCOR1,SMARCA2,MEF2C,HAP1,FOXG1,SCN2A,SATB2,TBL1X,GNAO1,SCN1A,SRRM3,HDAC5,GABBR2,SCN8A,KDM5B,CHD4,SMC1A,GRIN2B,TCF4,HDAC8,CDKL5,SYNGAP1,GABRD,SHANK3,SYNE2,HDAC1,CECR2,BRAF,GPS2,HTT,SMARCA1,ACTL6B,IMPDH2,STXBP1,TBL1XR1,EIF2B2,HIVEP2,SMARCA4,TCF4,NCOR2,KCNJ10,GRIN2A,XAB2,TRRAP,KCNQ2,RHOBTB2,CRK
Ferroptosis (WP4313);PCBP1,ACSL1,STEAP3,VDAC2,PRNP,TF,MAP1LC3B,GCLC,CYBB,SLC3A2,FTMT,MAP1LC3C,SLC39A8,ATG5,HMOX1,PCBP2,FTH1,TFRC,GPX4,SLC39A14,SLC40A1,SLC7A11,GCLM,GSS,SAT1,SAT2,TP53,LPCAT3,ACSL3,ACSL4,ACSL6,ACSL5,TF,TFRC,CP,PCBP2,FTL,NCOA4,FTH1,FTL,MAP1LC3A,ATG7,TF,TFRC,SLC11A2,SLC39A8,SLC39A14,VDAC3
Neovascularisation processes (WP4331);FLT4,KDR,EPHB4,MMP9,KIT,DLL4,JAG1,NOTCH3,CXCR4,EPHB4,SMAD1,SMAD2,ACVRL1,TGFBR1,EPHB2,MAPK3,MAPK1,Akt,MAPK8,SMAD5,SMAD9,SMAD3
ncRNAs involved in Wnt signaling in hepatocellular carcinoma (WP4336);DVL3,PLAU,FRAT1,GSK3B,CSNK2B,APC,WNT3A,FZD3,LEF1,CSNK1E,CCND1,FZD8,TCF7L1,WNT7A,TCF7L2,WNT11,SOX7,WNT1,JUN,LRP5,FZD10,FZD7,WNT5B,CTNNB1,WNT2,CSNK1A1,WNT2B,FZD4,DVL2,WNT6,CCND3,WNT5A,ROR1,FZD1,LRP6,KREM1,WNT16,FZD6,MIR452,RYK,WNT4,WNT3,CSNK2A1,AXIN1,WNT10B,FZD5,WNT7B,DVL1,CHD8,WNT10A,CSNK1A1L,CSNK2A3,FOSL1,MYC,CSNK2A2,CCND2,FZD9,TCF7,WNT16,FZD2,ELAVL1,EZH2,ROR2,CTNNB1,CTNNB1,DKK1,DKK2,DKK4,SOST,SERPINF1,FRAT2,CTNNB1,SFRP1,SFRP2,SFRP4,SFRP5,NOTUM,CER1,WIF1,PORCN,NKD1,NKD2,CXXC4,SENP2,NLK,CTNNBIP1,SOX17,CTBP1,CTBP2,MTDH,MIR18A,KLF4,MIR320A
Vitamins A and D (WP4342);VDR,RXRA,RARA,RXRA,RARA,RXRA
Ciliary landscape (WP4352);RPGR,DCAF11,DYNLL1,SPATA7,H3F3A,COPS4,IFT122,HDAC1,TFAP2B,TFAP2D,DCAF7,TFAP2C,HDAC2,BBIP1,SNAP29,COPS7B,GLA,DYNLL2,IFT52,MFAP1,VPS4A,NDUFA9,RHBDD2,MCM2,MCM3,CNOT10,LZTFL1,TFAP2E,MKS1,YAP1,RBM14,DVL3,CD2BP2,EIPR1,CNOT1,BBS9,APC,MCM9,CEP170,CBS,COPS2,UBE2D2,NUP88,CNOT6L,CTBP2,EXOC8,CTSA,CEP97,ARFGAP3,IFT43,TFAP2A,IFT27,RAB3IL1,MCM8,TMED1,SNRPB2,LCA5,POM121,MCM5,TNKS1BP1,NUP133,EFTUD2,MCM4,IFT46,ARHGDIA,WEE1,COPS8,RAB2A,UQCC1,CTNNB1,LSM4,NDUFA5,CCDC40,COPS6,MCM10,RAB14,MCM7,CREBBP,RAB21,ERF,USH1C,NINL,IFT74,CAMK2A,DNPEP,NFKB1,IFT81,IFT57,CDR2,MSH2,IFT20,COPS3,IFT140,EHBP1,CDH23,ARL8B,MCM6,CLUAP1,ACSL3,NUDC,DGKE,AIMP1,RABEP2,GDI1,SSNA1,ECHS1,TTC8,EXOSC9,COPS7A,WNK1,RB1,NME8,IFT88,IFT80,IFT172,IFT22,TTC30B,TTC30A,TTC26,HSPB11,CLUAP1,TRAF3IP1,EXOC6B,EXOC6,EXOC7,EXOC5,EXOC2,EXOC3,EXOC1,EXOC4,EXOC2,EXOC3,EXOC1,EXOC6B,EXOC6,EXOC7,EXOC5,EXOC4,RALB,BBS1,BBS2,BBS5,BBS4,BBS7,TCTEX1D2,PAFAH1B1,DYNLRB2,DYNLRB1,MAPRE2,WDR60,DYNLT1,WDR34,DYNLT3,TIPRL,TCTEX1D2,DYNLT3,DYNC1H1,DYNLT1,PAFAH1B1,DYNC1I2,DYNC1LI1,WHRN,VIM,ZYG11B,GLB1,NEFL,NEFM,XPNPEP3,GID4,ARMC8,RANBP9,RMND5B,RANBP10,MAEA,MKLN1,GID8,LCN2,WDR26,YPEL5,EFHC2,PGRMC2,UBE2H,RMND5A,HTRA2,DDX5,ZMYND19,RAB8A,ANKS6,ANKS3,NEK7,NEK8,MYL6,TBC1D4,CEP290,IQGAP2,CALM1,LRPPRC,IQCB1,IQGAP3,IQGAP1,COX6C,STOM,MYL6B,RAC1,EIF5B,EXOSC2,EXOSC4,EXOSC7,COPS4,PSMD13,EHD3,AAR2,DOCK5,FUZ,PSMD8,APMAP,SMC4,AGPAT2,PSMD7,AFG3L2,RNGTT,PSMC6,PSMD12,VAPB,INTU,PSMC4
Bile Acids synthesis and enterohepatic circulation (WP4389);MAPK1,FXR1,ABCG8,LDLR,CYP7A1,ABCB11,ABCG5,FXR1,MAPK3,FGF19
Nonalcoholic fatty liver disease (WP4396);NFKB1,RELA,PIK3CA,PIK3CD,PIK3CB,PIK3R1,PIK3R2,PIK3R3,AKT1,AKT2,AKT3,GSK3A,GSK3B,IL1A,IL1B,MLX,MLXIP,MLXIPL,ADIPOR1,ADIPOR2,PRKAA1,PRKAA2,PRKAB1,PRKAB2,PRKAG1,PRKAG3,PRKAG2,CDC42,RAC1,JNK2,CXCL8,TGFB1,CASP3,CASP7,NDUFV1,NDUFV2,NDUFV3,NDUFA1,NDUFA2,NDUFA3,NDUFA4,NDUFA4L2,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFA10,NDUFAB1,NDUFA11,NDUFA12,NDUFA13,NDUFB1,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFB10,NDUFB11,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFC1,NDUFC2,NDUFC2-KCTD14,SDHA,SDHB,SDHC,SDHD,UQCRFS1,CYTB,CYC1,UQCRC1,UQCRC2,UQCRH,UQCRHL,UQCRB,UQCRQ,UQCR10,UQCR11,COX3,COX1,COX2,COX4I2,COX4I1,COX5A,COX5B,COX6A1,COX6A2,COX6B1,COX6B2,COX6C,COX7A1,COX7A2,COX7A2L,COX7B,COX7B2,COX7C,COX8C,COX8A,TRAF2,SREBF1,IRS1,CYCS,TNF,FXR,EIF2AK3,BAK1,XBP1,ATF4,CEBPA,NR1H3,PKLR,INS,BAX,DDIT3,IL6R,FASLG,LEPR,LEP,MAP3K5,CASP8,EIF2S1,ERN1,INSR,BID,IKBKB,FAS,PPARA,RXRA,MAP3K11,BBC3,JNK1,TNFR1,IRS2,CYP2E1,JUN,ITCH,SOCS3,ADIPOQ,IL6,IL6,IL1A,TNF,TNF,FASLG,IL1B,BIM,CCL2,VCAM1,SMAD7
MicroRNA network associated with chronic lymphocytic leukemia (WP4399);ZAP70,BCL2,TP53,MIR15A,MIR16-1,MCL1
Platelet-mediated interactions with vascular and circulating cells (WP4462);SELE,IL1B,CD40,VCAM1,ICAM1,PF4,CCL5,TGFB1,CD40LG,IL1B,CCL2,TGFB2,TGFB3
Supression of HMGB1 mediated inflammation by THBD (WP4479);IkKA,IkKB,IkKG,IkBA,RELA,THBD,HMGB1,RAGE,NFkB,HMGB1,THBD,HMGB1,IkBA,RELA,NFkB
Resistin as a regulator of inflammation (WP4481);ERK1,ERK2,PI3KA,PI3KB,PI3KD,PI3KG,AKT1,AKT2,AKT3,NFkB,IkBA,PLCB1,PLCB2,PLCB3,PLCB4,PLCG1,PLCG2,PLCD1,PLCD4,PLCD3,PLCE1,IL6,IL8,TNF,IL12B,IL12A,IkKA,IkKB,IkKG,RELA,ITP3R,p38,RETN,NFkB,IkBA,RELA,NFkB,RELA
Control of immune tolerance by vasoactive intestinal peptide (WP4484);CD95,IL12A,IL12B,IFNG,IL2,IL4,IL5,IL10,CTLA4,TGFB,VIP,CD80,CD86,CD28,IL10,CD86
Selective expression of chemokine receptors during T-cell polarization (WP4494);CCL3,CCR7,CXCR4,IL12A,IL12B,IL4,IL5,TGFB1,TGFB2,TGFB3,CD4,IL2,CSF2,IFNG,CCL4,CD28,CD40LG,IL12RB1,IL12RB2,IL18R1,IL12RB1,IL12RB2,IL4R,CD28,CD40LG,IFNGR1,IFNGR2,IL4,IL2,CCR3,CCR4,CXCR3,CCR2,CCR1,CCR5,CCR3,CCR4,CCR2,IL12B,IL12A,IL12B,IL12A,IL12B,IL12A,IFNG
Signal transduction through IL1R (WP4496);IFNA1,IL6,IRAK2,IRAK3,NFKB1,NFKBIA,RELA,TGFB1,TGFB2,TGFB3,TNF,TOLLIP,MAP2K3,TRAF6,MAP3K1,IKBKB,IRAK1,MAPK8,IFNB1,MAP3K7,MAP3K14,MYD88,IL1RN,JUN,MAPK14,CHUK,ECSIT,MAP2K6,TAB1,IL1RAP,IL1R1,IL1A,IL1B,IL1RAP,IL1R1,IL1A,IL1B,MAP3K1,NFKB1,NFKBIA,RELA,JUN,IKBKB
The alternative pathway of fetal androgen synthesis (WP4524);CYP11A1,STAR,SRD5A2,HSD17B3,HSD3B2,AKR1C2,AKR1C4,CYP17A1,HSD3B2,HSD17B3
Transcription co-factors SKI and SKIL protein partners (WP4533);TEAD1,TEAD2,TEAD3,TEAD4,LATS1,LATS2,SKIL,MECP2,SATB2,MERTK,NF1,ING2,SKI,HDAC1,PRMT5,HDAC3,STK3,SIN3A
Envelope proteins and their potential roles in EDMD physiopathology (WP4535);ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,SYNE1,TGFB1,TGFB2,TAZ,YY1AP1,TMPO,SYNE4,PLEC,MAP2K2,Smad3,Cofilin-1,SYNE3,HRAS,SOS2,Grb2,SUN,NRAS,MAP2K1,Smad2,MAPK1,EMD,CTGF,BANF1,MAPK3,SYNE2,Smad4,TMEM43,ADCY10,MAP3K9,LEMD3,SRF,KIF5B,KRAS,SOS1,LBR,RhoA,TGFB3,MAP3K9,ADCY9,ADCY1,ADCY10,ADCY4,ADCY7,ADCY3,ADCY2,ADCY8,ADCY5,ADCY6,MAP3K9,MAPK1,MAPK3,Smad2,Smad3,Smad4,Smad3,YY1AP1,TAZ,BANF1,SUN,SUN,BANF1,Smad2
Genes related to primary cilium development (based on CRISPR) (WP4536);RABL2A,BBS2,IFT88,EVC,IFT52,TXNDC15,CLUAP1,TMEM67,IFT74,IFT27,DYNC2LI1,IFT20,CDK20,IFT80,IFT172,FAM92A,BBS10,MKS1,CEP83,TMEM216,CEP192,IFT81,TTC30B,IFT46,TCTN3,WDR60,DYNLL1,TRAF3IP1,RPGRIP1L,CBY1,TTC26,CEP76,TCTEX1D2,IFT57,B9D1,HSPB11,KATNB1,TMEM107,WDR34,TEDC2,TMEM17,TEDC1,DYNC2H1,DYNLT1,ARL3,ARL13B,BBS4,BBS5,BBS9,BBS7,BBS1,TTC8,MKKS,LZTFL1,BBS12,KIFAP3,ICK,RAB23,CEP104,ARMC9,INPP5E,TRAPPC11,BGD2,TMEM231,TCTN2,CC2D2A,TCTN1,SCLT1,FBF1,EVC2,EFCAB7,IQCE,WDR19,WDR35,IFT122,IFT140,TULP3,IFT43,FUZ,FOPNL,CEP19,OFD1,C5orf42,C2CD3,PIBF1,RSG1,TTBK2,TUBD1,CEP44,CEP120,FGFR1OP,WDPCP,KIAA0753,TUBE1,CEP295,CEP162,MIB1,CEP97,SASS6
Synaptic signaling pathways associated with autism spectrum disorder (WP4539);AKT2,PRKAA1,PRKAA2,PRKAB1,PRKAB2,PRKAG1,PRKAG2,PRKAG3,GRM1,GRIN1,GRIN2A,GRIN2B,GRIN2D,PIK3CA,PIK3CB,PIK3CD,PIK3R3,DLG4,HRAS,SYNGAP1,MTOR,GSK3B,MAPK3,HOMER1,KRAS,NTRK2,RPS6KB1,EIF4EBP1,GRIN3B,NF1,UBE3A,BDNF,PTEN,AKT1,TSC1,NRAS,GRIN3A,RHEB,ARC,CACNA1C,CAMK2B,MAPK1,GRIN2C,TSC2,AKT3,RPTOR,SHANK3,PIK3R2,PIK3R1,RHEB,CAMK4
Pathways Regulating Hippo Signaling (WP4540);PRKAA1,PRKAA2,PRKAB1,PRKAB2,PRKAG1,PRKAG2,PRKAG3,CDH1,CDH10,CDH11,CDH12,CDH13,CDH15,CDH16,CDH17,CDH18,CDH19,CDH2,CDH20,CDH22,CDH24,CDH3,CDH4,CDH5,CDH6,CDH7,CDH8,CDH9,GNA11,GNAI2,GNAI3,GNAL,GNAQ,GNAS,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCA,PRKCB,PRKCD,PRKCE,PRKCG,PRKCH,PRKCI,PRKCQ,PRKCZ,PRKD3,PLCB1,PLCB2,PLCB3,PLCB4,SMAD3,CDC42,SMAD2,MTOR,LATS2,STK3,LATS1,YY1AP1,NF2,TAZ,MST1,TEAD1,YY1AP1,TAZ,TEAD2,TEAD3,TEAD4,FGFR2,KDR,INSR,FGFR3,IGF1R,KIT,FGFR1,EPHA2,EGFR,CSF1R,FGFR4,FLT1,FLT4,NGFR,MET,PDGFRA,PDGFRB,TEK,FLT3,NTRK1,NTRK2,RHOA,RAC1,LEF1,TCF7L1,TCF7L2,TCF7,CTNNB1
Hippo-Merlin Signaling Dysregulation (WP4541);CDH1,CDH10,CDH11,CDH12,CDH13,CDH15,CDH16,CDH17,CDH18,CDH19,CDH2,CDH20,CDH22,CDH24,CDH3,CDH4,CDH5,CDH6,CDH7,CDH8,CDH9,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR2A,PRKAR2B,PRKAR1B,LATS2,STK3,LATS1,NF2,MST1,TEAD1,YY1AP1,TAZ,TEAD2,TEAD3,TEAD4,FGFR2,KDR,INSR,FGFR3,IGF1R,KIT,FGFR1,EPHA2,EGFR,CSF1R,FGFR4,FLT1,FLT4,NGFR,MET,PDGFRA,PDGFRB,TEK,FLT3,NTRK1,NTRK2,CXCL10,CD44,PAK5,SAV1,PAK3,PAK6,PPP1R14A,CTNNB1,CCND1,MYC,PTK2,PLCB4,AMOT,LIN28B,PAK4,CTGF,VGLL4,NRAS,HRAS,PPP1R12A,FOXM1,PAK1,AJUBA,PAK2,KRAS,CTNNA1,YY1AP1,TAZ,LATS2,LATS1,NF2,MIR98,PPP1CA,PPP1CB,PPP1CC,DCAF1,CUL4A,DDB1,RBX1
Interactions between immune cells and microRNAs in tumor microenvironment (WP4559);TLR4,TRA,TGFBR2,SOCS1,IL2RA,CTLA4,CD80,CD86,MIR138-1,MIR138-2,PDCD1,MIR212,MIR203A,MIR203B,MIR34A,MIR138-1,MIR138-2,CD274,MIR200B,MIR200C,MIR21,PIAS3,STAT3,CCL5,CXCL10,CCL2,TGFB1,TGFB2,TGFB3,IL2RB,IL2RG,TRB,CCL5,CXCL10,MIR24-1,MIR24-2,MIR214,CCL2,MIRLET7D,MIR210,MIR23A,MIR21,MIR29A,IRAK4,TRAF6,MIR21,STAT3,MIR24-2,MIR23A,MIR27A,STAT6,MIR146A,TLR7,TLR8,NFKB1,NFKB2,IL4,IL4R
MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement (WP4560);ITPR1,TJP1,ITGAV,MYL2,PTK2,MAPK1,JUN,MYLK,MFAP5,VCL,ITGB3,PTK2,LPP,ACTN1,CREB1,CREB1,CREB1,LPP,MAPK3,MAPK1,MAPK3,PXN,LPP,ACTN1,PLCG1,PLCG1,PRKCQ,PRKCQ,ITGAV,ITGB3,TJP1,LPP,ACTN1
Canonical NF-KB pathway (WP4562);RELA,NFKBIA,REL,NFKB1,NFKBIE,CHUK,IKBKB,IKBKG,RELA,REL,NFKB1,NFKBIA,NFKBIE,RELA,NFKBIA,REL,NFKB1,NFKBIE
Neural Crest Cell Migration in Cancer (WP4565);AKT2,AKT3,CDH11,NGEF,FOS,EPHB1,MMP9,MMP2,PIK3CA,PIK3CB,PIK3CD,PIK3R3,PIK3R4,PIK3R5,PIK3R6,TIAM1,TRIO,NTRK2,MMP8,TWIST1,PIK3CG,ARF1,RAC1,AKT1,KIDINS220,BDNF,F2RL2,JUN,RHOA,STAT3,CDH11,AKT3,AKT1,AKT2,NGFR,NGFR,EPHB2,EPHB3,EPHB4,EPHB6,BDNF,STAT3,MMP2,TWIST1,MMP9,RAC1,PAK2,PAK3,PAK4,PAK5,PAK6,RAC1,PAK1,NGFR,proBDNF,NTRK2,NTRK2,SORT1,NGFR-ICD
Translation inhibitors in chronically activated PDGFRA cells (WP4566);PRKCD,MAPK14,MAP2K4,RPS6KA1,RPS6,RPS6KA4,RPS6KB1,PIM1,PDK1,RPS6KB2,AKT1,PDCD4,MTOR,RPTOR,MAP2K1,MAPK1,MAPK3,MAP2K2,PIK3CA,PIK3CB,PIK3R1,PIK3R2,PIK3R3,PIK3CG,MAP2K5,MAP2K6,MAP2K7,MAPK9,MAPK10,MAPK8,MAP2K3,MAP2K6,PRKCA,RPS6KA5,CSNK2A1,PRKACA,RPS6KA2,AKT2,AKT3,RPS6,EIF4EBP1,EIF4E,EIF4EBP1,PDCD4,EIF4A1,EIF4A2,EIF4G3,EIF4G1,EIF4A1,EIF4A2,EIF4E,PIM2,EIF4B,EIF4B,EIF4G3,EIF4G1,EIF4A1,EIF4A2,EIF4E,EIF4B
